# EDGAR Filing Document

**Accession Number:** 0001966494
**File Stem:** 0001193125-25-163464
**Filing Date:** 2025-7
**Character Count:** 330513
**Document Hash:** 7352635f270aaccfb7a6c81b33099562
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-163464.hdr.sgml**: 20250723

**ACCESSION NUMBER**: 0001193125-25-163464

**CONFORMED SUBMISSION TYPE**: SC 14D9

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20250723

**DATE AS OF CHANGE**: 20250723

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CARGO Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001966494
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 844080422
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 14D9
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94225
- **FILM NUMBER:** 251143676

**BUSINESS ADDRESS:**
- **STREET 1:** 835 INDUSTRIAL ROAD, SUITE 400
- **CITY:** SAN CARLOS
- **STATE:** CA
- **ZIP:** 94070
- **BUSINESS PHONE:** 650-499-8950

**MAIL ADDRESS:**
- **STREET 1:** 835 INDUSTRIAL ROAD, SUITE 400
- **CITY:** SAN CARLOS
- **STATE:** CA
- **ZIP:** 94070
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CARGO Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001966494
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 844080422
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 14D9

**BUSINESS ADDRESS:**
- **STREET 1:** 835 INDUSTRIAL ROAD, SUITE 400
- **CITY:** SAN CARLOS
- **STATE:** CA
- **ZIP:** 94070
- **BUSINESS PHONE:** 650-499-8950

**MAIL ADDRESS:**
- **STREET 1:** 835 INDUSTRIAL ROAD, SUITE 400
- **CITY:** SAN CARLOS
- **STATE:** CA
- **ZIP:** 94070

##### [**Table of Contents**](#toc)
**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE 14D-9** 

**Solicitation/Recommendation Statement** 

**Under Section 14(d)(4) of the Securities Exchange Act of 1934** 

## CARGO Therapeutics, Inc.
**(Name of Subject Company)** 

**(Name of Persons Filing Statement)** 

**Common Stock, $0.001 par value per share** 

**(Title of Class of Securities)** 

**14179K101** 

**(CUSIP Number of Class of Securities)** 

**Anup Radhakrishnan** 

**Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer** 

**CARGO Therapeutics, Inc.** 

**835 Industrial Road, Suite 400** 

**San Carlos, CA 94070** 

**(650) 499-8950** 

**(Name, address, and telephone number of person authorized to receive notices and communications** 

**on behalf of the persons filing statement)** 

***With a copy to:***

**Tessa Bernhardt** 

**Benjamin A. Potter** 

**Joshua M. Dubofsky** 

**Latham & Watkins LLP** 

**140 Scott Drive** 

**Menlo Park, CA 94025** 

**(650) 328-4600** 

☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

------

##### [**Table of Contents**](#toc)
**CONTENTS** 

---

| | |
|:---|:---|
|  [ITEM 1. SUBJECT COMPANY INFORMATION](#toc78481_1) | 1 |
|  [ITEM 2. IDENTITY AND BACKGROUND OF FILING PERSON](#toc78481_2) | 1 |
|  [ITEM 3. PAST CONTACTS, TRANSACTIONS, NEGOTIATIONS AND AGREEMENTS](#toc78481_3) | 4 |
|  [ITEM 4. THE SOLICITATION OR RECOMMENDATION](#toc78481_4) | 11 |
|  [ITEM 5. PERSONS/ASSETS RETAINED, EMPLOYED, COMPENSATED OR USED](#toc78481_5) | 34 |
|  [ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY](#toc78481_6) | 34 |
|  [ITEM 9. EXHIBITS](#toc78481_7) | 42 |

---

------

##### [**Table of Contents**](#toc)
**ITEM 1. SUBJECT COMPANY INFORMATION** 

**Name and Address** 

The name to which this Solicitation/Recommendation Statement on Schedule 14D-9 (together with any exhibits and annexes attached hereto, as it may be amended or supplemented, this "Schedule 14D-9") relates is CARGO Therapeutics, Inc., a Delaware corporation ("CARGO" or the "Company"). The address of the Company's principal executive office is 835 Industrial Road, Suite 400, San Carlos, California 94070. The telephone number of the Company is (650) 499-8950.

**Securities** 

The title of the class of equity securities to which this Schedule 14D-9 relates is CARGO's common stock, par value $0.001 per share ("CARGO Common Stock," and shares of CARGO Common Stock, the "Shares"). As of July 2, 2025, there were (i) 46,516,983 Shares issued and outstanding, of which 922,095 Shares constitute Company restricted stock, (ii) 3,574,041 Shares subject to issuance pursuant to options to purchase CARGO Common Stock (each, a "CARGO Option") pursuant to CARGO's 2021 Stock Option and Grant Plan, as amended, and CARGO's 2023 Incentive Award Plan (together, the "CARGO Equity Plans"), with a weighted average exercise price of approximately $13.01 per share, of which 218,676 were In-the-Money Options (as defined below) with a weighted average exercise price of approximately $3.70 per share, (iii) 260,571 Shares underlying restricted stock units ("CARGO RSUs"), (iv) 8,581,285, Shares reserved for issuance pursuant to the CARGO Equity Plans and the Company's 2023 Employee Stock Purchase Plan ("CARGO ESPP"), 6,933,123 of which were available for future issuance, (v) 798,780 Shares reserved for issuance subject pursuant to the CARGO ESPP, all of which were available for future issuance, (vi) 1,842,499 Shares underlying pre-funded warrants (each, a "CARGO Pre-Funded Warrant") with an exercise price of $0.001 per share, and (vii) no shares of Company preferred stock were issued or outstanding.

**ITEM 2. IDENTITY AND BACKGROUND OF FILING PERSON** 

**Name and Address** 

The name, address for stockholder communications and business telephone number of CARGO, which is both the person filing this Schedule 14D-9 and the subject company, are set forth above in Item 1 under the heading "*Name and Address,*" which information is incorporated herein by reference. Information relating to the Offer (as defined below) is available online under the "SEC Filings" subsection of the "Financial Information" section of CARGO's website at *https://investors.cargo-tx.com/*. The information on the Company's website is not considered a part of this Schedule 14D-9, nor is such information incorporated herein by reference.

**Tender Offer** 

This Schedule 14D-9 relates to a tender offer by Concentra Biosciences, LLC, a Delaware limited liability company ("Parent") to purchase all of the issued and outstanding Shares, for (i) $4.379 per Share in cash (the "Cash Amount") plus (ii) one non-transferable contractual contingent value right per Share (a "CVR," and each CVR together with the Cash Amount, the "Offer Price"), all upon the terms and subject to the conditions as set forth in the Offer to Purchase, dated July 21, 2025 (as amended or supplemented from time to time, the "Offer to Purchase"), and in the related Letter of Transmittal (as amended or supplemented from time to time, the "Letter of Transmittal," which, together with the Offer to Purchase, as each may be amended or supplemented from time to time, constitute the "Offer").

The Offer is described in a Tender Offer Statement on Schedule TO (as amended or supplemented from time to time, the "Schedule TO") filed by Parent, Concentra Merger Sub VII, Inc., a Delaware corporation ("Merger Sub") and a wholly owned subsidiary of Parent, Tang Capital Partners, LP ("TCP") and Tang Capital Management, LLC ("TCM") with the Securities and Exchange Commission (the "SEC") on July 21, 2025. The Offer to Purchase and the Letter of Transmittal are filed as Exhibits (a)(1)(A) and (a)(1)(B), respectively, hereto and are incorporated by reference herein.

------

##### [**Table of Contents**](#toc)
The Offer is being made pursuant to an Agreement and Plan of Merger, dated as of July 7, 2025 (together with any amendments or supplements thereto, the "Merger Agreement"), by and among CARGO, Parent and Merger Sub, pursuant to which, among other matters, after the completion of the Offer, the satisfaction or waiver of certain conditions set forth in the Merger Agreement and in accordance with the General Corporation Law of the State of Delaware, as amended (the "DGCL"), Merger Sub will merge with and into CARGO (the "Merger," and together with the Offer and the other transactions contemplated by the Merger Agreement, including the CVR Agreement (as defined below), Limited Guaranty (as defined below) and Support Agreements (as defined below), collectively, the "Transactions"), with CARGO continuing as the surviving corporation in the Merger (the "Surviving Corporation") and as a wholly owned subsidiary of Parent, without a meeting or vote of the stockholders of CARGO in accordance with Section 251(h) of the DGCL. Accordingly, if Parent consummates the Offer, the Merger Agreement contemplates that the parties will effect the closing of the Merger, and the transactions contemplated thereby (the "Merger Closing"), without a vote of the stockholders of CARGO in accordance with Section 251(h) of the DGCL.

At the effective time of the Merger (the "Effective Time"), by virtue of the Merger and without any action on the part of the holders of the Shares, the Shares not tendered pursuant to the Offer (other than (i) Shares held in the treasury of CARGO immediately prior to the Effective Time, which will be cancelled without any conversion thereof and no consideration will be delivered in exchange therefor (ii) any Shares held by stockholders or owned by beneficial owners who are entitled to demand, and have properly demanded, appraisal of such Shares in accordance with the DGCL and have neither failed to perfect nor effectively withdrawn or lost such rights prior to the Effective Time and (iii) Shares that were owned by Parent, Merger Sub or any other subsidiary of Parent at the commencement of the Offer and is owned by Parent, Merger Sub or any other subsidiary of Parent immediately prior to the Effective Time) will each be cancelled and converted into the right to receive the Offer Price without interest (the "Merger Consideration"), in each case, subject to any applicable tax withholding.

Pursuant to the terms of the Merger Agreement, as of immediately prior to the Effective Time, each CARGO Option that is then outstanding but not then vested or exercisable will become immediately vested and exercisable in full. After giving effect to such accelerated vesting, at the Effective Time, each CARGO Option that is then outstanding with a per share exercise price that is less than the Cash Amount (an "In-the-Money Option") will be cancelled in exchange for the right to receive: (A) an amount in cash without interest, subject to any applicable tax withholding, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the per share exercise price of the CARGO Common Stock underlying such CARGO Option by (y) the number of Shares underlying such CARGO Option (the "CARGO Stock Option Cash Consideration"); and (B) one CVR for each Share underlying such In-the-Money Option. Each CARGO Option that has a per share exercise price that is equal to or greater than the Cash Amount (each, an "Out-of-the-Money Option") will be cancelled for no consideration.

Pursuant to the terms of the Merger Agreement, as of immediately prior to the time at which Parent first irrevocably accepts for purchase the shares of the CARGO Common Stock tendered in the Offer (the "Offer Closing Time"), each CARGO RSU that is then outstanding immediately prior to the Effective Time will vest in full and automatically be cancelled and the holder will be entitled to receive: (A) an amount in cash without interest, subject to any applicable tax withholding, equal to the Cash Amount (the "CARGO Restricted Stock Unit Cash Consideration"); and (B) one CVR.

Pursuant to the terms of the Merger Agreement, prior to the Effective Time, each CARGO Pre-Funded Warrant that is then outstanding will be cancelled in exchange for the right to receive: (A) an amount in cash without interest, subject to any applicable tax withholding, equal to the product of (x) the excess of the Cash Amount over the exercise price per Share underlying such CARGO Pre-Funded Warrant and (y) the number of Shares underlying such CARGO Pre-Funded Warrant (the "CARGO Pre-Funded Warrant Cash Consideration"); and (B) one CVR for each Share underlying such CARGO Pre-Funded Warrant.

------

##### [**Table of Contents**](#toc)
Prior to the Effective Time, CARGO will provide that, on and following the Effective Time, no holder of a CARGO Option, CARGO RSU or CARGO Pre-Funded Warrant will have rights to acquire, or any other rights in respect of, the capital stock of the Company, the Surviving Corporation or any of their subsidiaries and each CARGO Equity Plan is terminated as of the Effective Time. In addition, as of prior to the Effective Time, CARGO will take all actions necessary required to (i) terminate the CARGO ESPP as of immediately prior to the date of the Merger Closing (the "Merger Closing Date") and (ii) provide that no new offering period will commence after the signing of the Merger Agreement. A copy of the Merger Agreement is filed as Exhibit (e)(1) hereto and is incorporated herein by reference.

The obligation of Parent to purchase Shares validly tendered pursuant to the Offer and not properly withdrawn prior to the expiration of the Offer is subject to the satisfaction or waiver of a number of conditions set forth in the Merger Agreement, including, but not limited to: (i) that the number of Shares validly tendered and not properly withdrawn (excluding shares tendered pursuant to guaranteed delivery procedures that have not yet been "received" by the "depository," as such terms are defined by Section 251(h) of the DGCL), when considered together with all other Shares (if any) owned by Parent and its "affiliates" (as defined in Section 251(h)(6)(a) of the DGCL, including Merger Sub) equals at least one Share more than 50% of the number of Shares that are then issued and outstanding as of the expiration of the Offer; (ii) the Closing Net Cash (as defined in the Merger Agreement) is at least $217.5 million as of the then-scheduled expiration of the Offer; (iii) the absence of any legal restraint in effect preventing or prohibiting the consummation of the Offer or any of the other transactions contemplated by the Merger Agreement or CVR Agreement; (iv) compliance in all material respects by CARGO with its obligations under the Merger Agreement; (v) the accuracy of representations and warranties made by CARGO in the Merger Agreement, subject to certain materiality thresholds; (vi) no termination of the Merger Agreement; and (vii) other customary conditions set forth in Exhibit A to the Merger Agreement and further summarized in Section 9 of the Offer to Purchase (each individually, an "Offer Condition," and collectively, the "Offer Conditions"). The obligations of Parent and Merger Sub to consummate the Offer and the Merger under the Merger Agreement are not subject to any financing condition.

The Offer will initially expire at the time that is one minute following 11:59 p.m., Eastern Time, on August 18, 2025, unless otherwise agreed to in writing by Parent and CARGO. The expiration time may also be extended under the following circumstances: (i) Parent may elect to (and if so requested by CARGO, Parent shall), extend the Offer for one or more consecutive increments of such duration as requested by CARGO (or if not so requested by CARGO, as determined by Parent), but not more than 10 business days each, if (A) as of the then-scheduled expiration time, any Offer Condition is not satisfied and has not been waived, to permit such Offer Condition to be satisfied or waived or (B) if, as of the then-scheduled expiration time, there is a dispute regarding the determination of the Closing Net Cash, to permit the resolution of the determination of the Closing Net Cash pursuant to the Merger Agreement, or (ii) to comply with any period required by the SEC or The Nasdaq Global Select Market applicable to the Offer. In no event will Parent be required or permitted to extend the Offer beyond 11:59 p.m., Eastern Time, on November 4, 2025, or on more than two occasions, which is the outside date of the Merger Agreement, without the prior written consent of CARGO.

Parent has formed Merger Sub for the purpose of consummating the Offer and effecting the Merger. As set forth in the Schedule TO, the address of Parent and Merger Sub is 4747 Executive Drive, Suite 210, San Diego, California 92121. The telephone number of each of Parent and Merger Sub is (858) 281-5372.

CARGO has made information relating to the Offer available online under the "Financial Information—SEC Filings" subsection of the "Investors" section of CARGO's website at *https://investors.cargo-tx.com/* and CAGRO has filed this Schedule 14D-9, and Parent and Merger Sub have filed the Schedule TO, with the SEC, and these documents are available free of charge at the website maintained by the SEC at *www.sec.gov*.

------

##### [**Table of Contents**](#toc)
**ITEM 3. PAST CONTACTS, TRANSACTIONS, NEGOTIATIONS AND AGREEMENTS** 

Except as set forth or incorporated by reference in this Schedule 14D-9, to the knowledge of CARGO, as of the date hereof, there are no material agreements, arrangements or understandings, or any actual or potential conflicts of interest between CARGO or its affiliates, on the one hand, and (i) CARGO's executive officer, directors or affiliates, or (ii) Parent, Merger Sub or their respective executive officers, directors or affiliates, on the other hand. The Board of Directors of CARGO (the "CARGO Board") was aware of the agreements and arrangements described in this Item 3 during its deliberations of the merits of the Merger Agreement and in determining to make the recommendation set forth in this Schedule 14D-9.

**Arrangements with Parent, Merger Sub and Their Affiliates** 

***Merger Agreement***

On July 7, 2025, CARGO, Parent and Merger Sub entered into the Merger Agreement. The summary of the material provisions of the Merger Agreement contained in Section 7 of the Offer to Purchase and the description of the conditions of the Offer contained in Section 9 of the Offer to Purchase are incorporated herein by reference. Such summary and description are qualified in their entirety by reference to the full text of the Merger Agreement.

The Merger Agreement governs the contractual rights among CARGO, Parent and Merger Sub in relation to the Offer and the Merger. The Merger Agreement has been included as an exhibit to this Schedule 14D-9 to provide CARGO stockholders with information regarding the terms of the Merger Agreement. The Merger Agreement contains representations and warranties made by CARGO to Parent and Merger Sub and representations and warranties made by Parent and Merger Sub to CARGO. Neither the inclusion of the Merger Agreement nor the summary of the Merger Agreement is intended to modify or supplement any factual disclosures about CARGO, Parent or Merger Sub in CARGO's public reports filed with the SEC. In particular, the assertions embodied in the representations and warranties set forth in the Merger Agreement are qualified by information in a confidential disclosure schedule provided by CARGO to Parent and Merger Sub in connection with the signing of the Merger Agreement. This disclosure schedule contains information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the Merger Agreement. In addition, the representations and warranties in the Merger Agreement were negotiated with the principal purpose of allocating risk among CARGO, Parent and Merger Sub, rather than establishing matters of fact. Additionally, such representations and warranties were made as of a specified date and may also be subject to a contractual standard of materiality that is different from what may be viewed as material by holders of Shares or from the standard of materiality generally applicable to reports or documents filed with the SEC. Accordingly, the representations and warranties in the Merger Agreement may not constitute the actual state of facts about CARGO, Parent or Merger Sub. CARGO's stockholders and investors are not third-party beneficiaries of the Merger Agreement (except with respect to (i) the right of Indemnified Parties (as defined in the Merger Agreement) to indemnification and other rights set forth in the Merger Agreement, as described below in this Item 3 under the heading "*Indemnification; Directors' and Officers' Insurance*," and (ii) from and after the time at which Parent irrevocably accepts for purchase all Shares validly tendered (and not validly withdrawn) pursuant to the Offer and the Effective Time (as applicable), the rights of holders of Shares, In-the-Money Options, CARGO RSUs and CARGO Pre-Funded Warrants to receive the Merger Consideration), and should not rely on the representations, warranties or covenants or any descriptions thereof as characterizations of the actual state of facts or conditions of CARGO, Parent, Merger Sub or any of their respective subsidiaries or affiliates. Information concerning the subject matter of such representations, warranties and covenants, which do not purport to be accurate as of the date of this Schedule 14D-9, may have changed since the date of the Merger Agreement, which subsequent information may or may not be fully reflected in CARGO's or Parent's public disclosure.

The summary of the material terms of the Merger Agreement and the descriptions of the conditions to the Offer contained in the Offer to Purchase and incorporated herein by reference do not purport to be complete and are qualified in their entirety by reference to the full text of the Merger Agreement, which is filed as Exhibit (e)(1) hereto and is incorporated herein by reference.

------

##### [**Table of Contents**](#toc)
***Form of Contingent Value Rights Agreement***

At or prior to the Effective Time, Parent and Merger Sub expect to enter into the CVR Agreement, with a rights agent (the "Rights Agent") and a representative, agent and attorney in-fact (the "Representative") of the holders of CVRs ("CVR Holders"). Each CVR represents the contractual right to receive certain contingent cash payments equal to "CVR Proceeds" calculated as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 80% of the Net Proceeds (as defined in the CVR Agreement), if any, from the sale, transfer, license or other
disposition by Parent or any of its affiliates, including CARGO after the Merger, of all or any part of CARGO's (a) product candidate known as CRG-022, or firicabtagene autoleucel (firi-cel), an autologous CD22 chimeric antigen receptor (CAR) T-cell; (b) product candidate known as CRG-023, a CD19/CD20/CD22 tri-specific CAR T; and (c) allogenic platform, a universal vector solution designed to limit immune-based rejection and enable durable response of CAR T-cell therapy
(the "Disposition Proceeds"), in each case during the period beginning on the Merger Closing Date and ending on the second anniversary following the Merger Closing Date (the "Disposition CVR Period").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 100% of the amount by which the Closing Net Cash, as finally determined pursuant to the Merger Agreement,
exceeds $217,500,000 (the "Additional Closing Net Cash Proceeds"), adjusted for any claims that arise prior to 30 days following the Merger Closing Date that are not accounted for in such Closing Net Cash (the "Additional Closing Net
Cash Period").

In the event that the applicable proceeds are not achieved prior to the end of the Disposition CVR Period or Additional Closing Net Cash Period, as applicable, holders of the CVRs may not receive any payment pursuant to the CVR Agreement.

Parent will, and will cause its subsidiaries, including the Company after the Merger, to use commercially reasonable efforts to spend up to $250,000 to, among other things, during the Disposition CVR Period (i) enter into one or more Disposition Agreements (as defined in the CVR Agreement) as soon as practicable following the Effective Time; (ii) retain an employee or consultant of Parent or Merger Sub for the purpose of maintaining and preserving the CVR Products (as defined in the CVR Agreement) and seeking, negotiating and entering into Disposition Agreements; (iii) maintain and prosecute the intellectual property relating to the CVR Product; and (iv) continue the CMC Activities (as defined in the Merger Agreement) of the CVR Products to the extent the costs associated with such CMC Activities were included in the Closing Net Cash Schedule (as defined in the Merger Agreement).

The right to the contingent payments contemplated by the CVR Agreement is a contractual right only and will not be transferable, except in the limited circumstances specified in the CVR Agreement. The CVRs will not be evidenced by a certificate or any other instrument and will not be registered with the SEC. The CVRs will not have any voting or dividend rights and will not represent any equity or ownership interest in Parent or Merger Sub, any constituent corporation party to the Merger or any of their respective affiliates. No interest will accrue or become payable in respect of any of the amounts that may become payable on the CVRs.

During the Disposition CVR Period, Parent will not terminate or negatively impact the required maintenance, including by failing to preserve and maintain, the CVR Products (as defined in the CVR Agreement). Parent will also comply with prosecution and maintenance obligations relating to the certain intellectual property required by any license or related term set forth in any Disposition Agreement (as defined in the CVR Agreement), to the extent such intellectual property is contemplated by said Disposition Agreement.

During the Disposition CVR Period, (i) Parent will, and will cause Merger Sub to, maintain records in the ordinary course of business pursuant to record-keeping procedures normally used by Parent and Merger Sub regarding its activities (including its resources and efforts) with respect to entering into Disposition Agreements and (ii) to the extent Merger Sub licenses, sells, assigns or otherwise transfers intellectual property and other rights (including, without limitation, all data, marketing authorizations and applications for marketing

------

##### [**Table of Contents**](#toc)
authorization), assets, rights, powers, privileges and contracts, Parent will require such licensee, purchaser, assignee, or transferee, as applicable to provide the information necessary for Merger Sub to comply with its obligations under the CVR Agreement.

The Representative, Parent, Merger Sub and the Rights Agent, without the consent of any CVR Holders, may amend the CVR Agreement for the purpose of adding, eliminating or changing any provisions of the CVR Agreement, unless such change is adverse to the interests of the CVR Holders.

With the consent of at least 30% of outstanding CVRs (the "Acting Holders"), the Representative, Parent, Merger Sub and the Rights Agent may amend the CVR Agreement, even if such change is materially adverse to the interests of the CVR Holders.

Parent will indemnify the Rights Agent against any loss, liability, damage, judgment, fine, penalty, cost or expense arising out of or in connection with the Rights Agent's duties under the CVR Agreement, including reasonable, documented and necessary out-of-pocket costs and expenses of defending the Rights Agent against any claims, charges, demands, actions or suits arising out of or in connection with the execution, acceptance, administration, exercise and performance of its duties under the CVR Agreement or enforcing its rights thereunder, unless such loss has been determined by a court of competent jurisdiction to be as a result of the Rights Agent's gross negligence, bad faith, fraud or willful misconduct.

The CVR Agreement will be terminated upon the earliest to occur of (i) the mailing by the Rights Agent to each CVR Holder of all CVR payment amounts, if any, (ii) the delivery of written notice of termination duly executed by Parent, Merger Sub and the Acting Holders, or (iii) the second (2<sup>nd</sup>) anniversary of the Merger Closing date.

*The foregoing summary and description of the material terms of the CVR Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the CVR Agreement, which is filed as Exhibit (e)(2) hereto and is incorporated herein by reference.* 

***Form of Tender and Support Agreement***

In connection with the execution of the Merger Agreement, on July 7, 2025, following approval thereof by the CARGO Board, Parent and Merger Sub entered into tender and support agreements (each, a "Support Agreement") with certain directors and officers of the Company and certain stockholders of the Company (collectively, the "Support Agreement Parties"). The Support Agreements provide that, among other things, the Support Agreement Parties irrevocably tender the Shares held by them in the Offer, upon the terms and subject to the conditions of such agreements. The Shares subject to the Support Agreements comprise approximately 17.4% of the outstanding Shares as of July 2, 2025. The Support Agreements will terminate upon certain circumstances, including upon termination of the Merger Agreement or if the CARGO Board votes to approve an alternative transaction.

*The foregoing summary and description of the material terms of the Form of Tender and Support Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Form of Tender and Support Agreement, the form of which is filed as Exhibit (e)(3) hereto and is incorporated herein by reference.* 

***Confidentiality Agreement***

On March 28, 2025, CARGO and TCM entered into a confidentiality agreement (the "Confidentiality Agreement"), pursuant to which CARGO and TCM and its affiliates, including TCP (as defined below) and Parent, agreed, subject to certain exceptions, to keep confidential any non-public, proprietary and/or confidential information about the other party, its affiliates or subsidiaries and its business, disclosed in connection with a possible negotiated transaction. The Confidentiality Agreement is effective until its termination on August 5, 2025. The Confidentiality Agreement contains a "standstill" provision that may be waived upon written consent of CARGO.

------

##### [**Table of Contents**](#toc)
*The foregoing summary and description of the material terms of the Confidentiality Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Confidentiality Agreement, which is filed as Exhibit (e)(4) hereto and is incorporated herein by reference.* 

***Limited Guaranty***

In connection with the execution of the Merger Agreement, TCP, TCM and Parent, provided an irrevocable limited guaranty (the "Limited Guaranty") pursuant to which TCP has agreed to guarantee (i) the payment of all amounts payable by Parent and or Merger Sub pursuant to the terms of the Merger Agreement in connection with the consummation of the transactions contemplated thereby (for the avoidance of doubt, such obligations shall include payment of Offer Price, the Merger Consideration, the CARGO Stock Option Cash Consideration, the CARGO Restricted Stock Unit Cash Consideration and the CARGO Pre-Funded Warrant Cash Consideration, without duplication); (ii) the obligation of Parent and/or Merger Sub to pay monetary damages to the Company in connection with fraud or a willful breach by Parent or Merger Sub of the Merger Agreement, together with certain enforcement costs; provided that the aggregate amount of all guaranteed obligations under clauses (i) and (ii) shall not exceed $213.1 million; and (iii) Parent and Merger Sub's payment obligations to CVR Holders under certain provisions of the CVR Agreement and performance of covenants set forth in the CVR Agreement (the "Guaranteed CVR Obligation"); provided that the maximum amount of the Guaranteed CVR Obligation shall not exceed the CVR Proceeds plus all enforcement costs up to the CVR Expense Cap (each as defined in the CVR Agreement).

The Limited Guaranty also contained customary representations and warranties, including regarding TCP's sufficiency of funds to fulfil its obligations with respect to the Limited Guaranty. The Guaranteed CVR Obligation is intended to be for the benefit of all CVR Holders and shall be enforceable by the Representative.

*The foregoing summary and description of the material terms of the Limited Guaranty do not purport to be complete and are qualified in their entirety by reference to the full text of the Limited Guaranty, which is filed as Exhibit (e)(5) hereto and is incorporated herein by reference.* 

**Arrangements Between CARGO and Its Executive Officer, Directors and Affiliates** 

***Interests of Certain Persons***

CARGO's executive officer and members of the CARGO Board may be deemed to have interests in the Offer and the Merger that may be different from or in addition to those of CARGO's stockholders generally. The CARGO Board was aware of these interests and considered them, among other matters, in reaching its decision to approve the Merger Agreement. As described in more detail below, these interests include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the accelerated vesting and payment in respect of each outstanding In-the-Money Option and each outstanding award
of CARGO RSUs at the Effective Time, including In-the-Money Options and CARGO RSUs held by CARGO's executive officer and In-the-Money Options held by non-employee members of the CARGO Board that were
granted pursuant to CARGO's Non-Employee Director Compensation Program (the "Director Compensation Program");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the potential receipt of severance payments and benefits by the current and former executive officers under
separation agreements with CARGO; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a retention bonus and additional bonus approved by the CARGO Board that are payable to CARGO's executive
officer.

***Outstanding Shares Held by the Executive Officer and Directors***

If the executive officer and directors of CARGO who own Shares tender their Shares for purchase pursuant to the Offer, they will receive the same Offer Price on the same terms and conditions as the other stockholders of

------

##### [**Table of Contents**](#toc)
CARGO as described in the Merger Agreement. As of July 21, 2025, the sole executive officer and directors of CARGO, and if applicable, certain of their respective affiliates, beneficially owned, in the aggregate, 60,577 Shares (which, for clarity, excludes Shares subject to outstanding CARGO Options and unvested CARGO RSUs).

As of July 21, 2025, CARGO's sole executive officer, Anup Radhakrishnan, beneficially owned 60,577 Shares and none of CARGO's directors beneficially owned Shares (which, for clarity, in each case, excludes Shares subject to outstanding CARGO Options and unvested CARGO RSUs). The aggregate cash consideration that would be payable for Mr. Radhakrishnan's Shares pursuant to the Offer is $265,266.68 based on the Cash Amount of $4.379 per Share, and he would receive 60,577 CVRs.

***Treatment of Equity Awards in the Transactions***

*Treatment of CARGO Options* 

Immediately prior to the Effective Time, each CARGO Option that is then outstanding but not then vested or exercisable will become immediately vested and exercisable in full. After giving effect to such accelerated vesting, at the Effective Time, each In-the-Money Option will be cancelled in exchange for the right to receive: (i) the CARGO Stock Option Cash Consideration and (ii) one CVR for each Share underlying such CARGO Option. At the Effective Time, each Out-of-the-Money Option will be cancelled for no consideration.

The table below sets forth the In-the-Money Option holdings for CARGO's executive officer and each member of the CARGO Board as of July 2, 2025, (i) the aggregate number of Shares subject to In-the-Money Options and (ii) the value of cash amounts payable in respect of such In-the-Money Options at the Effective Time, calculated by multiplying the difference between the Cash Amount and the exercise price per share of the In-the-Money Option by the number of Shares subject to such In-the-Money Option, which, in the case of Mr. Radhakrishnan, will be subject to reduction for the withholding of taxes. CARGO's executive officer and each of CARGO's directors will receive a CVR with respect to each Share underlying the individual's In-the-Money Options, but no amount has been included in the table below with respect to the CVRs to be received.

---

| | | |
|:---|:---|:---|
| **Name of Executive Officer or Non-Employee Director** | **Number of Shares<br>Underlying In-the-<br>Money Options<br>(#)** | **Cash Consideration<br>for In-the-Money<br>Options<br>($)** |
|  Abraham Bassan | 25000 | 725.00 |
|  Kapil Dhingra | 25000 | 725.00 |
|  Reid Huber, Ph.D. | 25000 | 725.00 |
|  David C. Lubner | 25000 | 725.00 |
|  John Orwin | 40865 | 52976.38 |
|  Jane Pritchett Henderson | 25000 | 725.00 |
|  Krishnan Viswanadhan, Pharm.D | 28173 | 11175.28 |
|  Anup Radhakrishnan | 14679 | 48345.29 |

---

*Treatment of CARGO RSUs* 

Immediately prior to the Offer Closing Time, each CARGO RSU that is outstanding immediately prior to the Effective Time will vest in full and automatically be cancelled and the holder will be entitled to receive (i) the CARGO Restricted Stock Unit Cash Consideration, and (ii) one CVR for each CARGO RSU.

The table below sets forth the CARGO RSU holdings for Mr. Radhakrishnan as of July 2, 2025, (i) the aggregate number of Shares subject to his CARGO RSUs and (ii) the value of cash amounts payable in respect of such CARGO RSUs at the Effective Time, calculated by multiplying the Cash Amount by the number of Shares subject to such CARGO RSUs, which amounts will be subject to reduction for the withholding of taxes.

------

##### [**Table of Contents**](#toc)
Mr. Radhakrishnan will also receive a CVR for each Share underlying his CARGO RSUs, but no amounts have been included in the table below with respect to the CVRs. None of CARGO's non-employee directors hold CARGO RSUs.

---

| | | |
|:---|:---|:---|
| **Name of Executive Officer or Non-Employee Director** | **Number of CARGO<br>Unvested RSUs<br>(#)** | **Cash Consideration<br>for CARGO<br>Unvested RSUs<br>($)** |
|  **Anup Radhakrishnan** | **63436** | **277786.24** |

---

*Treatment of the CARGO Equity Plans* 

The Merger Agreement provides that, prior to the Effective Time, CARGO will provide that, on or after the Effective Time, no holder of any CARGO Option or CARGO RSU will have the right to acquire any equity interest in CARGO or the Surviving Corporation and that each CARGO Equity Plan will be terminated as of the Effective Time.

*Treatment of CARGO ESPP* 

The Merger Agreement provides that, prior to the Effective Time, CARGO will take all reasonable actions required to (i) terminate the CARGO ESPP as of immediately prior to the Merger Closing Date, and (ii) provide that no new offering period will commence after the signing of the Merger Agreement.

***Change in Control and Severance Benefits***

*Severance Benefits* 

On April 9, 2025, CARGO entered into a separation agreement with Mr. Radhakrishnan (the "Radhakrishnan Separation Agreement"), which provides that his employment would terminate on November 13, 2025, and that, in exchange for a full release of claims, Mr. Radhakrishnan was to receive (i) the equivalent of 15 months of his base salary, to be paid in a lump sum no later than the CARGO's second regularly scheduled payroll date that is at least ten days after the Effective Date (as defined in the Radhakrishnan Separation Agreement) (the "Severance Payment Date"), (ii) an additional cash payment equivalent to 125% of his target bonus for 2025 to be paid no later than the Severance Payment Date, (iii) an additional $49,421 that he may use for any purpose (including obtaining health insurance coverage for himself and his dependents) to be paid no later than the Severance Payment Date, and (iv) 100% vesting acceleration of his outstanding equity awards. Under the Radhakrishnan Separation Agreement, in the event of a change in control, including the Merger, the Severance Payment Date for the foregoing severance benefits (i) through (iii) will be accelerated to a date prior to the closing of such change in control transaction.

The table below sets forth the estimated values of the additional payments and benefits that Mr. Radhakrishnan would receive under his Separation Agreement (which, for the avoidance of doubt, excludes the bonuses discussed below under the headings "Retention Bonus" and "Additional Bonus"), assuming for this purpose, that the Merger Closing will be effective as of August 19, 2025 (the "Merger Closing Date").

---

| | | | |
|:---|:---|:---|:---|
| **Name of Executive Officer** | **Salary<br>Severance<br>($)** | **Bonus<br>Severance<br>($)** | **Other<br>Benefits<sup>(1)</sup><br>($)** |
|  Anup Radhakrishnan | 625000 | 281250 | 375552 |

---

(1) Consists of the sum of the payment that Mr. Radhakrishnan may use for obtaining health care coverage for
himself and his dependents ($49,421), and the value of the acceleration of his outstanding In-the-Money Options and CARGO RSUs ($326,131), which was calculated by multiplying the number of Shares subject to each equity award by the difference
between the Cash Amount and any exercise price.

------

##### [**Table of Contents**](#toc)
If the amounts payable to Mr. Radhakrishnan would constitute "parachute payments" within the meaning of Section 280G of the Code and could be subject to the related excise tax, Mr. Radhakrishnan would be entitled to receive either full payment of benefits or such lesser amount which would result in no portion of the benefits being subject to the excise tax, whichever results in the greater amount of after-tax benefits to the executive officer.

*Retention Bonus* 

On March 28, 2025, CARGO entered into a retention bonus agreement with Mr. Radhakrishnan (the "Radhakrishnan Bonus Agreement"), which provides that he will receive a retention bonus in the amount of $250,000, contingent upon his continuous employment with CARGO through his termination date of November 13, 2025. In the event that CARGO consummates a "strategic transaction" (as defined in the Radhakrishnan Bonus Agreement), which includes the Merger, CARGO will pay the retention bonus, less deductions and withholdings, to Mr. Radhakrishnan within ten days of the closing of the transaction.

*Additional Bonus* 

On July 18, 2025, the CARGO Board approved a payment to Mr. Radhakrishnan of a performance bonus in the amount of $250,000, in recognition of the management team's strong performance in winding down the liabilities of CARGO in an efficient and effective manner under his leadership.

***Non-employee Director Compensation Program***

CARGO has granted stock options under the CARGO Equity Plans, including in accordance with the terms of the amended and restated non-employee director compensation program, effective November 14, 2023 (the "Non-Employee Director Compensation Program"), that are outstanding and held by CARGO's non-employee directors. Pursuant to the CARGO Equity Plans and the Non-Employee Director Compensation Program, the vesting of stock options held by CARGO's non-employee directors will accelerate in full upon a "change in control" transaction. The Merger Closing will be a "change in control" within the meaning of the CARGO Equity Plans and the stock options held by CARGO's non-employee directors.

The foregoing summary and description of the material terms of the Radhakrishnan Bonus Agreement, the Radhakrishnan Separation Agreement and Non-Employee Director Compensation Program do not purport to be complete and are qualified in their entirety by reference to the full text of the Radhakrishnan Bonus Agreement, the Radhakrishnan Separation Agreement and Non-Employee Director Compensation Program, which are filed as Exhibits (e)(15), (e)(16) and (e)(10) hereto and are incorporated herein by reference.

***Future Arrangements***

It is possible that employees of CARGO who remain employed following the Merger Closing Date, including the executive officer, will enter into new compensation arrangements or consulting agreements with Parent or its affiliates. As of the date of this Schedule 14D-9, no post-closing employment opportunities or consulting engagements were negotiated between Mr. Radhakrishnan or members of the CARGO Board and Parent.

***Section 16 Matters***

The Company and the CARGO Board will, to the extent necessary and in accordance with the Merger Agreement, take appropriate actions to approve, for purposes of Section 16(b)-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the dispositions or cancellations of Shares (including derivative securities with respect to such Shares) in connection with the Merger Agreement or the Transactions by each individual who is subject to the reporting requirements of Section 16 of Exchange Act.

------

##### [**Table of Contents**](#toc)
**Indemnification; Directors' and Officers' Insurance** 

Parent has agreed to cause the Surviving Corporation to honor and discharge all rights to indemnification existing in favor of the current or former directors or officers of CARGO for acts or omissions occurring at or prior to the Effective Time, as such indemnification provisions are provided for in the certificate of incorporation of CARGO, the bylaws of CARGO and/or indemnification agreements in effect as of the date of the Merger Agreement and previously made available to Parent, for a period of six (6) years.

At or prior to the Effective Time, CARGO has agreed to obtain and fully pay the premium for "tail" directors' and officers' liability insurance policies in respect of acts or omissions occurring at or prior to the Effective Time (including for acts or omissions occurring in connection with the Merger Agreement or any of the Transactions) for the period beginning upon the Offer Closing Time and ending six (6) years from the Effective Time in favor of the current or former directors or officers of CARGO; provided that the maximum aggregate annual premium for such "tail" insurance policies shall not exceed 200% of the aggregate annual premium payable by the Company for coverage pursuant to its most recent renewal under the Existing D&O Policies (as defined in the Merger Agreement). If such "tail" insurance policies have been obtained by the Company, Parent shall cause such "tail" insurance policies to be maintained in full force and effect, for their full term, and cause all obligations thereunder to be honored by it and the Surviving Corporation. In the event the Company does not obtain such "tail" insurance policies, then, for the period beginning upon the Offer Closing Time and ending six (6) years from the Effective Time, Parent shall either purchase such six (6) year "tail" insurance policies or Parent shall maintain in effect the Existing D&O Policies in respect of acts or omissions occurring at or prior to the Effective Time; provided that in no event will Parent or CARGO be required to pay annual premiums for insurance in excess of 200% of the amount of the annual premiums currently paid by CARGO for the Existing D&O Policies, it being understood that if the annual premium exceeds the annual premiums currently paid for the Existing D&O Policies, Parent will be obligated to provide as much coverage as may be obtained for such 200% amount.

In the event that (a) Parent or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any person, or (b), Parent or any of its successors or assigns dissolves the Surviving Corporation, then, and in each such case, Parent shall cause proper provision be made so that the applicable successors and assigns or transferees of Parent expressly assume the obligations described above.

**ITEM 4. THE SOLICITATION OR RECOMMENDATION** 

**Recommendation of the CARGO Board** 

On July 7, 2025, the CARGO Board unanimously: (i) determined that the Offer, the Merger and the other transactions contemplated by the Merger Agreement and the CVR Agreement (collectively, the "Transactions") are fair to, and in the best interests of the Company and its stockholders; (ii) duly authorized and approved the execution, delivery and performance by the Company of the Merger Agreement and the consummation by the Company of the Transactions; (iii) declared the Merger Agreement and the Transactions advisable; (iv) declared that the Merger shall be governed by and effected under Section 251(h) of the DGCL and, subject to the terms of the Merger Agreement, effected as soon as practicable following the consummation of the Offer and (v) recommended that the stockholders of the Company accept the Offer and tender their Shares to Parent pursuant to the Offer.

**Accordingly, and for the reasons described in more detail below in this Item 4 under the heading "*Reasons for the Recommendation of the CARGO Board*," the CARGO Board recommends that the Company's stockholders accept the Offer and tender their Shares pursuant to the Offer**.

A press release, dated July 8, 2025, issued by CARGO announcing the Offer, is included as Exhibit (a)(5)(A) hereto and is incorporated herein by reference.

------

##### [**Table of Contents**](#toc)
**Background of the Offer and the Merger** 

The following background summarizes the key meetings and events that led to the signing of the Merger Agreement. This background does not purport to catalog every conversation of or among the CARGO Board, its representatives or other parties.

The CARGO Board and management routinely evaluate the Company's performance, future growth prospects, business plans and overall strategic direction and consider a variety of strategic alternatives that may be available to the Company, including continuing to pursue the Company's strategy as a standalone company or pursuing potential strategic or financing transactions with third parties, in each case with the goal of maximizing stockholder value. In particular, the CARGO Board and management, from time to time, have considered a number of potential collaboration and licensing relationships, financings, restructurings and other strategic transactions, including evaluating a potential sale of the Company, especially in light of the Company's ad hoc data readout from its FIRCE-1 Phase 2 study of firicabtagene autoleucel (firi-cel) in January 2025.

On January 28, 2025, the CARGO Board approved a reduction of the Company's workforce by approximately 50% in connection with Company's decision to discontinue the FIRCE-1 Phase 2 study of firi-cel.

On January 29, 2025, the Company announced that it was discontinuing the FIRCE-1 Phase 2 study, reducing its headcount, and evaluating strategic options.

On February 6, 2025, the CARGO Board and management held a meeting with TD Securities (USA) LLC ("TD Cowen"), the Company's financial advisor, to discuss strategic alternatives, including a go-forward plan for certain product candidates and potential types of transactions available to the Company, including an acquisition, merger, reverse merger, other business combination, sales of assets or other strategic transactions to optimize value to the Company stockholders.

From early February 2025 to early March 2025, the Company and, in accordance with the Company's directives, TD Cowen contacted 16 potential strategic buyers. Ten of the potential strategic buyers expressed potential interest in the Company and/or its assets and, of those parties, seven parties held introductory calls with management and three parties entered into confidentiality agreements with the Company.

On February 21, 2025, representatives of the Company's senior management met with representatives of TCM, a stockholder of the Company since its initial public offering, to discuss a potential transaction with the Company and certain topics regarding the Company's business, including certain of the Company's clinical programs and financial information of the Company.

On February 23, 2025, the Company received a non-binding indication of interest from a financial buyer, which we refer to as Party A. Party A proposed a total cash consideration of $230,000,000, subject to a target net cash of at least $290,000,000, consisting of $215,000,000 upfront, plus (i) up to $15,000,000 via a cash CVR, (ii) a spin-off company ("SpinCo") CVR entitling shareholders to 33% of the realized value upon the subsequent sale of SpinCo. or its monetization of any assets in SpinCo, and (iii) 80% of net proceeds from the disposition of firi-cel within 24 months from the sale or out-license of firi-cel.

On February 28, 2025, the CARGO Board and management held another meeting with TD Cowen to discuss strategic alternatives in light of the Company's situation, including a go-forward plan for certain product candidates and the types of transactions available to the Company, including a sale of the Company, an asset sale or out-licensing and a merger, and a liquidation or other extraordinary return of capital to the Company's stockholders.

On March 13, 2025, the CARGO Board and management held a meeting with representatives of TD Cowen and the Company's outside counsel, Latham & Watkins LLP ("Latham"). At the board meeting, the CARGO Board resolved to appoint Anup Radhakrishnan as the Interim CEO. At this meeting, the CARGO Board also

------

##### [**Table of Contents**](#toc)
approved the formation of a transaction committee for the purpose of identifying, considering, evaluating and making recommendations to the CARGO Board regarding a potential strategic transaction (the "Transaction Committee"), and appointed Mr. David Lubner, Mr. John Orwin and Mr. Kapil Dhingra to serve on the Transaction Committee. The Transaction Committee was formed for expediency of process, and not in response to any actual or potential conflict of interest concerns. The CARGO Board delegated to the Transaction Committee the full power and authority of the CARGO Board to, among other things, (a) identify, consider, study, review, monitor and evaluate proposals, offers and other communications to and from third parties and potential strategic partners regarding the Company's interest in possibly entering into a potential transaction; (b) serve as a focal point for communications between non-committee directors, third parties and the Company's management with respect to a potential transaction; (c) monitor the progress and content of any negotiations and agreements between the Company and potential third-party strategic partners and investors with respect to a potential transaction; (d) provide such additional information and materials as it may deem necessary or advisable to make the CARGO Board aware of significant occurrences or changes in the Company's consideration and analysis of a potential transaction; and (e) make recommendations to the CARGO Board with respect to any potential transaction. Also at the meeting, TD Cowen provided an update on the Company's outreach process to strategic buyers and discussed with the CARGO Board a potential pivot to an evaluation of strategic alternatives, including a reverse merger, other business combination or transaction with a financial buyer.

On March 18, 2025, as directed by the CARGO Board's determination on March 13, 2025, the Company announced its decision to suspend further development of both CRG-023 and the Company's allogeneic platform, an increase in the reduction in force from 50% to 90% and the Company's decision to proceed with a reverse merger, other business combination or transaction with a financial buyer.

Commencing on March 18, 2025, 141 process letters were distributed to potential counterparties for a reverse merger transaction. During this period, the Company received 49 reverse merger proposals and three proposals for licensing transactions.

On March 20, 2025, representatives of the Company's senior management and TD Cowen contacted Parent and TCM to discuss a potential transaction with the Company.

On March 28, 2025, the Company received a revised non-binding indication of interest from Party A. Party A's revised proposal included a total cash consideration of $245,000,000, subject to a target net cash of at least $305,000,000, consisting of $225,000,000 upfront, plus (i) up to $20,000,000 via a cash CVR, (ii) 80% of net proceeds from the disposition of CRG-023 within 24 months from the sale or out-license of CRG-023 and (iii) 80% of net proceeds from the disposition of firi-cel within 24 months from the sale or out-license of firi-cel.

Also on March 28, 2025, the Company and TCM entered into a confidentiality agreement, which included a 90-day standstill provision and customary fall-away provisions.

On April 2, 2025, the Company received a non-binding indication of interest from Party B, a publicly held financial buyer. Party B's proposal included upfront cash consideration of $202,500,000, subject to a target net cash of at least $215,000,000, and a cash CVR for 90% of the net proceeds from the sale of the Company's legacy assets. To the extent net cash exceeded $215,000,000, 100% of the proceeds would be distributed to the Company's stockholders. Party B's proposal also included an alternative structure for upfront consideration of $202,500,000, consisting of (i) $162,500,000 cash upfront and (ii) $40,000,000 of Party B stock.

Also on April 2, 2025, the Company received a non-binding indication of interest from Party C, a privately held, clinical-stage biotechnology company, proposed a reverse merger transaction with an ascribed valuation of the Company of $200,000,000 (assuming closing net cash of $175,000,000) and an ascribed valuation of Party C of $438,000,000, with an implied ownership interest in the combined company of approximately 27% for existing CARGO stockholders following a contemplated concurrent financing of $100,000,000.

------

##### [**Table of Contents**](#toc)
Also on April 2, 2025, the Company received a non-binding indication of interest from Party D, a privately held, clinical-stage biotechnology company, proposed a reverse merger transaction with an ascribed valuation of the Company of $185,000,000 (assuming closing net cash of $175,000,000) and an ascribed valuation of Party D of $495,000,000, with an implied ownership interest in the combined company of approximately 24% for existing CARGO stockholders following a contemplated concurrent financing of $100,000,000.

Also on April 2, 2025, the Company received a non-binding indication of interest from Party E, a publicly traded, clinical-stage biotechnology company, proposed a reverse merger transaction with an ascribed valuation of the Company of $115,000,000 (assuming closing net cash of $100,000,000, with a $75,000,000 cash dividend to CARGO stockholders) and an ascribed valuation of Party E of $426,000,000, with an implied ownership interest in the combined company of approximately 21% for existing CARGO stockholders.

Also on April 2, 2025, the Company received a non-binding indication of interest from Party F, a privately held, clinical-stage biotechnology company, proposed a reverse merger transaction with an ascribed valuation of the Company of $175,000,000 (assuming closing net cash of $175,000,000) and an ascribed valuation of Party F of $200,000,000, with an implied ownership interest in the combined company of approximately 37% for existing CARGO stockholders following a contemplated concurrent financing of $100,000,000.

Also on April 2, 2025, the Company received a non-binding indication of interest from Party G, a privately held, clinical-stage biopharmaceutical company, proposed a reverse merger transaction with an ascribed valuation of the Company of $210,000,000 (assuming closing net cash of $200,000,000) and an ascribed valuation of Party G of $550,000,000, with an implied ownership interest in the combined company of approximately 24% for existing CARGO stockholders following a contemplated concurrent financing of $100,000,000.

On April 3, 2025, the CARGO Board and management held a meeting with TD Cowen present, during which the CARGO Board reviewed reverse merger proposals received during the Company's outreach period and provided preliminary guidance on prioritizing such proposals.

On April 7, 2025, representatives of the Company's senior management and TD Cowen held a call with representatives of Parent and TCM to further discuss a potential transaction with the Company and certain topics regarding the Company's business, including certain of the Company's clinical programs and financial information of the Company.

On April 8, 2025, the CARGO Transaction Committee and management held a meeting with TD Cowen present, during which the CARGO Transaction Committee continued to review reverse merger proposals and selected counterparties with which to hold management presentations. The CARGO Transaction Committee also discussed proposals from financial buyers.

On April 10, 2025, the CARGO Board convened, with management and TD Cowen present, and selected five parties from the approximately 49 reverse merger proposals received to invite for management presentations, including Party C, Party D, Party E, Party F and Party G. In addition, the CARGO Board determined to evaluate proposals from financial buyers in parallel, including the proposals received from Party A and Party B.

From April 10, 2025 to April 22, 2025, the Company and the selected reverse merger counterparties, Party C, Party D, Party E, Party F and Party G, entered into confidentiality agreements, and the selected reverse merger counterparties provided management presentations to the CARGO Board with representatives of TD Cowen present at such management presentations.

On April 23, 2025, the CARGO Transaction Committee and management held follow-up due diligence calls with Party D and Party G.

On April 24, 2025, the CARGO Board and management held a meeting with TD Cowen present, during which the potential prioritization and acceleration of a transaction with a financial buyer rather than a strategic buyer was discussed.

------

##### [**Table of Contents**](#toc)
From late April 2025 through early May 2025, financial buyer process letters were distributed to four potential buyers, including Parent, Party B, Party H (a subsidiary of a privately held biotechnology company), and Party I (a privately held financial buyer). Consistent with the CARGO Board's discussion at the CARGO Board meeting on April 24, 2025, negotiations with Party D, Party E and Party G were suspended. Other potential counterparties, including Party C and Party F, were informed that they were no longer in consideration.

On April 29, 2025, the Company and Party B entered into a confidentiality agreement, which included a standstill provision and customary fall-away provisions and, in accordance with the directives of the CARGO Board and management, representatives of TD Cowen held a call with representatives of Party B and provided a summary of the Company's closing cash and tax attributes.

Also on April 29, 2025, the Company received a non-binding proposal of investment and licensing agreement from Party H, which proposed an asset licensing from a third-party biotechnology company directly into the Company for $120,000,000 in total consideration (split into $50,000,000 in cash and $70,000,000 in equity). Party H's proposal also provided that net cash at the time of the transaction would be returned to the Company's stockholders and the Company itself would be recapitalized through a concurrent financing of $150,000,000, and the existing stockholders would be issued a contingent value right through which they would receive payment for any assets of the Company monetized (the "Party H Proposal").

On May 1, 2025, the CARGO Board and management held a meeting at which representatives of TD Cowen were present. During the meeting, TD Cowen provided an overview of the Company's outreach process and discussions with active financial buyers, which included Parent, Party B, Party H and Party I.

Also on May 1, 2025, in accordance with the directives of the CARGO Board and management, representatives of TD Cowen spoke with representatives of Parent and TCM to discuss process timelines.

Also on May 1, 2025, CARGO entered into confidentiality agreements with Party H and Party I, which included a standstill provision and customary fall-away provisions.

On May 5, 2025, the Company received two proposals: (i) a non-binding indication of interest proposal from Parent and (ii) a non-binding proposal of investment and licensing agreement from Party H. Parent proposed to acquire 100% of the equity of the Company for a cash price equal to closing net cash less a 6% retention, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of the Company's product candidates and/or intellectual property. Party H's proposed terms were consistent with the Party H Proposal received on April 29, 2025.

On May 7, 2025, Party B submitted an updated non-binding indication of interest to the Company ("Party B's Revised Proposal"). Party B's Revised Proposal was for the acquisition of 100% of CARGO Common Stock, and consisted of consideration of $218,000,000, which valued the Company at approximately $4.55 per Share, plus one contingent value right for 90% of the near-term net proceeds from the sale of the Company's legacy assets. Such valuation assumed that the Company would have $227,000,000 in cash at the time of closing a transaction less a $9,000,000 (or 4%) retention.

On May 9, 2025, the Company received a non-binding indication of interest from Party I. Party I proposed to acquire at least 95% of the outstanding shares of the Company for an aggregate purchase price of at least $220,000,000, and 3% of the aggregate purchase price would be deducted at closing for purposes of winding down the Company. Party I's proposal allowed for a reduction in the purchase price if the Company had a closing cash balance of less than 97% of $220,000,000. Party I's proposal also required that an exclusivity agreement be entered into between the Company and Party I.

Also on May 9, 2025, the CARGO Board and management held a meeting with representatives of TD Cowen and Latham present. During the meeting, the proposals from four separate financial buyers (Parent, Party

------

##### [**Table of Contents**](#toc)
B, Party H and Party I) were discussed and management provided an updated estimate of cash available at the time of an anticipated closing of a transaction.

Also on May 9, 2025, in accordance with the directives of the CARGO Board and management, representatives of TD Cowen held a call with Party B during which an expedited due diligence review process was discussed.

Also on May 9, 2025, Party H advised the Company that Party H was withdrawing from the process.

On May 12, 2025, in accordance with the directives of the CARGO Board and management, representatives of TD Cowen held a call with Parent and TCM, in which a due diligence list was requested from Parent and precedent merger agreements were discussed.

On May 13, 2025, representatives of Latham held a conference call with representatives of Covington & Burling LLP ("Party I's Counsel") to discuss additional details regarding Party I's original proposal, including the expected timeline required for due diligence and preparation of definitive documents and expected return of capital to CARGO stockholders. Representatives of Party I's Counsel indicated that the preliminary proposal had been approved by Party I's senior management and that they expected Party I's due diligence to be completed efficiently and without significant disruption.

On May 15, 2025, representatives of the Company and TD Cowen held a call with Party B in which the representatives of the Company addressed certain clinical and financial topics concerning the Company.

Also on May 15, 2025, the Company provided certain representatives of Parent and TCM with access to CARGO's electronic data room. Subsequently, Parent and TCM conducted due diligence review of non-public information provided in CARGO's electronic data room.

On May 16, 2025, Party I submitted an updated non-binding indication of interest to acquire all outstanding shares of the Company in exchange for (i) an upfront cash payment equal to 97% of the balance of the net cash and (ii) one contingent value right for each share entitling such holders to 80% of any proceeds received by the Company as a result of any disposition of the Company's assets, intellectual property or technology ("Party I's Revised Proposal"). Party I's Revised Proposal assumed that the Company would have a balance of net cash of at least $220,000,000 at the time of closing. Party I's Revised Proposal also noted that Party I would require debt financing in order to consummate the transaction.

On May 20, 2025, in accordance with the directives of the CARGO Board and management, representatives of TD Cowen held a call with Party B to provide a status update, including regarding the due diligence process, cash matters and timing on the merger agreement.

On May 21, 2025, representatives of Parent and TCM called representatives of TD Cowen providing an update regarding Parent's and TCM's due diligence process and timing for a draft merger agreement. On the call, Parent and TCM noted that the Company's assignment of its lease agreement (the "Lease Assignment") was the primary outstanding item in discussions with the Company.

Also on May 21, 2025, representatives of the Company and TD Cowen held a call with Parent in which the representatives of the Company addressed certain financial, clinical and chemistry, manufacturing and control topics concerning the Company.

On May 22, 2025, the CARGO Board and management held a meeting with representatives of TD Cowen present. At the meeting, representatives of TD Cowen provided an update on the active financial buyers, which included Parent, Party B and Party I, and a tentative timeline, subject to finalizing the Lease Assignment. Following these discussions, the CARGO Board decided to prioritize proposals from Parent and Party B given the status of ongoing due diligence, available funds to consummate the transaction, and certainty of closing taking into consideration Parent's and Party B's experience in consummating similar transactions.

------

##### [**Table of Contents**](#toc)
Also on May 22, 2025, representatives of Parent and TCM spoke with representatives of the Company's senior management and TD Cowen to discuss certain topics regarding the Company's business, including certain of the Company's clinical programs and certain financial information of the Company.

Also on May 22, 2025, the Company executed a non-binding letter of intent to begin working with a counterparty to draft the Lease Assignment and landlord consent.

On May 23, 2025, representatives of Parent and TCM shared with representatives of the Company's senior management and TD Cowen initial drafts of (i) the merger agreement and (ii) the CVR agreement. Representatives of Latham and representatives of Gibson, Dunn & Crutcher LLP ("Parent's Counsel") held a conference call to discuss Parent's proposal and process on the merger agreement, as well as the timing of the transaction and related matters. Parent's initial draft of the merger agreement generally reflected the terms of its May 5, 2025 proposal and included a fixed cash price per share representing a 6% retention based on a minimum net cash closing condition of $185,500,000. The draft Merger Agreement generally included customary terms and conditions for such an agreement including, among other things, for (a) the transaction to be structured as a cash tender offer followed immediately by a back-end merger pursuant to DGCL Section 251(h), (b) the acceleration and cash out of certain Company equity awards, (c) customary exceptions to the definition of "Company Material Adverse Effect," which generally defined the standard for certain closing risks, (d) customary representations and warranties with respect to the Company, Parent and Merger Sub, including a representation by Parent and Merger Sub regarding the concurrent delivery of an executed limited guaranty to guarantee Parent's and Merger Sub's obligations under the Merger Agreement and the CVR Agreement, (e) the Company's ability to provide due diligence to, and negotiate a merger agreement with, a party making an unsolicited acquisition proposal that constituted or would reasonably be expected to lead to a superior proposal and (f) the Company's ability to terminate the Merger Agreement to accept a superior proposal after providing Parent with a right to match such proposal. The draft Merger Agreement also included, among other things, (i) reductions to the Company's estimated closing net cash for all remaining lease-related obligations, up to $250,000 for any legal proceedings and settlements, up to $500,000 of transaction expenses incurred by Parent or Merger Sub and up to $400,000 to cover expenses under the CVR Agreement (the "CVR Expense Cap"), (ii) a termination fee payable by the Company in certain circumstances, including entry into a superior proposal, (iii) a minimum closing net cash condition of $185,500,000 and (iv) a cap on the annual premium for the D&O tail policy to be obtained.

The draft CVR Agreement provided by Parent provided for, among other things, (a) the payment of the 80% of the Net Proceeds (as defined in the CVR Agreement), if any, from the sale, transfer, license or other disposition by Parent or any of its affiliates, including CARGO after the Merger, of all or any part of the Company Products (as defined in the CVR Agreement), (b) the introduction of a "CVR Additional Net Closing Proceeds Amount" representing the right for CVR holders to receive a cash payment equal to 94% of the amount by which closing net cash exceeded the minimum closing net cash condition, as determined 30 days following the merger closing date, (c) the use of commercially reasonable efforts to maintain the Company's Products and continue certain CMC activities and (d) an expiration period of one year.

On May 27, 2025, representatives of Gibson, Dunn & Crutcher LLP ("Party B's Counsel") shared an initial draft of Party B's proposed merger agreement with representatives of Latham. Party B's draft generally reflected the terms of Party B's Revised Proposal and proposed, among other things, a two-part, fixed price per share and additional price per share, concept for the transaction based on minimum net cash closing condition of $227,000,000 less a 4% retention, as adjusted for excess cash prior to the closing of a tender offer. The draft merger agreement generally included customary terms and conditions for such an agreement including, among other things, for (a) the transaction to be structured as a cash tender offer followed immediately by a back-end merger pursuant to DGCL Section 251(h), (b) the acceleration and cash out of certain Company equity awards, (c) customary exceptions to the definition of "Company Material Adverse Effect," which generally defined the standard for certain closing risk, (d) customary representations and warranties with respect to the Company, Party B and its merger sub, (e) the Company's ability to provide due diligence to, and negotiate a merger agreement with, a party making an unsolicited acquisition proposal that constituted or would reasonably be expected to lead

------

##### [**Table of Contents**](#toc)
to a superior proposal and (f) the Company's ability to terminate the merger agreement to accept a superior proposal after providing Party B with a right to match such proposal. The draft merger agreement also included (i) reductions to the Company's closing net cash for all remaining lease-related obligations, all existing or anticipated legal proceedings and settlements, and 50% of all fees and expenses for the SEC filings and printing, mailing and distribution of the tender offer documents to be borne by the Company and the other 50% to be paid by Party B, (ii) termination rights for each of Party B and the Company, including a termination right for Party B if the Company's closing net cash was below $227,000,000, subject to Party B's completion of due diligence and the Company's final determination of closing net cash, pursuant to which the Company would be required to pay a termination fee equal to 3% of the Company's closing net cash, and an expense reimbursement payment of $1,250,000 and (iii) a cap on the annual premium for the D&O tail policy to be obtained.

Also on May 27, 2025, the Company received an initial draft of the CVR agreement from representatives of Party B. The draft CVR agreement provided for, among other things, (a) the payment of (i) 100% of the proceeds from dispositions, if any, from the sale, transfer, license or other disposition by Party B (under Party B's proposal) or any of its affiliates, including the Company after the merger, of all or any part of the Company's products (as defined therein) (each, a "disposition") if entered into prior to the tender offer closing and (ii) 90% of the proceeds for dispositions entered into after the tender offer closing, (b) the use of commercially reasonable efforts to maintain the Company's products and continue certain CMC activities and (c) an expiration period of one year, subject to certain exceptions.

Also on May 27, 2025, in accordance with the directives of the CARGO Board and management, representatives of TD Cowen held a call with Party B, in which Party B requested a call with the Company to review the Company's updated closing net cash schedule and cash and outstanding liabilities. Party B indicated its preference that the Lease Assignment matter be settled by no later than the closing of the proposed transaction.

On May 28, 2025, representatives of the Company held a call with representatives of Party B to review the Company's updated closing net cash schedule and cash and outstanding liabilities. Representatives of TD Cowen also attended this call.

Also on May 28, 2025, TD Cowen provided the CARGO Board with certain disclosures regarding TD Cowen's material investment banking relationships with the Company, Parent, Party B and Party I during the approximate prior two-year period, which indicated that TD Cowen had no material relationships with the Company, Parent, Party B or Party I during such period.

On May 29, 2025, the CARGO Board and management held a meeting with representatives of TD Cowen and Latham present. TD Cowen provided an update on the Company's process with financial buyers. The CARGO Board also discussed with management an overview of the Company's estimated cash at closing and current status of negotiations on the proposed Lease Assignment with the Company's landlord and potential sublessee, which Parent and Party B both indicated was an important issue and a condition for the Company to finalize in order to complete due diligence and sign and announce a proposed transaction.

Also on May 29, 2025, representatives from Parent and TCM requested an update on the status of the merger agreement and provided representatives of Latham with a draft of the Limited Guaranty and drafts of the exhibits and schedules to be included in the Merger Agreement, including the Form of Tender and Support Agreement.

On June 6, 2025, representatives of Latham shared a revised draft of the merger agreement with representatives of Party B's Counsel. The revised draft reflected certain provisions which covered, among other things, (a) changes to the definitions of the components used in the calculation of the Company's closing net cash, including adding a $150,000 cap for post-closing legal proceedings costs, (b) limits to transaction expenses incurred by Party B, (c) the Company's discretion in extending its proposed tender offer, (d) no cash or CVR consideration for out-of-the-money options, (e) cash consideration for each CARGO Pre-Funded Warrant,

------

##### [**Table of Contents**](#toc)
(f) raising the maximum cap on the annual premium for the D&O tail policy to be obtained to 300% of CARGO's previous D&O tail policy, (g) limiting the role of Party B in any potential stockholder litigation, (h) the burden in relation to the Company's obligation to terminate the 401(k) plans, (i) the inclusion of an outside date by which the merger must be consummated, and (j) a lesser termination fee payable by the Company of 1.75% of the Company's closing net cash, once determined, and an expense reimbursement payment of $500,000.

Also on June 6, 2025, representatives of Latham shared a revised draft of the merger agreement with representatives of Parent, TCM and Parent's Counsel. The revised draft reflected certain provisions which covered, among other things, (a) changes to the definitions of the components used in the calculation of the Company's closing net cash, including removing the $400,000 CVR Expense Cap in each of the merger agreement and CVR Agreement and decreasing the amount for any legal proceedings and settlements from $250,000 to $150,000, (b) changes to the definition of Transaction Expenses to (i) decrease the transaction expense cap for Parent and Merger Sub from $500,000 to $150,000, (ii) introduce a 50% split for all fees and expenses for the SEC filings and printing, mailing and distribution of the tender offer documents and (iii) exclude any fees or expenses payable to an information agent for the proposed transaction, (c) the introduction of the Wind-Down Process for purposes of winding down the Company's operations and reflecting such changes throughout the Merger Agreement, including in the representations and warranties and interim operating covenants sections, (d) an increase in certain material contract thresholds under the Merger Agreement, (e) raising the cap on the annual premium for the D&O tail policy to be obtained from 200% to 300%, (f) reducing the period in which a termination fee would be payable by the Company following a termination resulting from the acceptance of a superior proposal, (g) the introduction of certain covenants and post-closing obligations on Parent and Merger Sub related to maintenance of COBRA continuation coverage for CARGO's eligible former employees and to cause the payment of certain retention and separation bonuses, (h) an extension of the outside date from 90 to 120 days following the execution of the Merger Agreement, and (i) decreasing the termination fee payable by the Company from 2% of the cash purchase price to 1.75% of Closing Net Cash, once determined.

On June 10, 2025, in accordance with the directives of the CARGO Board and Company management, representatives of TD Cowen held a call with Party B whereby Party B confirmed it would provide comments to the draft merger agreement following the Company's resolution of the Lease Assignment.

Also on June 10, 2025, representatives of the Company's senior management and TD Cowen held a call with representatives of Parent and TCM to discuss a reduction of the retention amount in Parent's initial proposal and, after such discussions, Parent agreed that a reduced retention would be reflected in the next draft of the Merger Agreement.

On June 11, 2025, the Company received an updated draft of the Lease Assignment, which required further revisions as the Company continued to exchange comments on various commercial and legal terms.

On June 12, 2025, the CARGO Board and Company management held a meeting with representatives of TD Cowen and Latham present. Company management noted that the Wind-Down Process was going well and also provided an update on the negotiations and timeline for finalizing the Lease Assignment and obtaining the landlord's consent. In addition, TD Cowen provided the latest updates on discussions with Party B and Parent. Afterwards, representatives of Latham discussed key differences in the merger agreement drafts from Parent and Party B.

On June 17, 2025, the Company received an updated draft of the Lease Assignment, which reflected progress on the previously discussed items. The Company continued to work on providing the decommissioning certificate to the lease assignee and updating the landlord's consent to include release of liability language.

Also on June 17, 2025, representatives of Latham shared a revised draft of a CVR agreement with representatives of Party B's Counsel. The revised draft contemplated that out-of-the-money options would not be

------

##### [**Table of Contents**](#toc)
entitled to receive a CVR. The draft also incorporated representations made by the merger sub related to its ability to make payments under the CVR Agreement and added the concept of "Further Savings Proceeds" for the payment of any proceeds realized between the closing date and the expiration date under the CVR agreement, as well as audit rights related to such Further Savings Proceeds.

On June 18, 2025, the CARGO Board held a meeting, at which members of CARGO management, representatives of TD Cowen and representatives of Latham were present. Representatives of Latham provided a review of the fiduciary duties of directors in connection with evaluating the Company's strategic alternatives, including the transactions contemplated by the Merger Agreement, and summarized the material terms in each of the merger agreements with Parent and Party B, as well as key differences in the proposed drafts of the CVR agreements with Parent and Party B and provided an overview of TD Cowen's material relationships disclosure, which was provided to the CARGO Board in advance of the meeting. In addition, TD Cowen noted that the transaction was in a holding pattern until the Lease Assignment matter was resolved and provided an overview of financial terms of the potential transactions with Parent and Party B. The Company's Interim CEO provided an update on the Lease Assignment negotiations, noting it was under review for final comments and there was a strong desire by all parties to resolve the matter promptly prior to completing and announcing a transaction.

On June 20, 2025, representatives of the Company's senior management and Parent held a call during which the parties discussed the potential transaction, and a representative of Parent noted that Parent might be willing to increase its previous proposal. In accordance with the directives of the CARGO Board and management, TD Cowen thereafter held a call with Parent requesting its updated and final proposal. Parent communicated to TD Cowen that it would not be increasing its proposal.

On June 23, 2025, representatives of the Company's senior management held a call with representatives of Parent during which it provided an update on the Lease Assignment negotiations and indicated to Parent that it would have to increase its proposal to remain in the process.

On June 25, 2025, the CARGO Board and management held a meeting with representatives of TD Cowen present, at which management provided an update on the ongoing lease negotiations and TD Cowen provided an overview of potential next steps in completing a merger transaction.

On June 27, 2025, representatives of the Company's senior management held a call with Parent in which Parent verbally shared an updated proposal and indicated a willingness to close the transaction promptly. Parent's revised verbal proposal reflected a cash price equal to closing net cash less a 2% retention for Parent based on a $222,000,000 minimum closing net cash condition.

Also on June 27, 2025, in accordance with the directives of the CARGO Board and management, TD Cowen held a call with Party B, in which Party B expressed it was in a position to sign and announce the transaction before the end of the month. Party B also shared an update on its proposed merger agreement and related disclosure schedules, as well as remaining due diligence items.

Also on June 27, 2025, representatives of Party B's Counsel shared a revised draft of the merger agreement with representatives of the Company and representatives of Latham. The updated agreement proposed for Party B, rather than its merger sub, as the party initiating and consummating the tender offer. The updated agreement also (i) changed the cash amount construct from a base price per share with an additional price per share to only a base price per share generally reflecting Party B's Revised Proposal based on minimum net cash closing condition of $227,000,000 less a 4% retention, (ii) made changes to the time at which closing net cash would be calculated and what constituted a transaction expense for such calculation, (iii) increased the Company's expense reimbursement payment to Party B in case of a termination, (iv) increased the cap on stockholder litigation that constituted part of the estimated cost post-merger closing, (v) reduced the time-frame from the closing of the tender offer to closing, (vi) addressed the Company's public company requirements up until the effective time, (vii) increased the time for which the Company would be required to pay a termination

------

##### [**Table of Contents**](#toc)
fee if it accepted an alternate proposal, (viii) made general changes to the Company's tax covenants, and (ix) increased Party B's level of involvement in any legal proceeding to which the Company was a party.

On June 28, 2025, representatives of the Company held a call with representatives of Parent to discuss the Company's outstanding liabilities and certain legal matters.

On June 30, 2025, the CARGO Transaction Committee held a meeting at which representatives of Latham were present, during which the CARGO Transaction Committee discussed the status of the negotiations with, and revised proposals from, Parent and Party B. During the meeting, updates on wind-down activities and the Lease Assignment were also provided.

Also on June 30, 2025, representatives of the Company and Parent held a due diligence call to review the latest amounts related to the Company's cash burn and estimated closing net cash schedule.

Additionally, on June 30, 2025, in accordance with the directives of the CARGO Board and management, TD Cowen held a call with Parent in which Parent verbally shared an updated and final proposal and TD Cowen communicated on behalf of the CARGO Board that there needed to be more movement on the transaction documents so that the CARGO Board would have greater clarity on Parent's final proposal. Parent's revised verbal proposal reflected a cash price equal to closing net cash less a 2% retention based on a $222,000,000 minimum closing net cash condition, and the possibility of a fixed $4,400,000 retention in lieu of the 2% retention. Representatives of TD Cowen thereafter updated the Company regarding Parent's revised verbal proposal.

Additionally, on June 30, 2025, representatives of CARGO and representatives of Latham held a conference call with representatives of Party B and representatives of Party B's Counsel discussing (i) certain of the Company's legal matters and (ii) key commercial contracts that remained ongoing and/or contracts that were in the process of being terminated, settled or otherwise wound down.

Additionally, on June 30, 2025, representatives of Latham shared a revised draft of the merger agreement with representatives of Party B's Counsel. The revised draft included, among other things, changes to (i) finalize the definition of transaction expenses, (ii) the tax provisions such that any payments were "subject" to applicable withholding taxes, as well as materiality thresholds, (iii) propose a termination fee equal to 2.25% of the Company's closing net cash and (iv) reduce the Company's expense reimbursement payment in case of a termination from $1,000,000 to $750,000.

Also on June 30, 2025, representatives of Latham provided representatives of Parent, TCM and Parent's Counsel, with a revised draft of the CVR Agreement, which reflected certain revisions, including: (i) an updated Additional Closing Net Cash Proceeds CVR representing the right for CVR holders to receive a cash payment equal to 98% of the amount by which closing net cash exceeds the minimum closing net cash condition, as determined 30 days following the merger closing date; (ii) the introduction of a "Further Savings Proceeds" CVR representing the right for CVR holders to receive a cash payment equal to 80% of any net savings versus closing net cash realized between the Merger Closing Date and the third anniversary of the Merger Closing Date; and (iii) an extension of the disposition period from one to two years with respect to any license or disposition of the Company's product candidates and/or intellectual property.

Additionally, on June 30, 2025, representatives of Parent, TCM and Parent's Counsel shared a revised draft of the Merger Agreement with representatives of Latham. The revised draft defined the Cash Amount to be received by the Company stockholders as $4.379 per Share, representing a $4,400,000 retention. Parent's revised draft also (i) reinstated the originally proposed $250,000 CVR Expense Cap, (ii) updated the definition of "Estimated Costs Post-Merger Closing" to include costs associated with the Wind-Down Process and reinstated the originally proposed amount of $250,000 for any legal proceedings and settlements, (iii) increased the

------

##### [**Table of Contents**](#toc)
transaction expense cap for Parent and Merger Sub from $150,000 to $300,000, (iv) provided that Parent, rather than Merger Sub, would be the party initiating and consummating the Offer, (v) made certain changes to the tax-related provisions, (vi) reinstated the originally proposed cap on the annual premium for the D&O tail policy to be obtained to 200% based on estimates from D&O tail policy providers and (vii) reinstated the original period in which a termination fee would be payable by the Company following a termination resulting from the receipt of a superior proposal.

On July 1, 2025, representatives of Parent and TCM provided representatives of Latham with a revised draft of the CVR Agreement, which reflected certain revisions, including the removal of the Further Savings Proceeds CVR.

Also on July 1, 2025, representatives of the Company, TD Cowen and Parent held a call to discuss the latest drafts of the transaction documentation, material terms and current status of Parent's proposal.

Additionally, on July 1, 2025, TD Cowen provided an updated material relationships disclosure with respect to the Company, Parent, Party B and Party I during the approximate prior two-year period, which indicated that TD Cowen had no material relationships with the Company, Parent, Party B or Party I during such period.

On July 2, 2025, representatives of the Company's senior management held a call with a representative of Parent to discuss the expense reimbursement provisions for Transaction Expenses and the CVR Expense Cap, and, after such discussions, agreed to schedule an all-hands call for the following day to review all outstanding items under the transaction documents with the goal of agreeing on a firm timeline for signing. Parent also shared confirmatory due diligence requests and questions.

On July 3, 2025, representatives of Company management, the CARGO Transaction Committee and representatives of TD Cowen and Latham held a call to discuss the latest drafts of the transaction documents and a comparison of the proposals and material differences between Parent's and Party B's proposals, including the price per share for Company stockholders based on the minimum closing net cash condition less a 2% retention for Parent and 4% retention for Party B as well as greater caps on certain estimated costs post-merger closing and transaction expense carveouts for Party B. A representative of the Company and representatives of Latham also discussed maximizing value to stockholders from the transaction and closing certainty. At the meeting, the CARGO Board decided to proceed with Parent's proposal.

Later on July 3, 2025, representatives of the Company and TD Cowen held a call with representatives of Parent and TCM to discuss the status of the Merger Agreement and the CVR Agreement and in which CARGO management addressed certain topics regarding the Company's business, including certain of CARGO's clinical programs and financial information of the Company.

Also on July 3, 2025, representatives of Latham shared with representatives of Parent, TCM and Parent's Counsel updated drafts of (i) the Merger Agreement, (ii) the CVR Agreement and (iii) the limited guaranty. The revised draft of the Merger Agreement included certain minor changes to, among other things, certain tax-related provisions, the allocation of Transaction Expenses with respect to the Information Agent and an extension of the outside date.

From July 3, 2025 to July 7, 2025, representatives of Parent, TCM and Parent's Counsel, on the one hand, and representatives of the Company's management and Latham, on the other hand, exchanged drafts of the Merger Agreement and CVR Agreement to reflect certain minor revisions.

On July 4, 2025, Party I shared with representatives of TD Cowen a "highly interested letter," which stated a bank's interest in attempting to arrange financing in the amount of $210,000,000 for Party I's proposed acquisition of CARGO on a best-efforts basis and subject to due diligence and other approvals, without specifying a timeline.

------

##### [**Table of Contents**](#toc)
On July 7, 2025, the CARGO Board and management held a meeting, at which members of CARGO management, representatives of TD Cowen and Latham were present. At this meeting, TD Cowen reviewed its financial analysis of the $4.379 per Share upfront cash consideration with the CARGO Board and delivered an oral opinion, confirmed by delivery of a written opinion dated July 7, 2025, to the CARGO Board to the effect that, based on and subject to the various assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by TD Cowen as set forth in such opinion, as of July 7, 2025, the $4.379 per Share upfront cash consideration to be received in the Offer and the Merger, taken together as an integrated transaction, by holders of Shares (other than, as applicable, TCP, Parent, Merger Sub and their respective affiliates) was fair, from a financial point of view, to such holders. The representatives of TD Cowen then departed the meeting. Following additional discussion and consideration of the Merger Agreement and the Offer, the Merger and the other transactions contemplated by the Merger Agreement (including the factors described in this Item 4 under the heading "*Reasons for the Recommendation of the CARGO Board*"), the CARGO Board unanimously (i) determined that the Offer, the Merger and the other transactions contemplated by the Merger Agreement and the CVR Agreement (collectively, the "Transactions") are fair to, and in the best interests of the Company and its stockholders; (ii) duly authorized and approved the execution, delivery and performance by the Company of the Merger Agreement and the consummation by the Company of the Transactions; (iii) declared the Merger Agreement and the Transactions advisable; (iv) declared that the Merger shall be governed by and effected under Section 251(h) of the DGCL and, subject to the terms of the Merger Agreement, effected as soon as practicable following the consummation of the Offer and (v) recommended that the stockholders of the Company accept the Offer and tender their Shares to Parent pursuant to the Offer.

Thereafter, in the afternoon of July 7, 2025, the Merger Agreement was signed by CARGO, Parent and Merger Sub, and the Limited Guaranty was signed by CARGO, TCP, Parent and Merger Sub.

Before the opening of trading of the U.S. stock markets on July 8, 2025, the Company issued a press release and filed a Form 8-K with the SEC announcing the execution of the Merger Agreement and the forthcoming commencement of a tender offer by Parent to acquire all outstanding shares of CARGO Common Stock at the Offer Price.

On July 21, 2025, Parent commenced the Offer, and later on July 23, 2025, the Company filed this Schedule 14D-9.

**Reasons for the Recommendation of the CARGO Board** 

In evaluating the Offer and the Merger, the CARGO Board consulted with the Company's senior management and outside legal and financial advisors, and the CARGO Board considered and analyzed a number of reasons, including, without limitation, the following (which are not presented in any order of importance).

The CARGO Board believed that the following material factors and benefits supported their determination and recommendation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Certainty of Value**. The (i) Cash Amount provides certain and immediate value and liquidity to the
Company's stockholders for their Shares and (ii) CVR Proceeds, if any, may provide additional value and liquidity to the Company's stockholders for their Shares, especially when viewed against the internal and external risks and
uncertainties associated with macroeconomic conditions, including the current state of the U.S. and global economies, and the potential impact of such risks and uncertainties on the Company, the trading price of the Company's Shares and
the potential for an alternative strategic transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Results of Strategic Review Process**. The Transactions were the result of a reasoned, fully informed
process. CARGO conducted a fulsome strategic process to explore potential strategic alternatives, including a potential reverse merger transaction (as more fully described in this Item 4 under the

------

##### [**Table of Contents**](#toc)
heading "*Background of the Offer and the Merger*"). Following the review of the transaction proposals, the CARGO Board believed that the cash acquisition transaction proposals offered greater certainty of closing and value to the Company's stockholders than reverse merger transaction proposals considering prevailing public market conditions, the ability to secure PIPE financing in the amounts required to fund operations of the combined companies, the timeline on which such reverse merger transactions could be consummated (if at all), the ongoing cash needs of the combined companies post-transaction and other risks with respect to a reverse merger transaction structure. The CARGO Board also considered alternatives to a strategic process, including a liquidation or dissolution of CARGO to distribute any available cash; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Best Value**. The belief of the CARGO Board that (i) as a result of the negotiating process, the
Company had obtained Parent's best offer and (ii) based on the conversations and negotiations with Parent, as of the date of the Merger Agreement, the Offer Price represented the best value reasonably obtainable by the Company under the
circumstances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **No Financing Condition**. The fact that the Transactions are not subject to any financing condition, and
that TCP provided a Limited Guaranty to support the funding of the Transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **CVR**. The fact that (i) the Transactions offer stockholders a potential opportunity to, within
specified parameters, receive (A) the Disposition Proceeds and (B) the Additional Closing Net Cash Proceeds; and (ii) Parent has the obligation and financial incentive to pursue such transactions and elimination of outstanding
liabilities of the Company during the Disposition CVR Period or the period between the Merger Closing Date and 30 days thereafter, as applicable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Prospects of the Company on a Standalone Basis**. The CARGO Board's assessment of the assets,
liabilities and financial condition of the Company if it continued to operate independently and pursue its business on a standalone basis, taking into account the execution risks and substantial financing requirements and challenges associated with
continued independence, particularly in light of the discontinuation of certain of the Company's clinical programs, investor interest and value perception for possible further development of its programs, the Company's market
capitalization and its workforce reductions in January and March of 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Expected Return to Stockholders if the Company Liquidated**. The CARGO Board's belief that the Offer
Price is more favorable to such holders than the potential value that might be distributable to the holders of Shares if the Company were to effect a statutory liquidation or dissolution, which conclusion was based on a financial analysis performed
by the Company's management (as more fully described in this Item 4 under the heading "*CARGO Management Dissolution Analysis*") and, among other factors, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an orderly liquidation would require that the Company continue to operate until a liquidation process could be
completed, which would likely require the Company to continue to incur costs as a publicly listed company that would reduce the cash available for distribution to the Company's stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's directors and officer do not have substantial experience with the liquidation of companies,
which would necessitate engaging and compensating experienced consultants to assist with the liquidation effort, as well as incentivizing certain existing employees to remain with the Company through the liquidation process;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's directors and officer would also likely need to engage and compensate advisors and consultants
to assist with efforts to monetize the Company's technology and product candidates (including the CVR Products), which would reduce the liquidation proceeds otherwise available for distribution to stockholders and also potentially any benefits
available from such liquidation effort, if such compensation arrangement provided for a percentage compensation mechanism; and

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company would need to set aside cash for an extended period to be available to cover contingent liabilities
in connection with a liquidation, during which extended period of time, the Company's stockholders would not receive any of such withheld cash, and any such contingent liabilities that matured into actual liabilities would reduce the amount
available for ultimate distribution to the Company's stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Results of Market Check Process**. The fact that the Company conducted a robust market check, with the
assistance of the Company's outside legal counsel and financial advisor, including outreach and discussions with potential parties that were, in the view of the Company with input from the Company's management and financial advisor,
reasonably likely to have interest in a potential strategic transaction involving the Company, and that none of those potential parties offered a transaction that the CARGO Board and management considered more advantageous to stockholders than the
Transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Absence of Material Conflicts on the CARGO Board**. The members of the CARGO Board will not personally
benefit from the completion of the Offer and the Merger in a manner different from the Company's public stockholders, except (i) the acceleration and vesting of CARGO Options and receipt of the Offer Price and Merger Consideration in
connection with the CARGO Options upon the closing, on the terms set forth in the Merger Agreement, and (iii) the receipt of fees for service on the CARGO Board and its committees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Reasonable Likelihood of Consummation**. The belief of the CARGO Board that the Transactions have a
reasonable likelihood of closing on an acceptable timeline in light of the Company's cash runway and forecast, taking into account the speed at which Parent would be able to negotiate and consummate the Transactions given Parent's and its
affiliates' extensive experience in consummating similar transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Successful Negotiations with Parent**. The enhancements that the Company and its advisors were able to
obtain in the final Parent proposal during the course of negotiations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Opinion of CARGO's Financial Advisor**. The opinion of TD Cowen, dated July 7, 2025, to the CARGO
Board as to the fairness, from a financial point of view and as of the date of such opinion, of the $4.379 per Share upfront cash consideration to be received in the Offer and the Merger, taken together as an integrated transaction,  **** ** by
holders of Shares (other than, as applicable, TCP,  **** ** Parent, Merger Sub and their respective affiliates), which opinion was based on and subject to the various assumptions made, procedures followed, matters considered and limitations and
qualifications on the review undertaken by TD Cowen set forth in such opinion as more fully described in this Item 4 under the heading "*Opinion of CARGO's Financial Advisor*" and attached as Annex I to this Schedule 14D-9;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Terms of the Merger Agreement**. The terms of the Merger Agreement, which was the product of arm's-length negotiations, with the factors considered including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability, under certain circumstances, to furnish information to, and conduct negotiations
with, third parties regarding alternative acquisition proposals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the CARGO Board's belief that the terms of the Merger Agreement and the scope of the CVR Agreement would be
unlikely to deter third parties from making a superior proposal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the CARGO Board's ability, under certain circumstances, to withdraw or modify its recommendation that the
Company's stockholders accept the Offer and tender their Shares pursuant to the Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability, under certain circumstances, to terminate the Merger Agreement to enter into an
alternative acquisition agreement and the CARGO Board's belief that the termination fee payable by the Company in such instance was reasonable and not preclusive of other offers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the limited conditions to the Company's obligation to consummate the Merger, making the Merger reasonably
likely to be consummated; and

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to specifically enforce Parent's and Merger Sub's obligations to cause the
Offer and the Merger to be completed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Minimum Condition**. The fact that the minimum condition per the Merger Agreement, whereby the Offer and the
Merger will not be completed unless the number of Shares validly tendered and not validly withdrawn (excluding shares tendered pursuant to guaranteed delivery procedures that have not yet been "received" by the "depository," as
such terms are defined by Section 251(h) of the DGCL), when considered together with all other Shares owned by Parent and its "affiliates" (as defined in Section 251(h)(6)(a) of the DGCL, including Parent), equals at least one
Share more than 50% of Shares that are then issued and outstanding, which condition may not be waived;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Appraisal Rights**. The fact that stockholders of the Company who do not believe that the Offer Price
represents fair consideration for their Shares will have an opportunity to pursue appraisal rights under Section 262 of the DGCL; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Support Agreements**. The CARGO Board considered that the Support Agreement Parties that held, in the
aggregate, approximately 17.4% of the outstanding Shares as of July 2, 2025, entered into Support Agreements obligating each of them during the term of such agreement, among other things, to tender, pursuant to the Offer, their Shares in the
Offer and, subject to certain exceptions, not transfer any of the Shares that are subject to the Support Agreements.

The CARGO Board also considered and analyzed a number of uncertainties and risks and other potentially negative factors, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **No Premium**. The fact that the Cash Amount represents a negative premium to recent market prices of the
Shares, including an approximately 4.4% negative premium to the Company's closing share price prior to the Company's public announcement on July 8, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **No Stockholder Participation in Future Growth or Earnings**. The fact that the Transactions do not offer the
Company's stockholders an opportunity to participate in the potential benefits of a combination in a strategic reverse merger transaction and thus benefit from the potential of a combined company to create additional stockholder value through a
strategic reverse merger partner's development programs and business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **No Solicitation and Termination Fee**. Subject to certain exceptions, the Merger Agreement precludes the
Company from soliciting alternative acquisition proposals, and requires the Company to pay to Parent a termination fee of $3.8 million in certain circumstances, including in certain circumstances in which the Merger Agreement is terminated when
an alternative proposal became publicly known prior to such termination, and the Company later enters in any agreement with respect to an alternative proposal or consummates an alternative transaction within twelve months after such termination;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Risk Associated with Failure to Consummate the Merger**. The possibility that the Offer and the Merger might
not be consummated, and if not consummated, the Company will have significantly less cash that could potentially be distributed to stockholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Transaction Expenses**. The substantial transaction expenses to be incurred in connection with the
Transactions and the negative impact of such expenses on the Company's cash reserves and operating results should the Transactions not be completed, including the potential expense reimbursement amount of up to a maximum amount of $500,000
payable by the Company to Parent if the Merger Agreement is terminated by Parent under certain circumstances; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Interests of Insiders**. The interests that certain directors and the executive officer of the Company may
have with respect to the Merger that may be different from, or in addition to, their interests as stockholders of the Company or the interests of the Company's other stockholders generally, including the treatment of equity awards held by such
directors and executive officer in the Merger described in Item 3 under the heading "*Arrangements Between CARGO and its Executive Officer, Directors and* 

------

##### [**Table of Contents**](#toc)
 *Affiliates*" and the obligation of the Surviving Corporation to indemnify the Company's directors and officers against certain claims and liabilities.

This discussion is not meant to be exhaustive. Rather, it summarizes the material reasons and factors evaluated by the CARGO Board in their consideration of the Offer and the Merger. After considering these and other factors and thorough discussions with the assistance of CARGO's management and legal and financial advisors, the CARGO Board concluded that the potential benefits of entering into the Merger Agreement outweighed the uncertainties and risks associated therewith. In light of the variety of factors considered by the CARGO Board, and the complexity of these factors, the CARGO Board did not find it practicable to, and did not, quantify or otherwise assign relative weights, ranks or values to the foregoing factors in reaching their determination and recommendations. Moreover, each member of the CARGO Board applied his or her own personal business judgment to the process and may have assigned different relative weights, ranks or values to the different factors. The foregoing description of the CARGO Board's consideration of the reasons supporting the Transactions is forward-looking in nature. This information should be read in light of the reasons discussed in Item 8 under the heading "*Cautionary Note Regarding Forward-Looking Statements*."

**CARGO Management Dissolution Analysis** 

To assist the CARGO Board's analysis and decision with respect to whether to enter into the Merger Agreement and engage in the Transactions and to recommend that the Company's stockholders tender their Shares into the Offer, CARGO management prepared certain estimates upon a dissolution of the Company reflecting management's financial analysis of the per Share that might be realized in a liquidation as an alternative to pursuing the Merger. CARGO management's dissolution analysis was also provided to CARGO's financial advisor, TD Cowen, which was directed to use and rely upon such analysis for purposes of TD Cowen's financial analysis and opinion. In conducting this dissolution analysis, CARGO management determined the amount of cash available for distribution to CARGO stockholders in an orderly liquidation of CARGO. CARGO management's dissolution analysis, prepared as of July 3, 2025, assumed the commencement of the liquidation process and an initial distribution of cash to holders of Shares as of October 31, 2025. CARGO management estimated that, after considering the payment of operating and other costs, collection of interest and other income, estimated recoverability of certain assets and a litigation reserve, approximately $226.8 million in cash, cash equivalents and investments would be available as of October 31, 2025. Of the $226.8 million in cash, cash equivalents and investments, approximately $3.6 million would be required to satisfy liabilities and obligations within 36 months following the initial filing for dissolution (the "Holdback Period"). Of the remaining approximately $223.2 million, based on CARGO management's good faith estimate: (i) 71.1%, or approximately $158.7 million, would be disbursed to stockholders as an initial distribution upon the initial filing for dissolution (the "Initial Distribution"); and (ii) approximately $64.3 million would be held back for unknown or contingent liabilities, with $71.7 million, available to be disbursed to stockholders as a final distribution at the end of the Holdback Period, inclusive of anticipated interest income of approximately $7.3 million (the "Holdback Amount"), resulting in an undiscounted total distribution upon liquidation of approximately $4.59 per Share, assuming approximately 48.7 million fully diluted shares outstanding under the treasury stock method.

The timing of the distributions, if any, and the actual percentage of the remaining amount after the Initial Distribution that would be available for further distribution would depend on factors such as the actual expenses incurred, the amount of wind-down costs, the amount required to settle CARGO's remaining obligations under current contracts, the need to retain employees to facilitate the wind-down, the need to retain the services of outside contractors to assist with the wind-down and the satisfaction by CARGO of its remaining obligations (including obligations to continue SEC filings), and the need to retain funds beyond that Initial Distribution for unknown or contingent liabilities, each of which could be material and the total amount of which cannot currently be estimated. There can be no assurance that any fees, expenses, contingencies or other obligations that the Company may incur will be within the range of estimated amounts provided in the dissolution analysis, that the

------

##### [**Table of Contents**](#toc)
dissolution analysis accounts for all possible such fees, expenses, contingencies or other obligations of the Company or that the estimated distributions would be realized at the estimated amounts, if at all.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Estimated Company Obligations**<br>**Prior to Initial Distribution** | **Estimated Company Obligations**<br>**Prior to Initial Distribution** | **Estimated Company Obligations**<br>**Prior to Initial Distribution** | **Estimated Company Obligations**<br>**Prior to Initial Distribution** | **Estimated Company Obligations**<br>**During Holdback Period** | **Estimated Company Obligations**<br>**During Holdback Period** | **Estimated Company Obligations**<br>**During Holdback Period** | **Estimated Company Obligations**<br>**During Holdback Period** |
| *(in millions)* | **July<br>2025** | **August<br>2025** | **September<br>2025** | **October<br>2025** | **2025E<sup>(1)</sup>** | **2026E** | **2027E** | **2028E<sup>(2)</sup>** |
|  **Beginning Cash, Cash Equivalents and Investments** | $**252.1** | $**228.3** | $**227.1** | $**227.0** | $**68.0** | $**68.3** | $**69.4** | $**70.6** |
|  ***Operating Expenses:*** |  |  |  |  |  |  |  |  |
|  Corporate and Accounting Fees | $(0.2) | $(0.2) | $(0.2) | $(0.3) | $(0.1) | $(0.5) | $(0.5) | $(0.4) |
|  Legal | $(0.3) | $(0.3) | $(0.3) | $(0.3) | $(0.1) | $(0.8) | $(0.8) | $(0.6) |
|  Personnel Costs | $(0.5) | $(0.4) | $(0.4) | $(0.4) |  |  |  |  |
|  Clinical and CDMO Wind-Down Costs | $(7.8) |  |  |  |  |  |  |  |
|  Severance Costs | $(9.0) |  |  |  |  |  |  |  |
|  Lease Expense | $(0.6) |  |  |  |  |  |  |  |
|  Other Operating Expense | $(1.7) |  |  |  |  |  |  |  |
|  Lease Termination Expense | $(2.6) |  |  |  |  |  |  |  |
|  **Total Operating Expenses** | $**(22.6)** | $**(0.8)** | $**(0.8)** | $**(1.0)** | $**(0.2)** | $**(1.2)** | $**(1.2)** | $**(1.0)** |
|  ***Transaction Provisions and Recovery:*** |  |  |  |  |  |  |  |  |
|  Transaction-related Cost | $(1.0) |  |  |  |  |  |  |  |
|  Interest Income<sup>(3)</sup> | $0.8 | $0.8 | $0.8 | $0.8 | $0.5 | $2.4 | $2.4 | $2.1 |
|  Accounts Payable and Accrued Expenses | $(0.9) | $(1.2) |  |  |  |  |  |  |
|  **Total Transaction Provisions and Recovery** | $**(1.1)** | $**(0.4)** | $**0.8** | $**0.8** | $**0.5** | $**2.4** | $**2.4** | $**2.1** |
|  **Ending Cash, Cash Equivalents and Investments** | $**228.3** | $**227.1** | $**227.0** | $**226.8** | $**68.3** | $**69.4** | $**70.6** | $**71.7** |
|  **Less: Initial Distribution** |  |  |  | $**(158.7)** |  |  |  |  |
|  **Ending Cash, Cash Equivalents and Investments, Net** | $**228.3** | $**227.1** | $**227.0** | $**68.0** | $**68.3** | $**69.4** | $**70.6** | $**71.7** |

---

\* Figures may not foot due to rounding.

(1) Represents estimates from November 1, 2025 through December 31, 2025.

(2) Represents estimates from January 1, 2028 through October 30, 2028.

(3) Assumes a 4.0% interest rate through 2025 and a 3.5% interest rate thereafter.

------

##### [**Table of Contents**](#toc)
***Estimated Dissolution Distributions***

---

| | |
|:---|:---|
|  | **(***in millions***)** |
|  Estimated cash, cash equivalents and investments upon filing for dissolution | $**226.8** |
|  Less: Holdback Period obligations | $(68.0) |
|  **Initial Distribution** | $**158.7** |
|  Cash per Share for Initial Distribution<sup>(1)</sup> | $**3.26** |
|  Net Holdback Amount after Operating Expenses, net of Interest Income, payable after three years | $**71.7** **<sup>(2)</sup>** |
|  Cash per Share for Holdback Amount<sup>(1)</sup> | $1.33 |
|  **Total Cash per Share** | $**4.59** |

---

(1) Based on Total Shares Outstanding under the Treasury Stock Method, which includes 46.5 million basic shares
outstanding, 0.3 million RSUs, 1.8 million pre-funded warrants and 3.6 million options with weighted-average exercise price of $13.01 per share.

(2) Assumes 90% will remain to be distributed to CARGO stockholders after the three-year Holdback Period based on
CARGO management's good faith estimate for future unknown liabilities that may arise prior to CARGO's dissolution.

**Opinion of CARGO's Financial Advisor** 

CARGO has engaged TD Cowen as CARGO's financial advisor in connection with the Offer and the Merger. In connection with this engagement, the CARGO Board requested that TD Cowen evaluate the fairness, from a financial point of view, of the $4.379 per Share upfront cash consideration to be received in the Offer and the Merger, taken together as an integrated transaction, ****by holders of Shares (other than, as applicable, TCP, Parent, Merger Sub and their respective affiliates).

At a meeting of the CARGO Board held on July 7, 2025, TD Cowen reviewed its financial analysis of the $4.379 per Share upfront cash consideration with the CARGO Board and delivered an oral opinion, confirmed by delivery of a written opinion dated July 7, 2025, to the CARGO Board to the effect that, based on and subject to the various assumptions made, procedures followed, matters considered and limitations and qualifications on the review undertaken by TD Cowen as set forth in such opinion, as of July 7, 2025, the $4.379 per Share upfront cash consideration to be received in the Offer and the Merger, taken together as an integrated transaction, ****by holders of Shares (other than, as applicable, TCP, Parent, Merger Sub and their respective affiliates) was fair, from a financial point of view, to such holders. **The full text of TD Cowen's written opinion, dated July 7, 2025, is attached as Annex I to this Schedule 14D-9 and is incorporated herein by reference. The summary of TD Cowen's written opinion set forth herein is qualified in its entirety by reference to the full text of such opinion. TD Cowen's analysis and opinion were prepared for and addressed to the CARGO Board and were directed only to the fairness, from a financial point of view, of the $4.379 per Share upfront cash consideration to be received in the Offer and the Merger, taken together as an integrated transaction, by holders of Shares (other than, as applicable, TCP, Parent, Merger Sub and their respective affiliates). TD Cowen's opinion did not in any manner address CARGO's underlying business decision to effect the Transaction or the relative merits of the Transaction as compared to other business strategies or transactions that might be available to CARGO. The $4.379 per Share upfront cash consideration was determined through negotiations between CARGO and Parent and TD Cowen's opinion did not constitute a recommendation to the CARGO Board on whether or not to approve the Offer or the Merger and does not constitute a recommendation to any securityholder or any other person as to whether to tender Shares in the Offer or take any other action in connection with the Offer or the Merger or otherwise.**

------

##### [**Table of Contents**](#toc)
In connection with its opinion, TD Cowen reviewed and considered such financial and other matters as it deemed relevant, including, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an execution version, provided to TD Cowen on July 7, 2025, of the Merger Agreement and a form of the
related CVR Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• certain publicly available financial and other information for CARGO and certain other relevant financial and
operating data furnished to TD Cowen by the management of CARGO;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• certain internal financial forecasts, estimates and other information, primarily relating to a potential
liquidation of CARGO, provided by the management of CARGO and considered, based on CARGO management's liquidation analysis, the net present value of the estimated amount per Share potentially distributable to holders of Shares upon such
liquidation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• discussions TD Cowen had with certain members of the management of CARGO concerning the historical and current
business operations, financial condition and prospects of CARGO and such other matters that TD Cowen deemed relevant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• such other information, financial studies, analyses and investigations and such other factors that TD Cowen
deemed relevant for the purposes of its opinion.

As the CARGO Board was aware, TD Cowen was advised by the management of CARGO that (i) CARGO did not have a standalone business plan and that CARGO intended, in the absence of a sale or similar transaction involving CARGO, to pursue a liquidation of CARGO, and (ii) the internal financial forecasts, estimates and other information prepared by the management of CARGO relating to such liquidation reflected that a de minimis portion of the CVR Additional Net Closing Proceeds Amount would be payable to holders of Shares and did not reflect any sales or other divestitures of legacy CARGO product candidates or programs in the ordinary course of business. Accordingly, at the direction of the CARGO Board, TD Cowen relied for purposes of its analysis and opinion primarily on management's liquidation analysis of CARGO and TD Cowen ascribed no value to the CVR.

In conducting its review and arriving at its opinion, TD Cowen, at the direction of the CARGO Board, assumed and relied, without independent investigation, upon the accuracy and completeness of all financial and other information provided to TD Cowen by CARGO or that was publicly available or was otherwise reviewed by TD Cowen. TD Cowen did not undertake any responsibility for the accuracy, completeness or reasonableness of, or independent verification of, such information. TD Cowen relied upon the representations of CARGO that all information provided to TD Cowen by CARGO was accurate and complete in all material respects and TD Cowen expressly disclaimed any undertaking or obligation to advise any person of any change in any fact or matter affecting its opinion of which TD Cowen becomes aware after the date of TD Cowen's opinion.

TD Cowen was advised, and TD Cowen assumed, that the financial forecasts, estimates and other information provided by the management of CARGO that TD Cowen was directed to utilize for purposes of its analysis and opinion were reasonably prepared by the management of CARGO on bases reflecting the best currently available estimates and good faith judgments of such management as to a potential liquidation of CARGO and the other matters covered thereby, and that such financial forecasts, estimates and other information provided a reasonable basis for its analysis and opinion. TD Cowen relied on the assessments of the management of CARGO as to, among other things, (i) CARGO's product candidate, pipeline, technology and other intellectual property, and the viability of and risks associated with such product candidate, pipeline, technology and other intellectual property, and (ii) the liquidity needs of, and capital resources available to, CARGO for its business and operations. TD Cowen assumed that there would be no developments with respect to any such matters that would have an adverse effect on CARGO, the Offer or the Merger or that otherwise would be meaningful in any respect to TD Cowen's analyses or opinion. TD Cowen expressed no opinion as to the financial forecasts, estimates and other information utilized in TD Cowen's analysis or the assumptions on which they were based.

------

##### [**Table of Contents**](#toc)
In addition, TD Cowen assumed that there had been no material changes in the assets, liabilities, financial condition, results of operations, business or prospects of CARGO since the dates of the last financial statements made available to TD Cowen. TD Cowen did not make or obtain any independent evaluations, valuations or appraisals of the assets or liabilities (contingent, accrued, derivative, off-balance sheet or otherwise) of CARGO or any other entity, nor was TD Cowen furnished with such materials. TD Cowen did not conduct nor did TD Cowen assume any obligation to conduct any physical inspection of the properties or facilities of CARGO or any other entity. TD Cowen also did not evaluate the solvency or fair value of CARGO or any other entity under any state, federal or foreign laws relating to bankruptcy, insolvency or similar matters. In addition, TD Cowen did not undertake an independent evaluation of any actual or potential litigation, settlements, governmental or regulatory proceedings or investigations, possible unasserted claims or other contingent liabilities to which CARGO or any other entity may be a party or subject. TD Cowen's opinion did not address any legal, tax, accounting or regulatory matters related to the Merger Agreement, the CVR Agreement, the Offer or the Merger, as to which TD Cowen assumed that CARGO and the CARGO Board received such advice from legal, tax, accounting and regulatory advisors as each determined appropriate.

TD Cowen's opinion addressed only the fairness of the $4.379 per Share upfront cash consideration from a financial point of view and as of the date of its opinion, without regard to individual circumstances of specific holders (whether by virtue of control, voting or consent, liquidity, contractual arrangements, vesting or acceleration of securities or otherwise) that may distinguish such holders or the securities of CARGO held by such holders, and TD Cowen's opinion did not in any way address proportionate allocation or relative fairness among such holders, holders of any other securities of CARGO or otherwise. TD Cowen expressed no view as to any other aspect or implication of the Offer or the Merger, including, without limitation, the form or structure of the Offer or the Merger or any term, aspect or implication of the CVR, any tender and support agreement, guaranty or any other agreement, arrangement or understanding entered into in connection with the Offer, the Merger or otherwise. TD Cowen's opinion was necessarily based upon economic and market conditions and other circumstances as they existed and could be evaluated by TD Cowen on the date of such opinion. It should be understood that although subsequent developments may affect TD Cowen's opinion, TD Cowen does not have any obligation to update, revise or reaffirm its opinion and TD Cowen expressly disclaims any responsibility to do so. As the CARGO Board was aware, the credit, financial and stock markets, the industry in which CARGO operates and CARGO's business and securities, have experienced and may continue to experience volatility and disruptions, and TD Cowen expressed no view as to any potential effects of such volatility or disruptions on CARGO, the Offer or the Merger.

TD Cowen did not consider any potential legislative or regulatory changes currently being considered or recently enacted by the United States or any foreign government, or any domestic or foreign regulatory body, or any changes in accounting methods or generally accepted accounting principles that may be adopted by the SEC, the Financial Accounting Standards Board, or any similar foreign regulatory body or board.

For purposes of rendering its opinion, TD Cowen assumed in all respects relevant to its analyses that the representations and warranties of each party contained in the Merger Agreement and the CVR Agreement were true and correct, that each party would perform all of the covenants and agreements required to be performed by it under the Merger Agreement and the CVR Agreement and that all conditions to the consummation of the Offer and the Merger would be satisfied without waiver thereof. TD Cowen also assumed that the final versions of the Merger Agreement and the CVR Agreement, when executed, would be substantially similar to the versions reviewed by TD Cowen. TD Cowen further assumed that all governmental, regulatory and other consents and approvals contemplated by the Merger Agreement and the CVR Agreement would be obtained and that in the course of obtaining any of those consents no restrictions would be imposed or waivers made that would have an adverse effect on CARGO, the Offer or the Merger. In addition, TD Cowen assumed that the Offer and the Merger would be consummated in a manner that complies with the provisions of applicable securities laws and all other applicable state, federal or foreign statutes, rules and regulations.

It was understood that TD Cowen's opinion was intended for the benefit and use of the CARGO Board (in its capacity as such) in its evaluation of the $4.379 per Share upfront cash consideration. TD Cowen's opinion did

------

##### [**Table of Contents**](#toc)
not constitute a recommendation to the CARGO Board on whether or not to approve the Offer or the Merger and does not constitute a recommendation to any securityholder or any other person as to whether to tender Shares in the Offer or take any other action in connection with the Offer, the Merger or otherwise. TD Cowen expressed no opinion as to the actual value, price or trading range of Shares or any other securities of CARGO following announcement or consummation of the Offer or the Merger. TD Cowen was not requested to opine as to, and its opinion did not in any manner address, CARGO's underlying business decision to effect the Offer or the Merger or the relative merits of the Offer or the Merger as compared to other business strategies or transactions that might be available to CARGO. In addition, TD Cowen was not requested to opine as to, and its opinion did not in any manner address, (i) the fairness of the amount or nature of the compensation to the officers, directors or employees, or class of such persons, of any parties to the Offer or the Merger relative to the $4.379 per Share upfront cash consideration or otherwise, (ii) the fairness of the Offer, the Merger, the $4.379 per Share upfront cash consideration (except to the extent expressly specified in TD Cowen's opinion) or the CVR to the holders of any class of securities, creditors or other constituencies of CARGO or (iii) whether Parent or Merger Sub has sufficient cash, available lines of credit or other sources of funds to enable it to pay the $4.379 per Share upfront cash consideration at the closing of the Transaction.

***Financial Analysis***

The summary of the financial analysis described below under this heading "—*Financial Analysis*" is a summary of the material financial analysis performed by TD Cowen to arrive at its opinion. The summary of TD Cowen's financial analysis includes information presented in tabular format. In order to fully understand the financial analysis, the table must be read together with the text of such summary. The table alone does not constitute a complete description of the financial analysis. Considering the data set forth in the table without considering the full narrative description of the financial analysis, including the methodologies and assumptions underlying the analysis, could create a misleading or incomplete view of the financial analysis. TD Cowen performed certain procedures, including the financial analysis described below, and reviewed with the CARGO Board certain assumptions on which such analysis was based and other factors, including the historical and projected financial results of CARGO.

Given that CARGO management advised TD Cowen that CARGO did not have a standalone business plan and that CARGO intended, in the absence of a sale or similar transaction involving CARGO, to pursue a liquidation of CARGO, traditional methodologies typically used for purposes of analyzing a business as a going concern were not applicable with respect to CARGO. Accordingly, TD Cowen was directed to use and rely upon CARGO management's liquidation analysis for purposes of TD Cowen's analysis and opinion.

As reflected in CARGO management's liquidation analysis, CARGO management assumed an initial distribution of approximately $3.26 per Share in October 2025 and a final distribution of approximately $1.33 per Share in calendar year 2028 upon a liquidation, resulting in a total distribution (undiscounted) upon liquidation of approximately $4.59 per Share. TD Cowen applied to such total estimated distributable amount a selected discount rate ranging from 6.8% to 15.5%, assuming 80% to 100% of the amount available for the final distribution payable in calendar year 2028, to derive an estimated net present value per Share reference range for the total estimated per Share amount distributable upon liquidation as estimated by CARGO management. No value was attributable to the CVR for purposes of such analysis. This analysis indicated the following approximate implied estimated net present value (as of August 31, 2025) per Share reference range for the total per Share distributable amount upon liquidation of CARGO based on CARGO management's liquidation analysis, as compared to the per Share upfront cash consideration payable in the Offer and the Merger:

---

| | |
|:---|:---|
| **Approximate Implied Estimated Net Present Value Per Share<br>Reference Range of Total Distributable Per Share Amount Upon<br>Liquidation** | **Upfront Per Share Cash Consideration Payable in the Offer<br>and the Merger** |
| $3.93 - $4.42 | $4.379 |

---

------

##### [**Table of Contents**](#toc)
***Miscellaneous***

The summary set forth above does not purport to be a complete description of all analyses performed or factors considered by TD Cowen. The preparation of a fairness opinion involves various determinations as to the most appropriate and relevant methods of financial analysis and the application of these methods to the particular circumstances and, therefore, such an opinion is not readily susceptible to partial analysis or summary description. TD Cowen did not attribute any particular weight to any analysis or factor considered by it, but rather made qualitative judgments as to the significance and relevance of each analysis and factor. TD Cowen believes that such analysis and factors must be considered as a whole and that selecting portions of its analysis or factors considered by it, without considering all aspects of such analysis and factors, could create an incomplete view of the process underlying its opinion. In performing its analysis, TD Cowen made numerous assumptions with respect to industry performance, business and economic conditions and other matters, many of which are beyond the control of CARGO. The analysis performed by TD Cowen is not necessarily indicative of actual values or future results, which may be significantly more or less favorable than suggested by such analysis. In addition, analyses relating to the value of businesses do not purport to be appraisals or to reflect the prices at which businesses or securities may actually be acquired or sold. Accordingly, such analyses and estimates are inherently subject to uncertainty and are based upon numerous factors or events beyond the control of the parties or their respective advisors. None of CARGO, TD Cowen or any other person assumes responsibility if future results are materially different from those projected. The analysis performed by TD Cowen and its opinion were only one among many factors taken into consideration by the CARGO Board in evaluating the $4.379 per Share upfront cash consideration and should not be considered as determinative of the views of the CARGO Board or CARGO management with respect to the Offer, the Merger, the consideration payable in the Offer and the Merger or otherwise.

TD Cowen was selected by CARGO to act as CARGO's financial advisor in connection with the Offer and the Merger because TD Cowen is a nationally recognized investment banking firm with experience in transactions similar to the Offer and the Merger and is familiar with CARGO and its business. As part of its investment banking business, TD Cowen is continually engaged in the valuation of businesses and their securities in connection with mergers and acquisitions, negotiated underwritings, secondary distributions of listed and unlisted securities, private placements and valuations for corporate and other purposes.

TD Cowen is acting as financial advisor to CARGO in connection with the Offer and the Merger and will receive for such services an aggregate fee currently estimated to be approximately $4.3 million, of which a portion was payable in connection with TD Cowen's opinion and approximately $3.3 million is payable contingent upon consummation of the Offer. In addition, CARGO has agreed to reimburse TD Cowen's expenses, including fees and expenses of counsel, and indemnify TD Cowen for certain liabilities, including liabilities under federal securities laws, that may arise out of TD Cowen's engagement.

As the CARGO Board was aware, TD Cowen and its affiliates in the past have provided, currently are providing, and in the future may provide, financial advisory and/or investment banking services to CARGO and/or its affiliates unrelated to the Offer and the Merger, for which services TD Cowen and its affiliates have received and would expect receive compensation, including during the approximate two-year period preceding the date of TD Cowen's opinion, having acted or acting as (i) bookrunning underwriter for the initial public offering of Shares, (ii) joint placement agent for a private placement of Shares and (iii) sales agent for CARGO's at-the-market equity offering program, for which services described in clauses (i) through (iii) above TD Cowen received during such two-year period aggregate fees of approximately $6.5 million. As the CARGO Board also was aware, although TD Cowen and its affiliates were not providing as of the date of its opinion, and during the approximate two-year period preceding the date of its opinion had not provided, financial advisory and/or other investment banking services to Parent, TD Cowen and/or its affiliates in the future may provide services to Parent and/or its affiliates and may receive compensation for such services.

TD Cowen and its affiliates provide investment and commercial banking, lending, asset management and other financial and non-financial services to a wide range of corporations and individuals and, as part of their

------

##### [**Table of Contents**](#toc)
investment banking business, are continually engaged in the valuation of businesses and their securities in connection with mergers and acquisitions, negotiated underwritings, secondary distributions of listed and unlisted securities, private placements and valuations for corporate and other purposes. In the ordinary course of business, TD Cowen and/or its affiliates may at any time hold long or short positions, and may trade or otherwise effect transactions in, debt, equity and/or other securities or loans of CARGO, Parent and/or their respective affiliates for the accounts of TD Cowen and/or its affiliates and for the accounts of customers. TD Cowen and its affiliates also conduct research on securities and may, in the ordinary course of business, provide research reports and investment advice to their clients on investment matters, including matters with respect to the Offer and the Merger, CARGO, Parent and/or their respective affiliates. The issuance of TD Cowen's opinion was approved by TD Cowen's fairness opinion review committee.

**Intent to Tender** 

To the knowledge of CARGO, after making reasonable inquiry to the extent permitted by applicable securities laws, rules or regulations, all of CARGO's executive officers, directors and affiliates currently intend to tender, or cause to be tendered, all Shares held of record or beneficially owned by such persons or entities pursuant to the Offer, as it may be extended (other than Shares for which such holder does not have discretionary authority). The foregoing does not include any Shares over which, or with respect to which, any such executive officer or director acts in a fiduciary or representative capacity or is subject to the instructions of a third party with respect to such tender.

**ITEM 5. PERSONS/ASSETS RETAINED, EMPLOYED, COMPENSATED OR USED** 

Neither CARGO nor any person acting on its behalf has or currently intends to employ, retain or compensate any person to make solicitations or recommendations to the stockholders of CARGO on its behalf with respect to the Offer or the Merger, except that such solicitations or recommendations may be made by directors, officers or employees of CARGO, for which services no additional compensation will be paid.

**ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY** 

Other than (i) the scheduled vesting of CARGO RSUs and issuances by CARGO with respect thereto, (ii) the scheduled vesting of CARGO Options, and (iii) the grant of CARGO Options and CARGO RSUs in the ordinary course (including pursuant to the Non-Employee Director Compensation Program), no transactions with respect to Shares have been effected by CARGO or, to the knowledge of CARGO after making reasonable inquiry, by any of its executive officer, directors or affiliates during the sixty (60) days prior to the date of this Schedule 14D-9, except for the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** | **Date of<br>Transaction** | **Nature of Transaction** | **Number of Shares** | **Price Per<br>Share ($)** |
|  Anup Radhakrishnan | 07/02/2025 | Sale to cover withholding taxes upon vesting of CARGO RSUs | 1632 | 4.18 |

---

**ITEM 7. PURPOSES OF THE TRANSACTION AND PLANS OR PROPOSALS** 

Except as set forth in this Schedule 14D-9 (including the exhibits to this Schedule 14D-9 or incorporated in this Schedule 14D-9 by reference), CARGO is not currently undertaking or engaged in any negotiations in response to the Offer that relate to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a tender offer for, or other acquisition of, CARGO's securities by CARGO or any other person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any extraordinary transaction, such as a merger, reorganization or liquidation, involving CARGO;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any purchase, sale or transfer of a material amount of assets of CARGO; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any material change in the present dividend rate or policy or indebtedness or capitalization of CARGO.

------

##### [**Table of Contents**](#toc)
Except as set forth in this Schedule 14D-9 (including the exhibits to this Schedule 14D-9 or incorporated in this Schedule 14D-9 by reference), there are no transactions, resolutions of the CARGO Board or the Transaction Committee thereof, agreements in principle or signed contracts entered into in response to the Offer that relate to, or would result in, one or more of the matters referred to in the preceding paragraph.

**ITEM 8. ADDITIONAL INFORMATION** 

The information set forth in Item 3 under the heading *"Arrangements Between CARGO and its Executive Officer, Directors and Affiliates"* is incorporated herein by reference.

**Vote Required to Approve the Merger** 

The CARGO Board has unanimously approved the Merger Agreement and the Transactions, including the Offer and the Merger, in accordance with the DGCL. The CARGO Board approved the Merger Agreement and the Transactions, including the Offer and the Merger, in accordance with the DGCL. Section 251(h) of the DGCL provides that following consummation of a successful tender offer for a public corporation (the shares of which are listed on a national securities exchange or held of record by more than 2,000 holders), and subject to certain statutory provisions, if the acquirer holds at least the number of shares of the target corporation and of each class or series of stock of the target corporation that would otherwise be required to approve a merger for the target corporation, and the other stockholders receive the same consideration for their stock in the merger as was payable in the tender offer, the acquirer can effect a merger without the action of the other stockholders of the target corporation. Accordingly, if the Offer is consummated, CARGO, Parent and Merger Sub intend to effect the Merger Closing without a vote of the stockholders of CARGO in accordance with Section 251(h) of the DGCL.

**Anti-Takeover Statute** 

***Delaware***

As a Delaware corporation, the Company is subject to Section 203 of the DGCL ("Section 203"). In general, Section 203 would prevent an "interested stockholder" (generally defined as a person beneficially owning 15% or more of a corporation's voting stock) from engaging in a "business combination" (as defined in Section 203) with a Delaware corporation for three (3) years following the date such person became an interested stockholder unless: (i) before such person became an interested stockholder, the board of directors of the corporation approved the transaction in which the interested stockholder became an interested stockholder or approved the business combination, (ii) upon consummation of the transaction which resulted in the interested stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced (excluding, for purposes of determining the number of shares of outstanding stock (but not the outstanding voting stock owned by the interested stockholder), shares held by directors who are also officers and by employee stock plans that do not allow plan participants to determine confidentially whether to tender shares), or (iii) following the transaction in which such person became an interested stockholder, the business combination is (A) approved by the board of directors of the corporation and (B) authorized at a meeting of stockholders by the affirmative vote of the holders of at least 66 2/3% of the outstanding voting stock of the corporation not owned by the interested stockholder. In accordance with the provisions of Section 203, the CARGO Board has approved the Merger Agreement and the Transactions, as described in Item 4 under the heading "*The Solicitation or Recommendation*" and, therefore, the restrictions of Section 203 are inapplicable to the Merger and the Transactions.

**Appraisal Rights** 

No appraisal rights are available in connection with the Offer and stockholders who tender their Shares in the Offer will not have appraisal rights in connection with the Merger. However, if the Offer is successful and the Merger is consummated, holders of record and beneficial owners of Shares outstanding as of immediately prior to

------

##### [**Table of Contents**](#toc)
the Effective Time and beneficial owners of the Company who: (i) did not tender their Shares in the Offer (or, if tendered, validly and subsequently withdrew such Shares prior to the time Parent accepts properly tendered Shares for purchase (the "Acceptance Time")); (ii) otherwise comply with the applicable procedures under Section 262 of the DGCL; (iii) do not thereafter withdraw their demand for appraisal of such Shares or otherwise lose their appraisal rights, in each case in accordance with the DGCL; and (iv) in the case of a beneficial owner, have submitted a demand that (A) reasonably identifies the holder of record of the shares for which the demand is made, (B) is accompanied by documentary evidence of such beneficial owner's beneficial ownership of stock and a statement that such documentary evidence is a true and correct copy of what it purports to be, and (C) provides an address at which such beneficial owner consents to receive notices given by the Company and to be set forth on the Verified List (as defined below) to be filed with the Register in Chancery in the Delaware Court of Chancery (the "Delaware Court"), will be entitled to demand appraisal of their Shares and receive, in lieu of the consideration payable in the Merger, a cash payment equal to the "fair value" of their Shares, as determined by the Delaware Court, in accordance with Section 262 of the DGCL, plus interest if any, on the amount determined to be the fair value. Stockholders and beneficial owners should be aware that the fair value of their Shares could be more than, the same as or less than the Offer Price or the consideration to be received pursuant to the Merger and that an investment banking opinion as to the fairness, from a financial point of view, of the consideration payable in a sale transaction, such as the Offer and the Merger, is not an opinion as to, and does not otherwise address, fair value under Section 262 of the DGCL.

**The following is a summary of the appraisal rights of stockholders and beneficial owners under Section 262 of the DGCL in connection with the Merger, assuming that the Merger is consummated in accordance with Section 251(h) of the DGCL. The full text of Section 262 of the DGCL may be accessed without subscription or cost at *https://delcode.delaware.gov/title8/c001/sc09/index.html#262*. This summary does not purport to be a complete statement of, and is qualified in its entirety by reference to, Section 262 of the DGCL**. All references in Section 262 of the DGCL and in this summary to a (i) "stockholder" are to the record holder of Shares immediately prior to the Effective Time as to which appraisal rights are asserted and (ii) "beneficial owner" are to a person who is the beneficial owner of Shares held either in voting trust or by a nominee on behalf of such person. Failure to follow any of the procedures of Section 262 of the DGCL may result in termination or waiver of appraisal rights under Section 262 of the DGCL. Any stockholder or beneficial owner who desires to exercise his, her or its appraisal rights should carefully review Section 262 of the DGCL and is urged to consult his, her or its legal advisor before electing or attempting to exercise such rights.

Under Section 262 of the DGCL, where a merger is approved under Section 251(h), either a constituent corporation before the effective date of the merger, or the surviving corporation within ten (10) days thereafter, will notify each of the holders of any class or series of stock of such constituent corporation who are entitled to appraisal rights of the approval of the merger, consolidation or conversion and that appraisal rights are available for any or all shares of such class or series of stock of such constituent corporation, and will include in such notice a copy of Section 262 of the DGCL or information directing the stockholders to a publicly available electronic resource at which Section 262 of the DGCL may be accessed without subscription or cost. **The record date for determining the stockholders entitled to receive this notice of appraisal shall be the close of business on the day next preceding the date this notice is given, in accordance with Section 262(d)(2) of the DGCL. This Schedule 14D-9 constitutes the formal notice of appraisal rights under Section 262 of the DGCL. Any holder of record or beneficial owner of Shares who wishes to exercise such appraisal rights or who wishes to preserve his, her or its right to do so should review the following discussion and Section 262 of the DGCL carefully because failure to timely and properly comply with the procedures specified will result in the loss of appraisal rights under the DGCL**.

If a stockholder or beneficial owner elects to exercise appraisal rights under Section 262 of the DGCL such stockholder or beneficial owner must do all of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• prior to the later of the consummation of the Offer, which occurs when Parent has accepted for payment Shares
tendered into the Offer following the expiration date of the Offer, and twenty (20) business days

------

##### [**Table of Contents**](#toc)
after the date this Schedule 14D-9 is provided (which such date is July 23, 2025), deliver to the Company at the address indicated below a written demand for appraisal of Shares held, which demand must reasonably inform the Company of the identity of the person seeking appraisal and that such person is demanding appraisal; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• not tender such stockholder's or beneficial owner's Shares in the Offer (or, if tendered, validly and
subsequently withdraw such Shares prior to the Acceptance Time);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continuously hold of record or beneficially own the Shares from the date on which the written demand for
appraisal is made through the Effective Time; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• comply with the procedures of Section 262 of the DGCL for perfecting appraisal rights thereafter.

In addition, one of the ownership thresholds (as defined below) must be met and a stockholder (or any person who is the beneficial owner of Shares held either in a voting trust or by a nominee on behalf of such person) who has complied with the requirements of Section 262 of the DGCL or the Surviving Corporation must file a petition in the Delaware Court demanding a determination of the value of the stock of all such persons entitled to appraisal within 120 days after the Effective Time. The Surviving Corporation is under no obligation to file any such petition and has no intention of doing so.

If the Merger is consummated pursuant to Section 251(h) of the DGCL, within ten (10) days after the Effective Time, Parent will cause the Surviving Corporation to notify all of the Company's stockholders or beneficial owners who delivered a written demand to the Company of the Effective Time (in accordance with Section 262). However, only stockholders or beneficial owners who have delivered a written demand in accordance with Section 262 will receive such notice. If the Merger is consummated pursuant to Section 251(h) of the DGCL, a failure to deliver a written demand for appraisal in accordance with the time periods specified in the first bullet above (or to take any of the other steps specified in the above bullets or summarized below) will be deemed to be a waiver or a termination of your appraisal rights.

***Written Demand***

All written demands for appraisal should be addressed to CARGO Therapeutics, Inc., 835 Industrial Drive, Suite 400, San Carlos, California 94070.

A record stockholder, such as a broker, bank, fiduciary, depositary or other nominees, who holds Shares as a nominee for several beneficial owners may exercise appraisal rights with respect to the Shares held for one or more beneficial owners while not exercising such rights with respect to the Shares held for other beneficial owners. In such case, the written demand for appraisal must set forth the number of Shares covered by such demand. Unless a demand for appraisal specifies a number of Shares, such demand will be presumed to cover all Shares held in the name of such record owner. Alternatively, a beneficial owner may demand appraisal, in his, her or its own name, of such beneficial owner's shares, provided that (i) such beneficial owner continuously owns such Shares through the Effective Time and (ii) the demand made by such beneficial owner reasonably identifies the holder of record of the Shares for which the demand is made, is accompanied by documentary evidence of such beneficial owner's beneficial ownership of stock and a statement that such documentary evidence is a true and correct copy of what it purports to be, and provides an address at which such beneficial owner consents to receive notices given by the Surviving Corporation under Section 262 and to be set forth on the Verified List (as defined below).

***Filing a Petition for Appraisal***

Within 120 days after the Effective Time, but not thereafter, the Surviving Corporation, or any holder of record or beneficial owner of Shares who has complied with Section 262 of the DGCL and is entitled to appraisal rights under Section 262, may commence an appraisal proceeding by filing a petition in the Delaware Court demanding a determination of the fair value of the Shares held of record or beneficially owned by all persons who

------

##### [**Table of Contents**](#toc)
did not tender in the Offer (or, if tendered, subsequently and validly withdrew such Shares before the Acceptance Time) and who timely and properly demanded appraisal. If no such petition is filed within that 120-day period, appraisal rights will be lost for all persons who had previously demanded appraisal of their Shares. The Company is under no obligation, and has no present intention, to file a petition, and holders should not assume that the Surviving Corporation will file a petition or that it will initiate any negotiations with respect to the fair value of the Shares. Accordingly, it is the obligation of the holders of record or beneficial owners of Shares to initiate all necessary action to perfect their appraisal rights in respect of the Shares within the period prescribed in Section 262 of the DGCL.

Within 120 days after the Effective Time, any stockholder or beneficial owner who has complied with the requirements for exercise of appraisal rights will be entitled, upon written request, to receive from the Surviving Corporation a statement setting forth the aggregate number of Shares not tendered into, and accepted for purchase in, the Offer and with respect to which demands for appraisal have been received and the aggregate number of holders of such Shares (provided that, where a beneficial owner makes a demand pursuant to paragraph (d)(3) of Section 262, the record holders of such Shares shall not be considered a separate stockholder holding such Shares for purposes of such aggregate number). Such statement must be provided to the stockholder or beneficial owner within ten (10) days after a written request by such stockholder or beneficial owner for the information has been received by the Surviving Corporation or within ten (10) days after the expiration of the period for delivery of demands for appraisal, whichever is later.

Upon the filing of such petition by any such holder of record or beneficial owners of Shares, service of a copy thereof must be made upon the Surviving Corporation, which will then be obligated within twenty (20) days to file with the Register in Chancery in the Delaware Court a duly verified list (the "Verified List") containing the names and addresses of all stockholders or beneficial owners who have demanded payment for their Shares and with whom agreements as to the value of their Shares has not been reached. Upon the filing of any such petition, the Delaware Court may order a hearing and that notice of the time and place fixed for the hearing on the petition be provided to the Surviving Corporation and all of the stockholders or beneficial owners shown on the Verified List. The forms of the notice by mail and by publication will be approved by the Delaware Court. The costs relating to these notices will be borne by the Surviving Corporation.

If a hearing on the petition is held, the Delaware Court is empowered to determine those stockholders or beneficial owners who have complied with the provisions of Section 262 of the DGCL and who have become entitled to appraisal rights thereunder, and whether the ownership thresholds are met. The Delaware Court may require the stockholders or beneficial owners who demanded an appraisal for their Shares and who hold Shares represented by certificates to submit their stock certificates to the Delaware Register in Chancery for notation thereon of the pendency of the appraisal proceedings. The Delaware Court is empowered to dismiss the proceedings as to any person who does not comply with such requirement. Accordingly, stockholders or beneficial owners are cautioned to retain the certificates evidencing their Shares pending resolution of the appraisal proceedings. Because, immediately before the Effective Time, the Shares will be listed on a nationally recognized securities exchange, and because the Merger will not be approved pursuant to Section 253 or Section 267 of the DGCL, the Delaware Court will dismiss the proceedings as to all holders of Shares who are otherwise entitled to appraisal rights unless (i) the total number of Shares entitled to appraisal exceeds 1% of the outstanding Shares eligible for appraisal or (ii) the value of the consideration provided in the Merger for such total number of Shares exceeds $1 million. We refer to the foregoing as the "ownership thresholds."

***Determination of Fair Value***

After the Delaware Court determines which stockholders or beneficial owners are entitled to appraisal, the appraisal proceeding will be conducted in accordance with the rules of the Delaware Court, including any rules specifically governing appraisal proceedings. Through such proceeding, the Delaware Court will determine the fair value of the Shares as of the Effective Time, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid upon the amount

------

##### [**Table of Contents**](#toc)
determined to be the fair value. Unless the Delaware Court in its discretion determines otherwise for good cause shown, interest from the Effective Time through the date of payment of the judgment will be compounded quarterly and will accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the Effective Time and the date of payment of the judgment. At any time before the entry of judgment in the proceedings, the Surviving Corporation may pay to each holder of Shares entitled to appraisal an amount in cash, in which case interest will accrue thereafter only upon the sum of (i) the difference, if any, between the amount so paid and the fair value of the Shares as determined by the Delaware Court and (ii) interest theretofore accrued, unless paid at that time. The Surviving Corporation is under no obligation to make such voluntary cash payment to the holder prior to such entry of judgment.

In determining the fair value, the court is to take into account all relevant factors. In *Weinberger v. UOP, Inc.*, the Supreme Court of Delaware discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that "proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court" should be considered, and that "[f]air price obviously requires consideration of all relevant factors involving the value of a company." The Supreme Court of Delaware stated that, in making this determination of fair value, the Delaware Court must consider market value, asset value, dividends, earning prospects, the nature of the enterprise and any other facts that could be ascertained as of the date of the merger that "throw any light on future prospects of the merged corporation." Section 262 of the DGCL provides that fair value is to be "exclusive of any element of value arising from the accomplishment or expectation of the merger." In *Cede & Co. v. Technicolor, Inc.*, the Supreme Court of Delaware stated that such exclusion is a "narrow exclusion [that] does not encompass known elements of value," but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In *Weinberger*, the Supreme Court of Delaware also stated that "elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered."

Stockholders and beneficial owners considering appraisal should be aware that the fair value of their Shares as so determined could be more than, the same as or less than the Offer Price and that an investment banking opinion as to the fairness, from a financial point of view, of the consideration payable in a sale transaction, such as the Offer and the Merger, is not an opinion as to, and does not otherwise address, "fair value" under Section 262 of the DGCL.

Although the Company believes that the Offer Price is fair, no representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court, and stockholders or beneficial owners should recognize that such an appraisal could result in a determination of a value higher or lower than, or the same as, the Offer Price. Neither Parent nor the Company anticipates offering more than the Offer Price to any stockholder or beneficial owner exercising appraisal rights, and they reserve the right to assert, in any appraisal proceeding, that for purposes of Section 262 of the DGCL, the fair value of a Share is less than the Offer Price.

Upon application by the Surviving Corporation or by any holder of record or beneficial owner of Shares entitled to participate in the appraisal proceeding, the Delaware Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the stockholders or beneficial owners entitled to an appraisal. Any person whose name appears on the Verified List and who has submitted such person's certificates of stock to the Register in Chancery in the Delaware Court, if such is required, may participate fully in all proceedings until it is finally determined that such stockholder or beneficial owner is not entitled to appraisal rights. The Delaware Court will direct the payment of the fair value of the Shares, together with interest, if any, by the Surviving Corporation to the stockholders or beneficial owners entitled thereto. Payment will be so made to each such stockholder or beneficial owner upon the surrender to the Surviving Corporation of such person's certificates. The Delaware Court's decree may be enforced as other decrees in such Court may be enforced.

If a petition for appraisal is not timely filed, then the right to an appraisal will cease. The Delaware Court may also (i) determine the costs of the proceeding (which do not include attorneys' fees or the fees and expenses

------

##### [**Table of Contents**](#toc)
of experts) and tax such costs among the parties as the Delaware Court deems equitable and (ii) upon application of a stockholder or beneficial owner whose name appears on the Verified List who participated in the proceeding and incurred expenses in connection therewith (an "application"), order all or a portion of the expenses incurred by any stockholder or beneficial owner in connection with the appraisal proceeding, including, without limitation, reasonable attorneys' fees and fees and expenses of experts, to be charged pro rata against the value of all Shares entitled to appraisal. In the absence of such determination or assessment, each party bears its own expenses. Determinations by the Delaware Court are subject to appellate review by the Supreme Court of Delaware.

From and after the Effective Time, any stockholder or beneficial owner who has duly demanded and perfected appraisal rights in compliance with Section 262 of the DGCL will not be entitled to vote his, her or its Shares for any purpose and will not be entitled to receive payment of dividends or other distributions in respect of such Shares (except dividends or other distributions payable to stockholders or beneficial owners of record as of a date prior to the Effective Time if so declared by the Surviving Corporation).

If any stockholder or beneficial owner who demands appraisal of Shares under Section 262 of the DGCL fails to perfect, successfully withdraws or loses such holder's right to appraisal, such stockholder's or beneficial owner's Shares will be deemed to have been converted at the Effective Time into the right to receive the Merger Consideration, net to the stockholder or beneficial owner in cash, without interest, subject to any withholding taxes required by applicable law. A stockholder or beneficial owner will fail to perfect, or effectively lose, the stockholder's or beneficial owner's right to appraisal if no petition for appraisal is filed with the Delaware Court within 120 days after the Effective Time; however, such stockholder or beneficial owner is entitled to receive the Merger Consideration. In addition, a stockholder or beneficial owner who has not commenced an appraisal proceeding or joined that proceeding as a named party may withdraw his, her or its demand for appraisal in accordance with Section 262 of the DGCL and accept the consideration payable in connection with the Merger by delivering to the Surviving Corporation a written withdrawal of such stockholder's or beneficial owner's demand for appraisal and acceptance of the Merger either within sixty (60) days after the effective date of the Merger or thereafter with the written approval of the Surviving Corporation.

Notwithstanding the foregoing, no appraisal proceedings in the Delaware Court will be dismissed as to any stockholder or beneficial owner without the approval of the Delaware Court, and this approval may be conditioned upon such terms as the Delaware Court deems just, including, without limitation, a reservation of jurisdiction (a "reservation") for any application to the Delaware Court; provided, however, that the limitation set forth in this sentence will not affect the right of any stockholder or beneficial owner who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such stockholder's or beneficial owner's demand for appraisal and to accept the terms offered upon the Merger within sixty (60) days after the Effective Time.

The process of exercising appraisal rights requires compliance with technical prerequisites. If you fail to take any required step in connection with the exercise of appraisal rights, it may result in the termination or waiver of your appraisal rights. Stockholders or beneficial owners wishing to exercise appraisal rights should consult with their own legal counsel in connection with compliance with Section 262 of the DGCL.

This summary of appraisal rights under the DGCL is not complete and is qualified in its entirety by reference to Section 262 of the DGCL, a copy of which may be accessed without subscription or cost at *https://delcode.delaware.gov/title8/c001/sc09/index.html#262*. The proper exercise of appraisal rights requires strict adherence to the applicable provisions of the DGCL.

**STOCKHOLDERS OR BENEFICIAL OWNERS WHO SELL SHARES IN THE OFFER AND DO NOT WITHDRAW THEIR TENDER SHARES PRIOR TO THE ACCEPTANCE TIME WILL NOT BE ENTITLED TO EXERCISE APPRAISAL RIGHTS WITH RESPECT THERETO BUT, RATHER, WILL RECEIVE THE OFFER PRICE**.

------

##### [**Table of Contents**](#toc)
**Annual and Quarterly Reports** 

For additional information regarding the business and the financial results of CARGO, please see CARGO's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 12, 2025 and Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, filed with the SEC on May 8, 2025.

**Legal Proceedings** 

There is no pending litigation that CARGO is aware of challenging the Offer, the Merger or the other Transactions.

**Regulatory Approvals** 

Parent and CARGO are not currently aware of any other material governmental consents, approvals or filings that are required prior to the parties' completion of the Offer or the Merger. If the parties become aware of any notices, reports and other documents required to filed with respect to the Offer or the Merger, Parent and CARGO have agreed to use reasonable best efforts to file, as soon as practicable, such notices, reports and other documents, and to submit promptly any information reasonably requested by any governmental entity in connection therewith.

*Important Additional Information and Where to Find It* 

In connection with the proposed acquisition of the Company, Parent commenced the Offer on July 21, 2025 pursuant to the terms of the Merger Agreement. This Schedule 14D-9 is neither an offer to purchase nor a solicitation of an offer to sell any Shares or any other securities. Parent has filed a tender offer statement on the Schedule TO, including the Offer to Purchase, the Letter of Transmittal and related documents, with the SEC, and the Company has filed this Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC. The Offer to purchase the outstanding Shares is only made pursuant to the Offer to Purchase, the Letter of Transmittal and related documents filed as a part of the Schedule TO. **INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE TENDER OFFER MATERIALS (INCLUDING THE OFFER TO PURCHASE, THE LETTER OF TRANSMITTAL AND RELATED DOCUMENTS) AND THIS SOLICITATION/ RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 REGARDING THE OFFER, AS THEY MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND SECURITY HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES, INCLUDING THE TERMS AND CONDITIONS OF THE OFFER.** Investors and security holders may obtain a free copy of these statements and other documents filed with the SEC at the website maintained by the SEC at *www.sec.gov* or by directing such requests to the information agent for the Offer, Alliance Advisors, LLC, toll-free at 1-844-202-5733, email at crgx@allianceadvisors.com. Investors and security holders may also obtain, at no charge, the documents filed or furnished to the SEC by the Company under the "SEC Filings" subsection of the "Financial Information" section of the Company's website at *https://investors.cargo-tx.com/*.

*Cautionary Note Regarding Forward-Looking Statements* 

This Schedule 14D-9 contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as "aim," "anticipate," "believe," "contemplate," "continue," "could," "design," "due," "estimate," "expect," "goal," "intend," "may," "objective," "plan," "positioned," "potential," "predict," "seek," "should," "target," "will," "would" and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. Forward-looking statements are neither historical facts nor assurances of future performance and involve risks and uncertainties that could cause actual results to differ materially from those

------

##### [**Table of Contents**](#toc)
projected, expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the possibility that various closing conditions set forth in the Merger Agreement may not be satisfied or waived, including uncertainties as to the percentage of the Company's stockholders tendering their shares in the Offer; the possibility that competing offers will be made; the risk that the Transactions may not be completed in a timely manner, or at all, which may adversely affect the Company's business and the price of the its common stock; significant costs associated with the proposed Transactions; the risk that any stockholder litigation in connection with the Transactions may result in significant costs of defense, indemnification and liability; the risk that activities related to the CVR Agreement may not result in any value to the Company's stockholders; and other risks and uncertainties discussed in the Company's filings with the SEC, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2024 filed on March 12, 2025. Any forward-looking statements that the Company makes in this Schedule 14D-9 are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, and speak only as of the date hereof. As a result of such risks and uncertainties, the Company's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. There can be no assurance that the proposed Transactions will in fact be consummated. The Company cautions investors not to unduly rely on any forward-looking statements.

The forward-looking statements contained in this Schedule 14D-9 are made as of the date hereof, and the Company undertakes no obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise, except as expressly required by law. All forward-looking statements in this document are qualified in their entirety by this cautionary statement.

**ITEM 9. EXHIBITS** 

---

| | |
|:---|:---|
| Exhibit No. | Description |
|  (a)(1)(A) | [Offer to Purchase, dated July 21, 2025 (incorporated by reference to Exhibit (a)(1)(A) to the Schedule TO).](http://www.sec.gov/Archives/edgar/data/1496323/000114036125025957/ny20051934x1_exa1a.htm) |
|  (a)(1)(B) | [Form of Letter of Transmittal (incorporated by reference to Exhibit (a)(1)(B) to the Schedule TO).](http://www.sec.gov/Archives/edgar/data/1496323/000114036125025957/ny20051934x1_exa1b.htm) |
|  (a)(1)(C) | [Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees (incorporated herein by reference to Exhibit (a)(1)(C) to the Schedule TO).](http://www.sec.gov/Archives/edgar/data/1496323/000114036125025957/ny20051934x1_exa1c.htm) |
|  (a)(1)(D) | [Form of Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(D) to the Schedule TO).](http://www.sec.gov/Archives/edgar/data/1496323/000114036125025957/ny20051934x1_exa1d.htm) |
|  (a)(1)(E)\* | [Opinion of TD Securities (USA) LLC, dated July 7, 2025 (included as Annex I to this Schedule 14D-9).](#annxi) |
|  (a)(5)(A) | [Press Release issued by CARGO on July 8, 2025 (incorporated by reference to Exhibit 99.1 to the Company's Current Report on Form 8-K (File No. 001-39592) filed on July 8, 2025).](http://www.sec.gov/Archives/edgar/data/1966494/000119312525156413/d74755dex991.htm) |
|  (e)(1) | [Agreement and Plan of Merger, dated July 7, 2025, by and among CARGO, Parent and Merger Sub (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K (File No. 001-41859) filed on July 8, 2025).](http://www.sec.gov/Archives/edgar/data/1966494/000119312525156413/d74755dex21.htm) |
|  (e)(2) | [Form of Contingent Value Rights Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 001-41859) filed on July 8, 2025).](http://www.sec.gov/Archives/edgar/data/1966494/000119312525156413/d74755dex101.htm) |
|  (e)(3) | [Form of Tender and Support Agreement (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K (File No. 001-41859) filed on July 8, 2025).](http://www.sec.gov/Archives/edgar/data/1966494/000119312525156413/d74755dex101.htm) |
|  (e)(4) | [Limited Guaranty, dated as of July 7, 2025 (incorporated by reference to Exhibit (d)(3) to the Schedule TO).](http://www.sec.gov/Archives/edgar/data/1496323/000114036125025957/ny20051934x1_exd3.htm) |
|  (e)(5) | [Mutual Confidentiality Agreement, dated March 28, 2025, by and between CARGO and Tang Capital Management, LLC (incorporated by reference to Exhibit (d)(2) to the Schedule TO).](http://www.sec.gov/Archives/edgar/data/1966494/000199937125009491/ex99-d2.htm) |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| Exhibit No. | Description |
|  (e)(6) | CARGO Therapeutics, Inc. [2021 Stock Option and Grant Plan](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex105a.htm), as amended, and [Forms of Incentive Stock Option Grant Notice](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex105b.htm), [Incentive Stock Option Agreement, Notice of Exercise and Notice of Early Exercise thereunder](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex105c.htm) (incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form S-1 (File No. 333-275113), as amended, filed with the SEC on November 6, 2023). |
|  (e)(7) | CARGO Therapeutics, Inc. [2023 Incentive Award Plan](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex106a.htm), and [Forms of Stock Option Agreement, Stock Option Grant Notice, Restricted Stock Unit Award Grant Notice and Restricted Stock Award Agreement thereunder](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex106b.htm) (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on S-1 (File No. 333-275113), as amended, filed with the SEC on November 6, 2023). |
|  (e)(8) | [CARGO Therapeutics, Inc. 2023 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form S-1 (File No. 333-275113), as amended, filed with the SEC on November 6, 2023).](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex107.htm) |
|  (e)(9) | [Form of Employment Agreement (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on form 10-K (File No 001-41859), filed with the SEC on March 12, 2025).](http://www.sec.gov/Archives/edgar/data/1966494/000095017025037929/crgx-ex10_22.htm) |
|  (e)(10) | [Amended and Restated Non-Employee Director Compensation Program (incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on form 10-Q (File No 001-41859), filed with the SEC on August 12, 2024).](http://www.sec.gov/Archives/edgar/data/1966494/000095017024095427/crgx-ex10_3.htm) |
|  (e)(11) | [Form of Indemnification and Advancement Agreement, by and between the Company and its directors and officers (incorporated by reference to Exhibit 10.11 to the Company's Registration Statement on Form S-1 (File No. 333-275113), as amended, filed with the SEC on November 6, 2023).](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex1011.htm) |
|  (e)(12) | [Amended and Restated Investors' Rights Agreement, by and among the Company and certain of its stockholders, dated February 9, 2023 (incorporated by reference to Exhibit 4.3 to the Company's Registration Statement on Form S-1 (File No. 333-275113), as amended, filed with the SEC on November 6, 2023).](http://www.sec.gov/Archives/edgar/data/1966494/000119312523270801/d486542dex43.htm) |
|  (e)(13) | [Form of Amended and Restated Certificate of Incorporation of the Company to be effective at the Effective Time (incorporated by reference to Exhibit B of Exhibit 2.1 to the Company's Current Report on Form 8-K (File No. 001-41859) filed on July 8, 2025).](http://www.sec.gov/Archives/edgar/data/1966494/000119312525156413/d74755dex21.htm) |
|  (e)(14)\* | [Form of Amended and Restated Bylaws of the Company to be effective at the Effective Time.](d78481dex99e14.htm) |
|  (e)(15)\* | [Retention Bonus Letter Agreement, dated March 28, 2025, by and between the Company and Anup Radhakrishnan.](d78481dex99e15.htm) |
|  (e)(16)\* | [Separation Agreement, dated April 9, 2025, by and between the Company and Anup Radhakrishnan.](d78481dex99e16.htm) |
| (g) | Not applicable. |

---

\* Filed herewith.

------

##### [**Table of Contents**](#toc)
**SIGNATURE** 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: July 23, 2025

---

| | |
|:---|:---|
| **CARGO Therapeutics, Inc.** | **CARGO Therapeutics, Inc.** |
|  By: | /s/ Anup Radhakrishnan |
| Name: | Anup Radhakrishnan |
| Title: | Interim Chief Executive Officer, Chief |
|  | Financial Officer and Chief Operating Officer |

---

------

##### [**Table of Contents**](#toc)
**ANNEX I** 

**Opinion of CARGO's Financial Advisor** 

July 7, 2025

The Board of Directors

CARGO Therapeutics, Inc.

855 Industrial Road, Suite 400

San Carlos, California 90470

The Board of Directors:

In your capacity as the Board of Directors (the "Board of Directors") of CARGO Therapeutics, Inc. ("CARGO"), you have requested our opinion (the "Opinion"), as investment bankers, as to the fairness, from a financial point of view, to holders of the common stock, par value $0.001 per share, of CARGO ("CARGO Common Stock"), other than as specified below, of the Upfront Cash Amount (as defined below) to be received by such holders pursuant to the terms of an Agreement and Plan of Merger (the "Merger Agreement"), among CARGO, Concentra Biosciences, LLC, a Delaware limited liability company ("Concentra") and an affiliate of Tang Capital Partners, LP ("Tang"), and Concentra Merger Sub VII, Inc., a Delaware corporation and wholly owned subsidiary of Concentra ("Merger Sub"), and related Contingent Value Rights Agreement (the "CVR Agreement" and together with the Merger Agreement, the "Agreements"). As more fully described in the Agreements, and subject to the terms and conditions set forth therein, (i) Concentra will commence a tender offer to purchase all outstanding shares of CARGO Common Stock (such tender offer, the "Tender Offer") for a purchase price consisting of (a) $4.379 per share in cash, payable upon consummation of the Tender Offer (the "Upfront Cash Amount") plus (b) one non-transferable contingent value right (the "CVR") representing the right to receive additional potential cash payments based on (x) 100% of the amount by which CARGO's net cash immediately prior to the closing of the Tender Offer exceeds $217.5 million (the "CVR Additional Net Closing Proceeds Amount"), and (y) 80% of any net proceeds received during the two-year period following the closing of the Merger (as defined below) from the disposition of specified legacy CARGO product candidates and programs (the "CVR Disposition Proceeds Amount") and (ii) subsequent to consummation of the Tender Offer, Merger Sub will merge with and into CARGO, with CARGO surviving as a wholly owned subsidiary of Concentra (the "Merger" and, together with the Tender Offer as an integrated transaction, the "Transaction"), pursuant to which each outstanding share of CARGO Common Stock not previously tendered will be converted into the right to receive the Upfront Cash Amount and the CVR. The terms and conditions of the Transaction are more fully set forth in the Agreements.

TD Securities (USA) LLC ("we" or "TD Cowen") and its affiliates provide investment and commercial banking, lending, asset management and other financial and non-financial services to a wide range of corporations and individuals and, as part of our investment banking business, are continually engaged in the valuation of businesses and their securities in connection with mergers and acquisitions, negotiated underwritings, secondary distributions of listed and unlisted securities, private placements and valuations for corporate and other purposes. In the ordinary course of business, TD Cowen and/or its affiliates at any time may hold long or short positions, and may trade or otherwise effect transactions, in debt, equity, equity-linked and/or other securities or loans of CARGO, Concentra and/or their respective affiliates for the accounts of TD Cowen and/or its affiliates and for the accounts of customers. We and our affiliates also conduct research on securities and may, in the ordinary course of business, provide research reports and investment advice to our clients on investment matters, including matters with respect to the Transaction or CARGO, Concentra and/or their respective affiliates.

We are acting as financial advisor to CARGO in connection with the Transaction and will receive a fee for our services, a significant portion of which is contingent upon consummation of the Tender Offer. We also will receive a fee in connection with this Opinion. In addition, CARGO has agreed to reimburse our expenses and indemnify us for certain liabilities that may arise out of our engagement.

Annex I-1

------

##### [**Table of Contents**](#toc)
As the Board of Directors is aware, TD Cowen and its affiliates in the past have provided, currently are providing, and in the future may provide, financial advisory and/or other investment banking services to CARGO and/or its affiliates unrelated to the Transaction for which services TD Cowen and/or its affiliates have received and would expect to receive compensation, including, during the approximate two-year period preceding the date of this Opinion, having acted or acting as (i) bookrunning underwriter for the initial public offering of CARGO Common Stock, (ii) joint placement agent for a private placement of shares of CARGO Common Stock and (iii) sales agent for CARGO's at-the-market equity offering program. As the Board of Directors also is aware, although TD Cowen and its affiliates currently are not providing, and during the approximate two-year period preceding the date of this Opinion have not provided, financial advisory and/or other investment banking services to Concentra, TD Cowen and/or its affiliates in the future may provide services to Concentra and/or its affiliates and may receive compensation for such services.

In connection with our Opinion, we have reviewed and considered such financial and other matters as we have deemed relevant, including, among other things:

• an execution version, provided to us on July 7, 2025, of the Merger Agreement and a form of the related CVR
Agreement;

• certain publicly available financial and other information for CARGO and certain other relevant financial and
operating data furnished to TD Cowen by the management of CARGO;

• certain internal financial forecasts, estimates and other information, primarily relating to a potential
liquidation of CARGO, provided by the management of CARGO and considered, based on CARGO management's liquidation analysis, the net present value of the estimated amount per share potentially distributable to holders of CARGO Common Stock upon
such liquidation;

• discussions we have had with certain members of the management of CARGO **<sup></sup>** concerning the historical and current business operations, financial condition and prospects of CARGO and such other matters that we deemed relevant; and

• such other information, financial studies, analyses and investigations and such other factors that we deemed
relevant for the purposes of this Opinion.

As the Board of Directors is aware, we have been advised by the management of CARGO that (i) CARGO does not have a standalone business plan and that CARGO intends, in the absence of a sale or similar transaction involving CARGO, to pursue a liquidation of CARGO, and (ii) the internal financial forecasts, estimates and other information prepared by the management of CARGO relating to such liquidation reflect that a de minimis portion of the CVR Additional Net Closing Proceeds Amount would be payable to holders of CARGO Common Stock and do not reflect any sales or other divestitures of legacy CARGO product candidates or programs in the ordinary course of business. Accordingly, at the direction of the Board of Directors, we have relied for purposes of our analysis and Opinion primarily on management's liquidation analysis of CARGO and we have ascribed no value to the CVR.

In conducting our review and arriving at our Opinion, we have, at your direction, assumed and relied, without independent investigation, upon the accuracy and completeness of all financial and other information provided to us by CARGO or that is publicly available or was otherwise reviewed by us. We have not undertaken any responsibility for the accuracy, completeness or reasonableness, or independent verification, of any such information. We have relied upon the representations of CARGO that all information provided to us by CARGO is accurate and complete in all material respects and we expressly disclaim any undertaking or obligation to advise any person of any change in any fact or matter affecting our Opinion of which we become aware after the date hereof.

We have been advised, and we have assumed, that the financial forecasts, estimates and other information provided by the management of CARGO that we have been directed to utilize for purposes of our analysis and Opinion were reasonably prepared by the management of CARGO on bases reflecting the best currently available estimates and good faith judgments of such management as to a potential liquidation of CARGO and the other

Annex I-2

------

##### [**Table of Contents**](#toc)
matters covered thereby, and that such financial forecasts, estimates and other information provide a reasonable basis for our analysis and Opinion. We have relied on the assessments of the management of CARGO as to, among other things, (i) CARGO's product candidate, pipeline, technology and other intellectual property, and the viability of and risks associated with such product candidate, pipeline, technology and other intellectual property, and (ii) the liquidity needs of, and capital resources available to, CARGO for its business and operations. We have assumed that there will be no developments with respect to any such matters that would have an adverse effect on CARGO or the Transaction or that otherwise would be meaningful in any respect to our analyses or Opinion. We express no opinion as to the financial forecasts, estimates and other information utilized in our analyses or the assumptions on which they are based.

In addition, we have assumed that there have been no material changes in the assets, liabilities, financial condition, results of operations, business or prospects of CARGO since the dates of the last financial statements made available to us. We have not made or obtained any independent evaluations, valuations or appraisals of the assets or liabilities (contingent, accrued, derivative, off-balance sheet or otherwise) of CARGO or any other entity, nor have we been furnished with such materials. We have not conducted nor have we assumed any obligation to conduct any physical inspection of the properties or facilities of CARGO or any other entity. We also have not evaluated the solvency or fair value of CARGO or any other entity under any state, federal or foreign laws relating to bankruptcy, insolvency or similar matters. In addition, we have not undertaken an independent evaluation of any actual or potential litigation, settlements, governmental or regulatory proceedings or investigations, possible unasserted claims or other contingent liabilities to which CARGO or any other entity may be a party or subject. Our Opinion does not address any legal, tax, accounting or regulatory matters related to the Agreements or the Transaction, as to which we have assumed that CARGO and the Board of Directors have received such advice from legal, tax, accounting and regulatory advisors as each has determined appropriate.

Our Opinion addresses only the fairness of the Upfront Cash Amount (to the extent expressly specified herein) from a financial point of view and as of the date hereof, without regard to individual circumstances of specific holders of CARGO Common Stock (whether by virtue of control, voting or consent, liquidity, contractual arrangements, vesting or acceleration of securities or otherwise) that may distinguish such holders or the securities of CARGO held by such holders, and our Opinion does not in any way address proportionate allocation or relative fairness among such holders, holders of any other securities of CARGO or otherwise. We express no view as to any other aspect or implication of the Transaction, including, without limitation, the form or structure of the Transaction or any term, aspect or implication of the CVR, any tender and support agreement, guaranty or any other agreement, arrangement or understanding entered into in connection with the Transaction or otherwise. Our Opinion is necessarily based upon economic and market conditions and other circumstances as they exist and can be evaluated by us on the date hereof. It should be understood that although subsequent developments may affect our Opinion, we do not have any obligation to update, revise or reaffirm our Opinion and we expressly disclaim any responsibility to do so. As the Board of Directors is aware, the credit, financial and stock markets, the industry in which CARGO operates and CARGO's business and securities, have experienced and may continue to experience volatility and disruptions, and we express no view as to any potential effects of such volatility or disruptions on CARGO or the Transaction.

We have not considered any potential legislative or regulatory changes currently being considered or recently enacted by the United States or any foreign government, or any domestic or foreign regulatory body, or any changes in accounting methods or generally accepted accounting principles that may be adopted by the Securities and Exchange Commission, the Financial Accounting Standards Board, or any similar foreign regulatory body or board.

For purposes of rendering our Opinion, we have assumed in all respects relevant to our analysis that the representations and warranties of each party contained in the Agreements are true and correct, that each party will perform all of the covenants and agreements required to be performed by it under the Agreements and that all conditions to the consummation of the Transaction will be satisfied without waiver thereof. We also have assumed that the final versions of the Agreements, when executed, will be substantially similar to the versions

Annex I-3

------

##### [**Table of Contents**](#toc)
reviewed by us. We further have assumed that all governmental, regulatory and other consents and approvals contemplated by the Agreements will be obtained and that in the course of obtaining any such consents or approvals no restrictions will be imposed or waivers made that would have an adverse effect on CARGO or the Transaction. In addition, we have assumed that the Transaction will be consummated in a manner that complies with the provisions of applicable securities laws and all other applicable state, federal or foreign statutes, rules and regulations.

It is understood that our Opinion is intended for the benefit and use of the Board of Directors (in its capacity as such) in its evaluation of the Upfront Cash Amount. Our Opinion may not be disclosed, referred to, or communicated (in whole or in part) to any third party for any purpose whatsoever except with our prior written approval. However, our Opinion may be reproduced in full in any Schedule 14D-9 or similar disclosure document relating to the Transaction that is required to be mailed to securityholders of CARGO. Our Opinion does not constitute a recommendation to the Board of Directors on whether or not to approve the Transaction or to any securityholder or any other person as to whether to tender shares of CARGO Common Stock in the Tender Offer or take any other action with respect to the Transaction or otherwise. We are not expressing any opinion as to the actual value, price or trading range of CARGO Common Stock or any other securities of CARGO following announcement or consummation of the Transaction. We have not been requested to opine as to, and our Opinion does not in any manner address, CARGO's underlying business decision to effect the Transaction or the relative merits of the Transaction as compared to other business strategies or transactions that might be available to CARGO. In addition, we have not been requested to opine as to, and our Opinion does not in any manner address, (i) the fairness of the amount or nature of the compensation to the officers, directors or employees, or class of such persons, of any parties to the Transaction relative to the Upfront Cash Amount, the CVR or otherwise, (ii) the fairness of the Upfront Cash Amount (except to the extent expressly specified herein), the CVR or the Transaction to the holders of any class of securities, creditors or other constituencies of CARGO or (iii) whether Concentra or Merger Sub have sufficient cash, available lines of credit or other sources of funds for the payment of the Upfront Cash Amount and any amounts payable pursuant to the CVR.

The issuance of this Opinion was reviewed and approved by TD Cowen's Fairness Opinion Review Committee.

Based upon and subject to the foregoing, including the various assumptions and limitations set forth herein, it is our opinion that, as of the date hereof, the Upfront Cash Amount to be received by holders of CARGO Common Stock (other than, as applicable, Tang, Concentra, Merger Sub, and their respective affiliates) in the Transaction is fair, from a financial point of view, to such holders.

Very truly yours,

TD SECURITIES (USA) LLC

Annex I-4

## Ex-99.(E)(14)

**Exhibit (e)(14)** 

**AMENDED AND RESTATED BYLAWS** 

**OF** 

**CARGO THERAPEUTICS, INC.** 

**(a Delaware corporation)** 

**ARTICLE I** 

**CORPORATE OFFICES** 

Section 1.1 <u>Registered Office</u>. The registered office of CARGO Therapeutics, Inc. (the "<u>Corporation</u>") shall be fixed in the Certificate of Incorporation of the Corporation (as may be amended or modified from time to time, the "<u>Certificate of Incorporation</u>").

Section 1.2 <u>Other Offices</u>. The Corporation may also have an office or offices, and keep the books and records of the Corporation, except as otherwise required by law, at such other place or places, either within or without the State of Delaware, as the Corporation may from time to time determine or the business of the Corporation may require.

**ARTICLE II** 

**MEETINGS OF STOCKHOLDERS** 

Section 2.1 <u>Annual Meeting</u>. Unless directors are elected by written consent in lieu of an annual meeting, the annual meeting of stockholders, for the election of directors and for the transaction of such other business as may properly come before the meeting, shall be held at such place, if any, either within or without the State of Delaware, on such date, and at such time as the Board of Directors of the Corporation (the "<u>Board of Directors</u>") shall fix. The Board of Directors may postpone, reschedule or cancel any annual meeting of stockholders previously scheduled by the Board of Directors.

Section 2.2 <u>Special Meeting</u>. Except as otherwise required by law, and except as otherwise provided for or fixed pursuant to the Certificate of Incorporation, a special meeting of the stockholders of the Corporation: (i) may be called at any time by the Board of Directors; and (ii) shall be called by the Chairman of the Board of Directors or the Secretary of the Corporation upon the written request or requests of one or more stockholders of record that, at the time a request is delivered, hold shares representing at least 10% of the voting power of the stock entitled to vote on the matter or matters to be brought before the proposed special meeting. Except as otherwise required by law, and except as otherwise provided for or fixed pursuant to the Certificate of Incorporation, special meetings of the stockholders of the Corporation may not be called by any other person or persons. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the Corporation's notice of meeting. If none of the stockholders who submitted the special meeting request (or their qualified representatives) appears at the special meeting to present the matter or matters to be brought before the special meeting that were specified in the special meeting request, the Corporation need not present the matter or matters for a vote at the meeting, notwithstanding that proxies in respect of such vote may have been received by the Corporation. The Board of Directors may postpone, reschedule or cancel any special meeting of stockholders previously scheduled pursuant to this Section 2.2.

------

Section 2.3 <u>Notice of Stockholders' Meetings</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Whenever stockholders are required or permitted to take any action at a meeting, notice of the place, if any, date, and time of the meeting of stockholders, the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for determining the stockholders entitled to notice of the meeting), the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting and, if the meeting is to be held solely by means of remote communications, the means for accessing the list of stockholders contemplated by Section 2.5 of these Amended and Restated Bylaws (these "<u>Bylaws</u>"), shall be given. The notice shall be given not less than 10 nor more than 60 days before the date on which the meeting is to be held, to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting, except as otherwise provided by law, the Certificate of Incorporation or these Bylaws. In the case of a special meeting, the purpose or purposes for which the meeting is called also shall be set forth in the notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any notice to stockholders given by the Corporation may be given in writing directed to the stockholder's mailing address (or by electronic transmission directed to the stockholder's electronic mail address, as applicable) as it appears on the records of the Corporation and shall be given (i) if mailed, when the notice is deposited in the U.S. mail, postage prepaid, (ii) if delivered by courier service, the earlier of when the notice is received or left at such stockholder's address or (iii) if given by electronic mail, when directed to such stockholder's electronic mail address unless the stockholder has notified the Corporation in writing or by electronic transmission of an objection to receiving notice by electronic mail or such notice is prohibited by Section 232(e) of the General Corporation Law of the State of Delaware (the "<u>DGCL</u>"). If notice is given by electronic mail, such notice shall comply with the applicable provisions of subsections (a) and (d) of Section 232 of the DGCL and must include a prominent legend that the communication is an important notice regarding the Corporation. If a notice given by electronic mail includes a file attached thereto or references information hyperlinked to a website, the electronic mail shall include the contact information of an agent or officer of the Corporation who is available to assist with accessing such files and information. If a notice given by electronic mail includes a file attached thereto or references information hyperlinked to a website, the electronic mail shall include the contact information of an agent or officer of the Corporation who is available to assist with accessing such files and information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notice may be given by other forms of electronic transmission with the consent of a stockholder in the manner permitted by Section 232(b) of the DGCL and shall be deemed given as provided therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) An affidavit that notice has been given, executed by the Secretary of the Corporation, Assistant Secretary or any transfer agent or other agent of the Corporation, shall be prima facie evidence of the facts stated in the notice in the absence of fraud. Notice shall be deemed to have been given to all stockholders who share an address if notice is given in accordance with Section 233 of the DGCL.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) When a meeting is adjourned to another time or place, notice need not be given of the adjourned meeting if the place, if any, date and time thereof, and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken; <u>provided</u>, <u>however</u>, that if the adjournment is for more than 30 days, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date for stockholders entitled to vote is fixed for the adjourned meeting, the Board of Directors shall fix a new record date for notice of such adjourned meeting in accordance with Section 7.5(a), and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date fixed for notice of such adjourned meeting.

------

Section 2.4 <u>Organization</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Unless otherwise determined by the Board of Directors, meetings of stockholders shall be presided over by the Chairman of the Board of Directors, if any, or in his or her absence, by the Chief Executive Officer or, in his or her absence, by another person designated by the Board of Directors. The Secretary of the Corporation, or in his or her absence, an Assistant Secretary, or in the absence of the Secretary and all Assistant Secretaries, a person whom the chairman of the meeting shall appoint, shall act as secretary of the meeting and keep a record of the proceedings thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The date and time of the opening and the closing of the polls for each matter upon which the stockholders shall vote at a meeting of stockholders shall be announced at the meeting. The Board of Directors may adopt such rules and regulations for the conduct of any meeting of stockholders as it shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chairman of the meeting shall have the authority to adopt and enforce such rules and regulations for the conduct of any meeting of stockholders and the safety of those in attendance as, in the judgment of the chairman, are necessary, appropriate or convenient for the conduct of the meeting. Rules and regulations for the conduct of meetings of stockholders, whether adopted by the Board of Directors or by the chairman of the meeting, may include without limitation, establishing: (i) an agenda or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting and the safety of those present; (iii) limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies and such other persons as the chairman of the meeting shall permit; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof; (v) limitations on the time allotted for consideration of each agenda item and for questions and comments by participants; (vi) regulations for the opening and closing of the polls for balloting and matters which are to be voted on by ballot (if any); and (vii) procedures (if any) requiring attendees to provide the Corporation advance notice of their intent to attend the meeting. Subject to any rules and regulations adopted by the Board of Directors, the chairman of the meeting may convene and, for any reason, from time to time, adjourn and/or recess any meeting of stockholders pursuant to Section 2.7. The chairman of the meeting, in addition to making any other determinations that may be appropriate to the conduct of the meeting, shall have the power to declare that a nomination or other business was not properly brought before the meeting if the facts warrant, and if such chairman should so declare, such nomination shall be disregarded or such other business shall not be transacted.

Section 2.5 <u>List of Stockholders</u>. The Corporation shall prepare, at least 10 days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting; <u>provided</u>, <u>however</u>, that if the record date for determining the stockholders entitled to vote is less than 10 days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the 10th day before the meeting date. Such list shall be arranged in alphabetical order and shall show the address of each stockholder and the number of shares registered in the name of each stockholder. Nothing in this Section 2.5 shall require the Corporation to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder for any purpose germane to the meeting at least 10 days prior to the meeting: (a) on a reasonably accessible electronic network, <u>provided</u> that the information required to gain access to such list is provided with the notice of meeting; or (b) during ordinary business hours at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. If the meeting is to be held at a place, then a list of stockholders entitled to vote at the meeting shall be produced and kept at the time and place of the meeting during the whole time thereof and may be examined by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting. Except as otherwise required by law, the stock ledger shall be the only evidence as to who are the stockholders entitled to examine the list of stockholders required by this Section 2.5 or to vote in person or by proxy at any meeting of stockholders.

------

Section 2.6 <u>Quorum</u>. Except as otherwise required by law, the Certificate of Incorporation or these Bylaws, at any meeting of stockholders, a majority of the voting power of the stock outstanding and entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum for the transaction of business. If a quorum is not present or represented at any meeting of stockholders, then the chairman of the meeting, or a majority of the voting power of the stock present in person or represented by proxy at the meeting and entitled to vote thereon, shall have power to adjourn or recess the meeting from time to time in accordance with Section 2.7, until a quorum is present or represented. Subject to applicable law, if a quorum initially is present at any meeting of stockholders, the stockholders may continue to transact business until adjournment or recess, notwithstanding the withdrawal of enough stockholders to leave less than a quorum, but if a quorum is not present at least initially, no business other than adjournment or recess may be transacted.

Section 2.7 <u>Adjourned or Recessed Meeting</u>. Any annual or special meeting of stockholders, whether or not a quorum is present, may be adjourned or recessed for any or no reason from time to time by the chairman of the meeting, subject to any rules and regulations adopted by the Board of Directors pursuant to Section 2.4(b). Any such meeting may be adjourned for any or no reason (and may be recessed if a quorum is not present or represented) from time to time by a majority of the voting power of the stock present in person or represented by proxy at the meeting and entitled to vote thereon. At any such adjourned or recessed meeting at which a quorum is present, any business may be transacted that might have been transacted at the meeting as originally called.

Section 2.8 <u>Voting</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Except as otherwise required by law or the Certificate of Incorporation, each holder of stock of the Corporation entitled to vote at any meeting of stockholders shall be entitled to one vote for each share of such stock held of record by such holder that has voting power upon the subject matter in question.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Except as otherwise required by law, the Certificate of Incorporation, these Bylaws or any law, rule or regulation applicable to the Corporation or its securities, at each meeting of stockholders at which a quorum is present, all corporate actions to be taken by vote of the stockholders shall be authorized by the affirmative vote of at least a majority of the voting power of the stock present in person or represented by proxy and entitled to vote on the subject matter. Voting at meetings of stockholders need not be by written ballot.

Section 2.9 <u>Proxies</u>. Every stockholder entitled to vote for directors, or on any other matter, shall have the right to do so either in person or by one or more persons authorized to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A proxy may be made irrevocable regardless of whether the interest with which it is coupled is an interest in the stock itself or an interest in the Corporation generally. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the Corporation a revocation of the proxy or executed new proxy bearing a later date.

------

Section 2.10 <u>Action by Written Consent</u>. Except as otherwise provided for or fixed pursuant to the Certificate of Incorporation, any action required or permitted to be taken at any annual or special meeting of stockholders of the Corporation may be taken without a meeting, without prior notice and without a vote by consent in accordance with Section 228 of the DGCL.

Section 2.11 <u>Meetings by Remote Communications</u>. The Board of Directors may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication in accordance with Section 211(a)(2) of the DGCL. If authorized by the Board of Directors in its sole discretion, and subject to such guidelines and procedures as the Board of Directors may adopt, stockholders and proxyholders not physically present at a meeting of stockholders may, by means of remote communication: (a) participate in a meeting of stockholders; and (b) be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or solely by means of remote communication, <u>provided</u> that: (i) the Corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or proxyholder; (ii) the Corporation shall implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings; and (iii) if any stockholder or proxyholder votes or takes other action at the meeting by means of remote communication, a record of such vote or other action shall be maintained by the Corporation.

**ARTICLE III** 

**DIRECTORS** 

Section 3.1 <u>Powers</u>. Except as otherwise required by the DGCL or as provided in the Certificate of Incorporation, the business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. In addition to the powers and authorities these Bylaws expressly confer upon it, the Board of Directors may exercise all such powers of the Corporation and do all such lawful acts and things as are not by law, the Certificate of Incorporation or these Bylaws required to be exercised or done by the stockholders.

Section 3.2 <u>Number, Term of Office and Election</u>. Except as otherwise provided for or fixed pursuant to the Certificate of Incorporation, the Board of Directors shall consist of such number of directors as shall be determined from time to time solely by resolution adopted by the affirmative vote of a majority of the total number of directors then authorized (hereinafter referred to as the "<u>Whole Board</u>"). The number of directors constituting the first Board of Directors shall be equal to the number of directors that are elected by the incorporator or designated in the Certificate of Incorporation. The first Board of Directors shall consist of the person or persons elected by the incorporator or designated in the Certificate of Incorporation. At any meeting of stockholders at which directors are to be elected, directors shall be elected by a plurality of the votes cast. Each director shall hold office until the next election of directors and until his or her successor shall have been duly elected and qualified. Directors need not be stockholders unless so required by the Certificate of Incorporation or these Bylaws, wherein other qualifications for directors may be prescribed.

Section 3.3 <u>Vacancies and Newly Created Directorships</u>. Unless otherwise required by law, newly created directorships resulting from any increase in the authorized number of directors and any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause may be filled by the affirmative vote of a majority of the remaining directors then in office, even though less than a quorum, or by the sole remaining director, and any director so chosen shall hold office until the next election of directors and until his or her successor shall have been duly elected and qualified. No decrease in the authorized number of directors shall shorten the term of any incumbent director.

------

Section 3.4 <u>Resignations and Removal</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Any director may resign at any time upon notice given in writing or by electronic transmission to the Board of Directors, the Chairman of the Board of Directors or the Secretary of the Corporation. Such resignation shall take effect upon delivery, unless the resignation specifies a later effective date or time or an effective date or time determined upon the happening of an event or events. Unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any director, or the entire Board of Directors, may be removed, with or without cause, by the affirmative vote of at least a majority of the voting power of the stock outstanding and entitled to vote thereon.

Section 3.5 <u>Regular Meetings</u>. Regular meetings of the Board of Directors shall be held at such place or places, within or without the State of Delaware, on such date or dates and at such time or times, as shall have been established by the Board of Directors and publicized among all directors. A notice of each regular meeting shall not be required.

Section 3.6 <u>Special Meetings</u>. Special meetings of the Board of Directors for any purpose or purposes may be called at any time by the Chairman of the Board of Directors, the Chief Executive Officer or a majority of the directors then in office. The person or persons authorized to call special meetings of the Board of Directors may fix the place, within or without the State of Delaware, date and time of such meetings. Notice of each such meeting shall be given to each director, if by mail, addressed to such director at his or her residence or usual place of business, at least five days before the day on which such meeting is to be held, or shall be sent to such director by electronic transmission, or be delivered personally or by telephone, in each case at least 24 hours prior to the time set for such meeting. A notice of special meeting need not state the purpose of such meeting, and, unless indicated in the notice thereof, any and all business may be transacted at a special meeting.

Section 3.7 <u>Participation in Meetings by Conference Telephone</u>. Members of the Board of Directors, or of any committee thereof, may participate in a meeting of such Board of Directors or committee by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation shall constitute presence in person at such meeting.

Section 3.8 <u>Quorum and Voting</u>. Except as otherwise required by law, the Certificate of Incorporation or these Bylaws, a majority of the Whole Board shall constitute a quorum for the transaction of business at any meeting of the Board of Directors, and the vote of a majority of the directors present at a duly held meeting at which a quorum is present shall be the act of the Board of Directors. The chairman of the meeting or a majority of the directors present may adjourn the meeting to another time and place whether or not a quorum is present. At any adjourned meeting at which a quorum is present, any business may be transacted which might have been transacted at the meeting as originally called.

Section 3.9 <u>Board of Directors Action by Written Consent Without a Meeting</u>. Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors, or any committee thereof, may be taken without a meeting, <u>provided</u> that all members of the Board of Directors or committee, as the case may be, consent in writing or by electronic transmission to such action. After an action is taken, the consent or consents relating

------

thereto shall be filed with the minutes or proceedings of the Board of Directors or committee in the same paper or electronic form as the minutes are maintained. Any person (whether or not then a director) may provide, whether through instruction to an agent or otherwise, that a consent to action shall be effective at a future time (including a time determined upon the happening of an event), no later than 60 days after such instruction is given or such provision is made and such consent shall be deemed to have been given at such effective time so long as such person is then a director and did not revoke the consent prior to such time. Any such consent shall be revocable prior to its becoming effective.

Section 3.10 <u>Chairman of the Board</u>. The Chairman of the Board shall preside at meetings of stockholders (unless otherwise determined by the Board of Directors) and at meetings of directors, and shall perform such other duties as the Board of Directors may from time to time determine. If the Chairman of the Board is not present at a meeting of the Board of Directors, another director chosen by the Board of Directors shall preside.

Section 3.11 <u>Rules and Regulations</u>. The Board of Directors shall adopt such rules and regulations not inconsistent with the provisions of law, the Certificate of Incorporation or these Bylaws for the conduct of its meetings and management of the affairs of the Corporation as the Board of Directors shall deem proper.

Section 3.12 <u>Fees and Compensation of Directors</u>. Unless otherwise restricted by the Certificate of Incorporation, directors may receive such compensation, if any, for their services on the Board of Directors and its committees, and such reimbursement of expenses, as may be fixed or determined by resolution of the Board of Directors.

Section 3.13 <u>Emergency Bylaws</u>. This Section 3.13 shall be operative during any emergency condition as contemplated by Section 110 of the DGCL (an "<u>Emergency</u>"), notwithstanding any different or conflicting provisions in these Bylaws, the Certificate of Incorporation or the DGCL. In the event of any Emergency, or other similar emergency condition, the director or directors in attendance at a meeting of the Board of Directors or a standing committee thereof shall constitute a quorum. Such director or directors in attendance may further take action to appoint one or more of themselves or other directors to membership on any standing or temporary committees of the Board of Directors as they shall deem necessary and appropriate. Except as the Board of Directors may otherwise determine, during any Emergency, the Corporation and its directors and officers, may exercise any authority and take any action or measure contemplated by Section 110 of the DGCL.

**ARTICLE IV** 

**COMMITTEES** 

Section 4.1 <u>Committees of the Board of Directors</u>. The Board of Directors may designate one or more committees, each such committee to consist of one or more of the directors of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee to replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent permitted by law and provided in the resolution of the Board of Directors establishing such committee, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it; but no such committee shall have the power or authority in reference to the following matters: (a) approving or adopting, or recommending to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval; or (b) adopting, amending or repealing any bylaw of the Corporation. All committees of the Board of Directors shall keep minutes of their meetings and shall report their proceedings to the Board of Directors when requested or required by the Board of Directors.

------

Section 4.2 <u>Meetings and Action of Committees</u>. Unless the Board of Directors provides otherwise by resolution, any committee of the Board of Directors may adopt, alter and repeal such rules and regulations not inconsistent with the provisions of law, the Certificate of Incorporation or these Bylaws for the conduct of its meetings as such committee may deem proper. A majority of the directors then serving on a committee shall constitute a quorum for the transaction of business by the committee except as otherwise required by law, the Certificate of Incorporation or these Bylaws, and except as otherwise provided in a resolution of the Board of Directors; <u>provided</u>, <u>however</u>, that in no case shall a quorum be less than one-third of directors then serving on the committee. Unless the Certificate of Incorporation, these Bylaws or a resolution of the Board of Directors requires a greater number, the vote of a majority of the members of a committee present at a meeting at which a quorum is present shall be the act of the committee.

**ARTICLE V** 

**OFFICERS** 

Section 5.1 <u>Officers</u>. The officers of the Corporation shall consist of a Chief Executive Officer, a Secretary and such other officers as the Board of Directors may from time to time determine, each of whom shall be elected by the Board of Directors, each to have such authority, functions or duties as set forth in these Bylaws or as determined by the Board of Directors. Each officer shall be elected by the Board of Directors and shall hold office for such term as may be prescribed by the Board of Directors and until such person's successor shall have been duly elected and qualified, or until such person's earlier death, disqualification, resignation or removal. Any number of offices may be held by the same person; <u>provided</u>, <u>however</u>, that no officer shall execute, acknowledge or verify any instrument in more than one capacity if such instrument is required by law, the Certificate of Incorporation or these Bylaws to be executed, acknowledged or verified by two or more officers. The Board of Directors may require any officer, agent or employee to give security for the faithful performance of his or her duties.

Section 5.2 <u>Compensation</u>. The salaries of the officers of the Corporation and the manner and time of the payment of such salaries shall be fixed and determined by the Board of Directors (or by a duly authorized officer) and may be altered by the Board of Directors from time to time as it deems appropriate, subject to the rights, if any, of such officers under any contract of employment.

Section 5.3 <u>Removal, Resignation and Vacancies</u>. Any officer of the Corporation may be removed, with or without cause, by the Board of Directors or by a duly authorized officer, without prejudice to the rights, if any, of such officer under any contract to which it is a party. Any officer may resign at any time upon notice given in writing or by electronic transmission to the Corporation, without prejudice to the rights, if any, of the Corporation under any contract to which such officer is a party. If any vacancy occurs in any office of the Corporation, the Board of Directors may elect a successor to fill such vacancy for the remainder of the unexpired term and until a successor shall have been duly elected and qualified.

Section 5.4 <u>Chief Executive Officer</u>. The Chief Executive Officer shall have general supervision and direction of the business and affairs of the Corporation, shall be responsible for corporate policy and strategy, and shall report directly to the Board of Directors. Unless otherwise provided in these Bylaws or determined by the Board of Directors, all other officers of the Corporation shall report directly to the Chief Executive Officer or as otherwise determined by the Chief Executive Officer. The Chief Executive Officer shall, if present and in the absence of the Chairman of the Board of Directors, preside at meetings of the stockholders.

------

Section 5.5 <u>Chief Operating Officer</u>. The Chief Operating Officer shall have general responsibility for the management and control of the operations of the Corporation. The Chief Operating Officer shall, when requested, counsel with and advise the other officers of the Corporation and shall perform such other duties as the Board of Directors or the Chief Executive Officer may from time to time determine.

Section 5.6 <u>Chief Financial Officer</u>. The Chief Financial Officer shall exercise all the powers and perform the duties of the office of the chief financial officer and in general have overall supervision of the financial operations of the Corporation. The Chief Financial Officer shall, when requested, counsel with and advise the other officers of the Corporation and shall perform such other duties as the Board of Directors or the Chief Executive Officer may from time to time determine.

Section 5.7 <u>Vice Presidents</u>. Each Vice President shall have such powers and duties as shall be prescribed by his or her superior officer or the Chief Executive Officer. A Vice President shall, when requested, counsel with and advise the other officers of the Corporation and shall perform such other duties as the Board of Directors, the Chief Executive Officer or another duly authorized officer may from time to time determine.

Section 5.8 <u>Treasurer</u>. The Treasurer shall supervise and be responsible for all the funds and securities of the Corporation, the deposit of all monies and other valuables to the credit of the Corporation in depositories of the Corporation, borrowings and compliance with the provisions of all indentures, agreements and instruments governing such borrowings to which the Corporation is a party, the disbursement of funds of the Corporation and the investment of its funds, and in general shall perform all of the duties incident to the office of the Treasurer. The Treasurer shall, when requested, counsel with and advise the other officers of the Corporation and shall perform such other duties as the Board of Directors, the Chief Executive Officer, the Chief Operating Officer or the Chief Financial Officer may from time to time determine.

Section 5.9 <u>Controller</u>. The Controller shall be the chief accounting officer of the Corporation. The Controller shall, when requested, counsel with and advise the other officers of the Corporation and shall perform such other duties as the Board of Directors, the Chief Executive Officer, the Chief Operating Officer, the Chief Financial Officer or the Treasurer may from time to time determine.

Section 5.10 <u>Secretary</u>. The powers and duties of the Secretary are: (i) to act as Secretary at all meetings of the Board of Directors, of the committees of the Board of Directors and of the stockholders and to record the proceedings of such meetings in a book or books to be kept for that purpose; (ii) to see that all notices required to be given by the Corporation are duly given and served; (iii) to act as custodian of the seal of the Corporation and affix the seal or cause it to be affixed to all certificates of stock of the Corporation and to all documents, the execution of which on behalf of the Corporation under its seal is duly authorized in accordance with the provisions of these Bylaws; (iv) to have charge of the books, records and papers of the Corporation and see that the reports, statements and other documents required by law to be kept and filed are properly kept and filed; and (v) to perform all of the duties incident to the office of Secretary. The Secretary shall, when requested, counsel with and advise the other officers of the Corporation and shall perform such other duties as the Board of Directors or the Chief Executive Officer may from time to time determine.

Section 5.11 <u>Additional Matters</u>. The Chief Executive Officer and the Chief Financial Officer of the Corporation shall have the authority to designate employees of the Corporation to have the title of Vice President, Assistant Vice President, Assistant Treasurer or Assistant Secretary. Any employee so designated shall have the powers and duties determined by the officer making such designation. The persons upon whom such titles are conferred shall not be deemed officers of the Corporation unless elected by the Board of Directors.

------

Section 5.12 <u>Checks; Drafts; Evidences of Indebtedness</u>. From time to time, the Board of Directors shall determine the method, and designate (or authorize officers of the Corporation to designate) the person or persons who shall have authority, to sign or endorse all checks, drafts, other orders for payment of money and notes, bonds, debentures or other evidences of indebtedness that are issued in the name of or payable by the Corporation, and only the persons so authorized shall sign or endorse such instruments.

Section 5.13 <u>Corporate Contracts and Instruments; How Executed</u>. Except as otherwise provided in these Bylaws, the Board of Directors may determine the method, and designate (or authorize officers of the Corporation to designate) the person or persons who shall have authority to enter into any contract or execute any instrument in the name of and on behalf of the Corporation. Such authority may be general or confined to specific instances. Unless so authorized, or within the power incident to a person's office or other position with the Corporation, no person shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.

Section 5.14 <u>Signature Authority</u>. Unless otherwise determined by the Board of Directors or otherwise provided by law or these Bylaws, contracts, evidences of indebtedness and other instruments or documents of the Corporation may be executed, signed or endorsed: (i) by the Chief Executive Officer or the Chief Operating Officer; or (ii) by the Chief Financial Officer, any Vice President, Treasurer, Secretary or Controller, in each case only with regard to such instruments or documents that pertain to or relate to such person's duties or business functions.

Section 5.15 <u>Action with Respect to Securities of Other Corporations or Entities</u>. The Chief Executive Officer or any other officer of the Corporation authorized by the Board of Directors or the Chief Executive Officer is authorized to vote, represent, and exercise on behalf of the Corporation all rights incident to any and all shares or other equity interests of any other corporation or entity, or corporations or entities, standing in the name of the Corporation. The authority herein granted may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by the person having such authority.

Section 5.16 <u>Delegation</u>. The Board of Directors may from time to time delegate the powers or duties of any officer to any other officers or agents, notwithstanding the foregoing provisions of this Article V.

**ARTICLE VI** 

**INDEMNIFICATION AND ADVANCEMENT OF EXPENSES** 

Section 6.1 <u>Right to Indemnification</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each person who was or is a party or is threatened to be made a party to, or was or is otherwise involved in, any action, suit, arbitration, alternative dispute resolution mechanism, investigation, inquiry, judicial, administrative or legislative hearing, or any other threatened, pending or completed proceeding, whether brought by or in the right of the Corporation or otherwise, including any and all appeals, whether of a civil, criminal, administrative, legislative, investigative or other nature (hereinafter a "<u>proceeding</u>"), by reason of the fact that he or she is or was a director or an officer of the Corporation or while a director or officer of the Corporation is or was serving at the request of the Corporation as a director, officer, employee, agent or trustee of another corporation or of a partnership,

------

joint venture, trust or other enterprise, including service with respect to an employee benefit plan (hereinafter an "<u>indemnitee</u>"), or by reason of anything done or not done by him or her in any such capacity, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended, against all expense, liability and loss (including attorneys' fees, judgments, fines, ERISA excise taxes, penalties and amounts paid in settlement by or on behalf of the indemnitee) actually and reasonably incurred by such indemnitee in connection therewith, all on the terms and conditions set forth in these Bylaws; <u>provided</u>, <u>however</u>, that, except as otherwise required by law or provided in Section 6.4 with respect to suits to enforce rights under this Article VI, the Corporation shall indemnify any such indemnitee in connection with a proceeding, or part thereof, voluntarily initiated by such indemnitee (including claims and counterclaims, whether such counterclaims are asserted by: (i) such indemnitee; or (ii) the Corporation in a proceeding initiated by such indemnitee) only if such proceeding, or part thereof, was authorized or ratified by the Board of Directors or the Board of Directors otherwise determines that indemnification or advancement of expenses is appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) To receive indemnification under this Article VI, an indemnitee shall submit a written request to the Secretary of the Corporation. Such request shall include documentation or information that is necessary to determine the entitlement of the indemnitee to indemnification and that is reasonably available to the indemnitee. Upon receipt by the Secretary of the Corporation of such a written request, unless indemnification is required by Section 6.3, the entitlement of the indemnitee to indemnification shall be determined by the following person or persons who shall be empowered to make such determination, as selected by the Board of Directors (except with respect to clause (v) of this Section 6.1(b)): (i) the Board of Directors by a majority vote of the directors who are not parties to such proceeding, whether or not such majority constitutes a quorum; (ii) a committee of such directors designated by a majority vote of such directors, whether or not such majority constitutes a quorum; (iii) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion to the Board of Directors, a copy of which shall be delivered to the indemnitee; (iv) the stockholders of the Corporation; or (v) in the event that a change of control (as defined below) has occurred, by independent legal counsel in a written opinion to the Board of Directors, a copy of which shall be delivered to the indemnitee. The determination of entitlement to indemnification shall be made and, unless a contrary determination is made, such indemnification shall be paid in full by the Corporation not later than 60 days after receipt by the Secretary of the Corporation of a written request for indemnification. For purposes of this Section 6.1(b), a "<u>change of control</u>" will be deemed to have occurred if, with respect to any particular 24-month period, the individuals who, at the beginning of such 24-month period, constituted the Board of Directors (the "<u>incumbent board</u>") cease for any reason to constitute at least a majority of the Board of Directors; <u>provided</u>, <u>however</u>, that any individual becoming a director subsequent to the beginning of such 24-month period whose election, or nomination for election by the stockholders of the Corporation, was approved by a vote of at least a majority of the directors then comprising the incumbent board shall be considered as though such individual were a member of the incumbent board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors.

Section 6.2 <u>Right to Advancement of Expenses</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In addition to the right to indemnification conferred in Section 6.1, an indemnitee shall, to the fullest extent permitted by law, also have the right to be paid by the Corporation the expenses (including attorneys' fees) incurred in defending any proceeding in advance of its final disposition (hereinafter an "<u>advancement of expenses</u>"); <u>provided</u>, <u>however</u>, that an advancement of expenses shall be made only upon delivery to the Corporation of an undertaking (hereinafter an "<u>undertaking</u>"), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision of a court of competent jurisdiction from which there is no further right to appeal (hereinafter a "<u>final adjudication</u>") that such indemnitee is not entitled to be indemnified for such expenses under this Article VI or otherwise.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) To receive an advancement of expenses under this Section 6.2, an indemnitee shall submit a written request to the Secretary of the Corporation. Such request shall reasonably evidence the expenses incurred by the indemnitee and shall include or be accompanied by the undertaking required by Section 6.2(a). Each such advancement of expenses shall be made within 20 days after the receipt by the Secretary of the Corporation of a written request for advancement of expenses.

Section 6.3 <u>Indemnification for Successful Defense</u>. To the extent that an indemnitee has been successful on the merits or otherwise in defense of any proceeding (or in defense of any claim, issue or matter therein), such indemnitee shall be indemnified under this Section 6.3 against expenses (including attorneys' fees) actually and reasonably incurred in connection with such defense. Indemnification under this Section 6.3 shall not be subject to satisfaction of a standard of conduct, and the Corporation may not assert the failure to satisfy a standard of conduct as a basis to deny indemnification or recover amounts advanced, including in a suit brought pursuant to Section 6.4 (notwithstanding anything to the contrary therein).

Section 6.4 <u>Right of Indemnitee to Bring Suit</u>. In the event that a determination is made that the indemnitee is not entitled to indemnification or if payment is not timely made following a determination of entitlement to indemnification pursuant to Section 6.1(b), if a request for indemnification under Section 6.3 is not paid in full by the Corporation within 60 days after a written request has been received by the Secretary of the Corporation, or if an advancement of expenses is not timely made under Section 6.2(b), the indemnitee may at any time thereafter bring suit against the Corporation in a court of competent jurisdiction in the State of Delaware seeking an adjudication of entitlement to such indemnification or advancement of expenses. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit to the fullest extent permitted by law. In any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that the indemnitee has not met any applicable standard of conduct for indemnification set forth in Section 145(a) or Section 145(b) of the DGCL. Further, in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that the indemnitee has not met any applicable standard of conduct for indemnification set forth in Section 145(a) or Section 145(b) of the DGCL. Neither the failure of the Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met such applicable standard of conduct, nor an actual determination by the Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to such advancement of expenses, under applicable law, this Article VI or otherwise shall be on the Corporation.

Section 6.5 <u>Non-Exclusivity of Rights</u>. The rights to indemnification and to the advancement of expenses conferred in this Article VI shall not be exclusive of any other right which any person may have or hereafter acquire under any law, agreement, vote of stockholders or disinterested directors, provisions of a certificate of incorporation or bylaws, or otherwise.

------

Section 6.6 <u>Insurance</u>. The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL.

Section 6.7 <u>Indemnification of Employees and Agents of the Corporation</u>. The Corporation may, to the extent and in the manner permitted by law, and to the extent authorized from time to time, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation.

Section 6.8 <u>Nature of Rights</u>. The rights conferred upon indemnitees in this Article VI shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director or officer and shall inure to the benefit of the indemnitee's heirs, executors and administrators. Any amendment, alteration or repeal of this Article VI that adversely affects any right of an indemnitee or its successors shall be prospective only and shall not limit or eliminate any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action or omission to act that took place prior to such amendment, alteration or repeal.

Section 6.9 <u>Settlement of Claims</u>. Notwithstanding anything in this Article VI to the contrary, the Corporation shall not be liable to indemnify any indemnitee under this Article VI for any amounts paid in settlement of any proceeding effected without the Corporation's written consent, which consent shall not be unreasonably withheld.

Section 6.10 <u>Subrogation</u>. In the event of payment under this Article VI, the Corporation shall be subrogated to the extent of such payment to all of the rights of recovery of the indemnitee (excluding insurance obtained on the indemnitee's own behalf), and the indemnitee shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable the Corporation effectively to bring suit to enforce such rights.

Section 6.11 <u>Severability</u>. If any provision or provisions of this Article VI shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law: (a) the validity, legality and enforceability of such provision in any other circumstance and of the remaining provisions of this Article VI (including, without limitation, all portions of any paragraph of this Article VI containing any such provision held to be invalid, illegal or unenforceable, that are not by themselves invalid, illegal or unenforceable) and the application of such provision to other persons or entities or circumstances shall not in any way be affected or impaired thereby; and (b) to the fullest extent possible, the provisions of this Article VI (including, without limitation, all portions of any paragraph of this Article VI containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent of the parties that the Corporation provide protection to the indemnitee to the fullest extent set forth in this Article VI.

**ARTICLE VII** 

**CAPITAL STOCK** 

Section 7.1 <u>Certificates of Stock</u>. The shares of the Corporation shall be represented by certificates; <u>provided</u>, <u>however</u>, that the Board of Directors may provide by resolution or resolutions that some or all of any or all classes or series of stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the Corporation. Every

------

holder of stock represented by certificates shall be entitled to have a certificate signed by or in the name of the Corporation by any two authorized officers of the Corporation, including, without limitation, the Chief Executive Officer, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, the Controller, the Secretary or an Assistant Treasurer or Assistant Secretary certifying the number of shares owned by such holder in the Corporation. Any or all such signatures may be facsimiles. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer, transfer agent or registrar at the date of issue.

Section 7.2 <u>Transfers of Stock</u>. Transfers of shares of stock of the Corporation shall be made only on the books of the Corporation upon authorization by the registered holder thereof or by such holder's attorney thereunto authorized by a power of attorney duly executed and filed with the Secretary of the Corporation or a transfer agent for such stock, and if such shares are represented by a certificate, upon surrender of the certificate or certificates for such shares properly endorsed or accompanied by a duly executed stock transfer power and the payment of any taxes thereon; <u>provided</u>, <u>however</u>, that the Corporation shall be entitled to recognize and enforce any lawful restriction on transfer.

Section 7.3 <u>Lost Certificates</u>. The Corporation may issue a new share certificate or uncertificated shares in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the Corporation may require the owner of the lost, stolen or destroyed certificate or the owner's legal representative to give the Corporation a bond (or other adequate security) sufficient to indemnify it against any claim that may be made against it (including any expense or liability) on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares. The Board of Directors may adopt such other provisions and restrictions with reference to lost certificates, not inconsistent with applicable law, as it shall in its discretion deem appropriate.

Section 7.4 <u>Registered Stockholders</u>. The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise required by law.

Section 7.5 <u>Record Date for Determining Stockholders</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjourned meeting, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall, unless otherwise required by law, not be more than 60 nor less than 10 days before the date of such meeting. If the Board of Directors so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjourned meeting; <u>provided</u>, <u>however</u>, that the Board of Directors may fix a new record date for the determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than 60 days prior to such action. If no such record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Unless otherwise restricted by the Certificate of Incorporation, in order that the Corporation may determine the stockholders entitled to express consent to corporate action without a meeting, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than 10 days after the date upon which the resolution fixing the record date is adopted by the Board of Directors. If no record date has been fixed by the Board of Directors, the record date for determining stockholders entitled to express consent to corporate action without a meeting, when no prior action of the Board of Directors is required by law, shall be the first date on which a signed consent setting forth the action taken or proposed to be taken was delivered to the Corporation in accordance with Section 2.10. If no record date has been fixed by the Board of Directors, the record date for determining stockholders entitled to express consent to corporate action without a meeting, if prior action by the Board of Directors is required by law, shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action.

Section 7.6 <u>Regulations</u>. To the extent permitted by applicable law, the Board of Directors may make such additional rules and regulations as it may deem expedient concerning the issue, transfer and registration of shares of stock of the Corporation.

Section 7.7 <u>Waiver of Notice</u>. Whenever notice is required to be given under any provision of the DGCL or the Certificate of Incorporation or these Bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders, the Board of Directors or a committee of the Board of Directors need be specified in any written waiver of notice or any waiver by electronic transmission unless so required by the Certificate of Incorporation or these Bylaws.

**ARTICLE VIII** 

**GENERAL MATTERS** 

Section 8.1 <u>Fiscal Year</u>. The fiscal year of the Corporation shall begin on the first day of January of each year and end on the last day of December of the same year, or shall extend for such other 12 consecutive months as the Board of Directors may designate.

Section 8.2 <u>Corporate Seal</u>. The Board of Directors may provide a suitable seal, containing the name of the Corporation, which seal shall be in the charge of the Secretary of the Corporation. If and when so directed by the Board of Directors or a committee thereof, duplicates of the seal may be kept and used by the Treasurer or by an Assistant Secretary or Assistant Treasurer.

------

Section 8.3 <u>Reliance Upon Books, Reports and Records</u>. Each director and each member of any committee designated by the Board of Directors shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books of account or other records of the Corporation and upon such information, opinions, reports or statements presented to the Corporation by any of its officers or employees, or committees of the Board of Directors so designated, or by any other person as to matters which such director or committee member reasonably believes are within such other person's professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation.

Section 8.4 <u>Subject to Law and Certificate of Incorporation</u>. All powers, duties and responsibilities provided for in these Bylaws, whether or not explicitly so qualified, are qualified by the Certificate of Incorporation and applicable law.

Section 8.5 <u>Electronic Signatures, etc.</u> Except as otherwise required by the Certificate of Incorporation or these Bylaws, any document, including, without limitation, any consent, agreement, certificate or instrument, required by the DGCL, the Certificate of Incorporation or these Bylaws to be executed by any officer, director, stockholder, employee or agent of the Corporation may be executed using a facsimile or other form of electronic signature to the fullest extent permitted by applicable law. All other contracts, agreements, certificates or instruments to be executed on behalf of the Corporation may be executed using a facsimile or other form of electronic signature to the fullest extent permitted by applicable law. The terms "electronic mail," "electronic mail address," "electronic signature" and "electronic transmission" as used herein shall have the meanings ascribed thereto in the DGCL.

**ARTICLE IX** 

**AMENDMENTS** 

Section 9.1 <u>Amendments</u>. In furtherance and not in limitation of the powers conferred by the laws of the State of Delaware, the Board of Directors is expressly authorized to adopt, amend or repeal these Bylaws. The stockholders may make additional Bylaws and may alter and repeal any Bylaws whether adopted by them or otherwise.

## Ex-99.(E)(15)

**Exhibit (e)(15)** 

March 28, 2025

Dear Anup:

As you know, CARGO Therapeutics, Inc. ("**CARGO**" or the "**Company**") is winding down its business operations and will over the coming months end all operations and terminate all employees. The Company considers your continued employment through your currently expected termination date, November 13, 2025, essential to CARGO's objectives and is offering you the retention bonus described below.

If you remain continuously employed by the Company through the Retention Date (as defined below), then you will earn a retention bonus in an amount equal to fifty percent (50%) of your current annual base salary, in an amount equal to $250,000 (the "**Retention Bonus**"). If earned, the Retention Bonus will be paid to you within ten (10) days of the Retention Date, less deductions and withholdings. In the event your employment ends for any reason before the Retention Date, then you will not be eligible for and will not earn any portion of the Retention Bonus, provided however you will remain eligible to receive all severance and separation benefits offered to you in your separation agreement, provided that you comply with the requirements therein and in your March 18, 2025 termination notice from the Company.

For purposes of this letter, the "Retention Date" means the earlier of the following events:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The date of termination by the Company not for Cause as defined in the Company's 2023 Equity Plan; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The closing of a Strategic Transaction<sup>1</sup>; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A date that the Compensation Committee of the Board of Directors of the Company (the "**Compensation Committee**") otherwise determines.

It is intended that this payment satisfy, to the greatest extent possible, any applicable exemption from the application of Internal Revenue Code (the "**Code**") Section 409A, and this letter will be construed to the greatest extent possible as consistent with the terms of any such exemption.

Nothing in this letter alters the status of your at-will employment relationship with the Company. Nor do the terms herein affect the terms and conditions of your offer letter from the Company or supersede such

<sup>1</sup> For purposes of eligibility to receive the Retention Bonus, "Strategic Transaction" means the: (i) the dissolution or liquidation of the Company; (ii) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity; (iii) a merger, reorganization or consolidation pursuant to which the holders of the Company's outstanding voting power immediately prior to such transaction do not own a majority of the outstanding voting power of the surviving or resulting entity (or its ultimate parent, if applicable); (iv) the acquisition of all or a majority of the outstanding voting stock of the Company in a single transaction or a series of related transactions; or (v) any other acquisition of the business of the Company, as determined by the Board of Directors.

------

offer letter or any other agreements with the Company.

The terms set forth herein form the complete and exclusive statement of terms between you and the Company with regard to this subject matter. These terms supersede any other agreements or promises made to you by anyone, whether oral or written, on this subject, and cannot be modified or amended except in a writing signed by the Compensation Committee.

Sincerely,

/s/ Halley Gilbert

Halley Gilbert

Chief Legal Officer, CARGO Therapeutics, Inc.

**I acknowledge that I have read, understand and agree with the terms set forth herein:** 

---

| | |
|:---|:---|
| /s/ Anup Radhakrishnan | 3/28/2025 |
| Anup Radhakrishnan | Date |

---

## Ex-99.(E)(16)

**Exhibit (e)(16)** 

April 9, 2025

Anup Radhakrishnan

[\*\*\*]

[\*\*\*]

Dear Anup:

This letter sets forth the terms of the separation agreement (the "**Agreement**") that CARGO Therapeutics, Inc. (the "**Company**") is offering to you to aid in your employment transition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1. SEPARATION.** Your last day of work with the Company and your employment termination date will be November 13, 2025 (the "**Separation Date**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2. TRANSITION DUTIES.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Duties.** Between now and the Separation Date (the "**Transition Period**"), you will remain employed by the Company in your current role and will continue to perform your regular job duties, as well as any other transitional duties reasonably assigned to you by the Company. You agree to perform your Transition Period services in good faith and to the best of your abilities. During the Transition Period you must continue to comply with all of the Company's policies and procedures and with all of your statutory and contractual obligations to the Company, including without limitation, your obligations under your Confidentiality and Proprietary Rights Agreement, which remains in full force and effect and is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Compensation/Benefits.** During the Transition Period, you will continue to be paid at your current base salary and you will continue to be eligible for the Company's standard benefits, subject to the terms and conditions applicable to such plans and programs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) Early Termination.** Nothing in this Agreement alters your employment at will status. Accordingly, during the Transition Period you are entitled to resign your employment with or without Cause (as defined in your employment agreement dated November 12, 2024 with the Company (the "**Employment Agreement**")) or advance notice, and the Company may terminate your employment with or without Cause or advance notice. If, at any time prior to the Separation Date, the Company terminates your employment without Cause or your employment terminates due to your death or disability, then you (or your estate) will remain eligible for the Severance Benefits (as defined below), provided that you (or your estate) have satisfied the Severance Preconditions (as defined below). If you stay employed through May 19, 2025 and resign from your employment for any reason thereafter and prior to the Separation Date, then you will also remain eligible for the Severance Benefits, provided that you have satisfied the Severance Preconditions. However, if you resign your employment for any reason prior to May 19, 2025 or the Company terminates your employment for Cause at any time prior to the Separation Date, then all salary payments to you will cease immediately, you will no longer be eligible for participation in any Company benefit plans, and you will not be eligible to receive any Severance Benefits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3. ACCRUED SALARY AND PAID TIME OFF.** On the Separation Date, or shortly thereafter as permitted by applicable law, the Company will pay you all accrued salary earned through the

------

Separation Date, subject to standard payroll deductions and withholdings. You are entitled to this payment by law. Since the Company has a nonaccrual vacation policy, you do not have any accrued vacation or other paid time off and thus will not be paid out for any accrued vacation or other paid time off.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4. COMPANY LAPTOP.** You will not be required to return your CARGO-provided laptop, and you will be allowed to keep it on an "as is" basis. CARGO will remote wipe the laptop and remove all CARGO access and materials prior to your Separation Date. You will be solely responsible for all fees and costs incurred in connection with the laptop after the Separation Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5. SEVERANCE BENEFITS.** Pursuant to your Employment Agreement, the Company's termination of your employment is not for Cause (as defined in the Employment Agreement). As such, if: (a) you timely sign and return this Agreement and allow it to become effective (by not revoking it); (b) you comply fully with the terms of this Agreement (including its exhibits) and any other agreement between you and the Company; (c) your employment is not terminated for Cause or due to death or disability prior to the Separation Date; (d) you have not resigned from your employment before May 19, 2025; and (e) on or after the Separation Date, you timely execute and return to the Company the Separation Date Release attached hereto as **<u>Exhibit B</u>** (the "**Separation Date Release**") and do not revoke it (collectively, the "**Severance Preconditions**"), then the Company will provide you with the following severance benefits (collectively, the "**Severance Benefits**"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Severance Pay.** The Company will pay you the equivalent of fifteen (15) months of your base salary in effect as of the Separation Date, subject to standard payroll deductions and withholdings. This amount will be paid in a lump sum by no later than the Company's second regularly scheduled payroll date that is at least ten (10) days after the Effective Date (as defined in Section 8(c) of this Agreement) (such date, the "**Severance Payment Date**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Bonus.** The Company will pay you an additional cash severance payment equivalent to one-hundred and twenty-five percent (125%) of your target Annual Bonus for calendar year 2025 (the "**Bonus**"). The Bonus will be paid to you in a lump sum, subject to standard payroll deductions and withholdings, by no later than the Severance Payment Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) COBRA Pay.** Unless you follow the procedures set forth in this paragraph, your participation in the Company's group health insurance plan will end on the last day of the month in which the Separation Date occurs. To the extent provided by the federal COBRA law or, if applicable, state insurance laws, and by the Company's current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense following the Separation Date. Later, you may be able to convert to an individual policy through the provider of the Company's health insurance, if you wish. You will be provided with a separate notice describing your rights and obligations under COBRA and a form for electing COBRA coverage. As an additional Severance Benefit under this Agreement, provided that you satisfy the Severance Preconditions set forth above, the Company will pay you an additional $49,421 that you may use for any purpose, including, but not limited to, obtaining health insurance coverage for you and your dependents. This amount will be paid in a lump sum by no later than the Severance Payment Date, subject to standard payroll deductions and withholdings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(d) Accelerated Vesting.** Under the terms of your stock option or other equity award agreement(s) and the applicable equity incentive plan documents, vesting of any stock options or other equity awards granted to you, if any (the "**Equity Awards**") will cease as of the

------

Separation Date. However, as an additional Severance Benefit, subject to satisfaction of the Severance Preconditions, vesting of your Equity Awards shall accelerate such that one hundred percent (100%) of the unvested shares of your Equity Awards shall be fully vested and exercisable as of the Separation Date. Except as expressly set forth in this paragraph, your Equity Awards will continue to be governed by the terms and conditions of the applicable stock option or other equity award agreement(s), applicable equity incentive plan documents, and other equity awards documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(e) Acceleration of Severance Payment Timing Upon Change in Control.** Notwithstanding the foregoing, if a Change in Control transaction, as defined in the Company's 2023 Incentive Award Plan (a "**Change in Control**") has been approved by the Company's board of directors, provided that you have satisfied all Severance Preconditions the Company will accelerate the Severance Payment Date such that you are paid all such outstanding Severance Benefits prior to the closing of such transaction. For avoidance of doubt, a reverse merger transaction in which a third party will merge with and into the Company will be considered a Change in Control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6. OTHER COMPENSATION OR BENEFITS.** You acknowledge that, except as expressly provided in this Agreement, you have not earned and will not receive from the Company any additional compensation (including base salary, bonus, incentive compensation, or equity), severance, or benefits before, on, or after the Separation Date, with the exception of any vested right you may have under the express terms of a written ERISA-qualified benefit plan (e.g., 401(k) account) or any vested stock options. You acknowledge that the Severance Benefits set forth in this Agreement are provided in full satisfaction of any severance benefits to which you may be entitled under your Employment Agreement, and that you are not otherwise entitled to, and will not receive, any additional consideration in exchange for your execution, non-revocation, and compliance with this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7. EXPENSE REIMBURSEMENTS.** You represent that you have submitted to the Company all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement, and that you have been fully reimbursed for all business-related expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8. RELEASE OF CLAIMS.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) General Release of Claims.** In exchange for the consideration provided to you under this Agreement to which you would not otherwise be entitled, you hereby generally and completely release the Company, and its affiliated, related, parent and subsidiary entities, and its and their current and former directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates, and assigns, both individually and in their business capacities, from any and all claims, liabilities, demands, causes of action, and obligations, both known and unknown, asserted or unasserted, arising from or in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date you sign this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Scope of Release.** This general release includes, but is not limited to: (i) all claims arising from or in any way related to your employment with the Company or the termination of that employment; (ii) all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership, equity, or profits interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach

------

of the implied covenant of good faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys' fees, or other claims arising under the federal Civil Rights Act of 1964, the federal Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act ("**ADEA**"), the California Labor Code, the California Family Rights Act, the California Fair Employment and Housing Act, the Massachusetts Fair Employment Practices Act (M.G.L. c. 151B), the Massachusetts Equal Rights Act, the Massachusetts Equal Pay Act, the Massachusetts Privacy Statute, the Massachusetts Sick Leave Law, the Massachusetts Civil Rights Act, the Massachusetts overtime regulations (M.G.L. c. 151 sections 1A and 1b), and the Massachusetts Meal Break regulations (M.G.L. c. 149 sections 100 and 101.), all as amended and as applicable. **You acknowledge that you have been advised, consistent with California Government Code Section 12964.5(b)(4), that you have the right to consult an attorney regarding this Agreement and that you were given a reasonable time period of at least five (5) business days in which to do so.** You further acknowledge and agree that, in the event you sign this Agreement prior to the end of the reasonable time period provided by the Company, your decision to accept such shortening of time is knowing and voluntary and is not induced by the Company through fraud, misrepresentation, or a threat to withdraw or alter the offer prior to the expiration of the reasonable time period, or by providing different terms to employees who sign such an agreement prior to the expiration of the time period. You further acknowledge and agree that the release of claims in this section is not provided in exchange for a raise, bonus, or as a condition of continued employment, but rather in exchange for the materially modified terms and conditions of employment during the Transition Period, eligibility for severance benefits you were not otherwise eligible to receive, and other consideration provided by the Company in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) ADEA Release**. You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you have under the ADEA, and that the consideration given for the waiver and releases you have given in this Agreement is in addition to anything of value to which you were already entitled. You further acknowledge that you have been advised, as required by the ADEA, that: (i) your waiver and release does not apply to any rights or claims arising after the date you sign this Agreement; (ii) you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (iii) you have forty-five (45) days to consider this Agreement (although you may choose voluntarily to sign it sooner); (iv) you have seven (7) days following the date you sign this Agreement to revoke this Agreement (in a written revocation sent to the Company); and (v) this Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after you sign this Agreement provided that you do not revoke it (the "**Effective Date"). You also hereby further acknowledge that the Company has provided you with the ADEA disclosure information (under 29 U.S.C. § 626(f)(1)(H)), attached hereto as <u>E</u><u>xhibit</u> <u>A</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(d) Section 1542 Waiver.** In giving the release herein, which includes claims which may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code, which reads as follows:

**"A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party."** 

------

You hereby expressly waive and relinquish all rights and benefits under that section and any law of any other jurisdiction of similar effect with respect to your release of claims herein, including but not limited to your release of unknown claims.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(e) Exceptions.** Notwithstanding the foregoing, you are not releasing the Company hereby from: (i) any obligation to indemnify you pursuant to the Articles and Bylaws of the Company, any valid fully executed indemnification agreement with the Company, applicable law, or applicable directors and officers liability insurance; (ii) any claims that cannot be waived by law; or (iii) any claims for breach of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(f) Protected Rights.** You understand that nothing in this Agreement limits your ability to file a charge or complaint with the Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Department of Justice, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission ("**Government Agencies**"). You further understand this Agreement does not limit your ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. While this Agreement does not limit your right to receive a government-issued award for information provided to any Government Agency in connection with a government whistleblower program or protected whistleblower activity, you understand and agree that, to maximum extent permitted by law, you are otherwise waiving any and all rights you may have to individual relief based on any claims that you have released and any rights you have waived by signing this Agreement. Nothing in this Agreement prevents you from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that you have reason to believe is unlawful. Furthermore, nothing in this Agreement waives any rights you may have under Section 7 of the National Labor Relations Act (subject to the release of claims set forth herein).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9. RETURN OF COMPANY PROPERTY.** Subject to Section 4 above, you agree that, by no later than seven (7) calendar days after your last day worked, or earlier if requested by the Company, you will return to the Company, without copying or reproducing, all Company documents (and all copies thereof) and other Company property in your possession or control, including, but not limited to, Company files, notes, drawings, records, plans, forecasts, reports, studies, analyses, proposals, agreements, drafts, financial and operational information, research and development information, sales and marketing information, customer lists, prospect information, pipeline reports, sales reports, personnel information, specifications, code, software, databases, computer-recorded information, tangible property and equipment (including, but not limited to, computing and electronic devices, mobile telephones, servers), credit cards, entry cards, identification badges and keys; and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions or embodiments thereof in whole or in part). You agree that you will make a diligent search to locate any such documents, property and information by the close of business on the Separation Date or as soon as possible thereafter. If you have used any personally owned computer or other electronic device, server, cloud storage device, or e-mail system to receive, store, review, prepare or transmit any Company confidential or proprietary data, materials or information, within seven (7) days after your last day worked, you shall provide the Company with a computer-useable copy of such information and then permanently delete and expunge such Company confidential or proprietary information from those systems; and you agree to provide the Company access to your system as requested to verify that the necessary copying and/or deletion is completed. **Your**

------

 **timely compliance with this paragraph is a condition to your receipt of the Severance Benefits provided under this Agreement.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10. CONFIDENTIAL INFORMATION OBLIGATIONS.** You acknowledge and reaffirm your continuing obligations under your Confidentiality and Proprietary Rights Agreement, incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11. CONFIDENTIALITY.** The provisions of this Agreement will be held in strictest confidence by you and will not be publicized or disclosed by you in any manner whatsoever; provided, however, that: (a) you may disclose this Agreement in confidence to your immediate family and to your attorneys, accountants, tax preparers and financial advisors; (b) you may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law; and (c) you may disclose this Agreement to the extent permitted by the "Protected Rights" Section above or in furtherance of your rights under Section 7 of the National Labor Relations Act, if applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12. NON-DISPARAGEMENT.** Except to the extent permitted by the "Protected Rights" Section above, you agree not to disparage the Company, its officers, directors, employees, shareholders, parents, subsidiaries, affiliates, and agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation, including but not limited to communications on social media such as Facebook, X, LinkedIn, Glassdoor, blogs, by text or email or other electronic means; provided that you may respond accurately and fully to any request for information if required by legal process or in connection with a government investigation. In addition, nothing in this provision or this Agreement prohibits or restrains you from making disclosures protected under the whistleblower provisions of federal or state law or from exercising your rights to engage in protected speech under Section 7 of the National Labor Relations Act, if applicable. In response to any reference request from a prospective employer, the Company will only confirm your dates of employment and positions held.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**13. NO VOLUNTARY ADVERSE ACTION.** You agree that you will not voluntarily (except in response to legal compulsion or as permitted under the section of this Agreement entitled "Protected Rights") assist any person in bringing or pursuing any proposed or pending litigation, arbitration, administrative claim or other formal proceeding against the Company, its parent or subsidiary entities, affiliates, officers, directors, employees or agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**14. COOPERATION.** You agree to reasonably cooperate with the Company regarding the transition of your business matters handled while employed by the Company. This cooperation includes, but is not limited to, signing any necessary documents for the assignment of inventions or other intellectual property and any other documents required to secure intellectual property protection developed during your employment. In addition, you agree to cooperate fully with the Company in connection with its actual or contemplated defense, prosecution, or investigation of any claims or demands by or against third parties, or other matters arising from events, acts, or failures to act that occurred during the period of your employment by the Company. Such cooperation includes, without limitation, making yourself available to the Company upon reasonable notice, without subpoena, to provide complete, truthful and accurate information in witness interviews, depositions, and trial testimony. The Company will reimburse you for reasonable out-of-pocket expenses you incur in connection with any such cooperation (excluding foregone wages) and will make reasonable efforts to accommodate your scheduling needs.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**15. NO ADMISSIONS.** You understand and agree that the promises and payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**16. REPRESENTATIONS.** You hereby represent that you have: been paid all compensation owed and for all hours worked; received all leave and leave benefits and protections for which you are eligible pursuant to the Family and Medical Leave Act or other applicable law or regulations; and not suffered any on-the-job injury for which you have not already filed a workers' compensation claim.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**17. DISPUTE RESOLUTION.** You and the Company agree that any and all disputes, claims, or controversies of any nature whatsoever arising from, or relating to, this Agreement or its interpretation, enforcement, breach, performance or execution, your employment or the termination of such employment (including, but not limited to, any statutory claims) shall be resolved, pursuant to the Federal Arbitration Act, 9 U.S.C. §1-16, and to the fullest extent permitted by law, by final, binding and confidential arbitration in San Francisco, California (or another mutually acceptable location) conducted before a single neutral arbitrator by JAMS, Inc. ("***JAMS***") or its successor, under the then applicable JAMS Arbitration Rules and Procedures for Employment Disputes (available at <u>http://www.jamsadr.com/rules-employment-arbitration/</u>). **By agreeing to this arbitration procedure, both you and the Company waive the right to have any claim resolved through a trial by jury or judge.** You will have the right to be represented by legal counsel at any arbitration proceeding, at your own expense. This paragraph shall not apply to any action or claim that cannot be subject to mandatory arbitration as a matter of law, to the extent such claims are not permitted by applicable law to be submitted to mandatory arbitration and the applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the "***Excluded Claims***"). In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be publicly filed with a court, while any other claims will remain subject to mandatory arbitration. You acknowledge and agree that proceedings of any non-individual claim(s) under the California Private Attorneys General Act ("***PAGA***"), if applicable, that may be brought in court shall be stayed for the duration and pending a final resolution of the arbitration of any individual PAGA claim. The arbitrator shall have sole authority for determining if a claim is subject to arbitration, and any other procedural questions related to the dispute and bearing on the final disposition. In addition, the arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be available under applicable law in a court proceeding; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator's essential findings and conclusions on which the award is based. The Company shall pay all arbitration administrative fees in excess of the administrative fees that you would be required to pay if the dispute were decided in a court of law. Nothing in this Agreement shall prevent you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. You hereby consent to the personal jurisdiction and venue of the state and federal courts in and for San Mateo county for any court action brought pursuant to this Section.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**18. MISCELLANEOUS.** This Agreement, including its exhibit(s), constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter. It is entered into without reliance on any promise or representation,

------

written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified by the court so as to be rendered enforceable to the fullest extent permitted by law, consistent with the intent of the parties. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the state in which you primarily worked for the Company. Any ambiguity in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and electronic or facsimile signatures will suffice as original signatures.

If this Agreement is acceptable to you, please sign below and return the original to me. You have forty-five (45) calendar days to decide whether to accept this Agreement, and the Company's offer contained herein will automatically expire if you do not sign and return it within that timeframe.

We wish you the best in your future endeavors.

Sincerely,

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Halley Gilbert** |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Chief Legal Officer** |

---

**I ACKNOWLEDGE THAT I HAVE THE RIGHT TO CONSULT AN ATTORNEY REGARDING THIS AGREEMENT, THAT I WAS GIVEN A REASONABLE TIME PERIOD TO DO SO, AND THAT I HAVE READ, UNDERSTAND AND AGREE FULLY TO THE FOREGOING AGREEMENT:** 

---

| |
|:---|
| **Anup Radhakrishnan** |
| Date |

---

------

**EXHIBIT A** 

**DISCLOSURE UNDER TITLE 29 U.S. CODE SECTION 626(f)(1)(H)** 

---

| | |
|:---|:---|
| ***Confidentiality Provision:*** | *The information contained in this document is private and confidential. You may not disclose this information to anyone except your professional advisors.* |

---

CARGO Therapeutics, Inc. (the "**Company**") is conducting a reduction in force, with separations being made between May 19, 2025 and November 13, 2025. As part of that reduction in force, all employees selected for separation are being given the opportunity to accept a severance package, in exchange for a separation and release agreement.

A decisional unit of all US-based employees was considered for separation. The factors used to determine eligibility for the reduction are the Company's assessment of its current and projected business and cost-reduction needs; the Company's projected pipeline; plans for various of its business functions; ability for certain functions to be absorbed by others; non-essential, surplus and redundant positions and/or services; and individual employee job performance, skill sets, experience, education and training. Not all factors were considered to make every selection.

In compliance with the Older Workers Benefit Protection Act, the following charts show the job titles and ages of each employee in this decisional unit that was and was not selected for the reduction in force.

All eligible employees who have attained the age of 40 years or older will receive this disclosure and have up to forty-five (45) days to review the terms and conditions of the severance package and seven (7) days to revoke the release of claims under the Age Discrimination in Employment Act of 1967, as amended.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> **EMPLOYEES SELECTED FOR THE REDUCTION IN FORCE AND ELIGIBLE FOR THE SEVERANCE**<br> **PROGRAM** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> **EMPLOYEES SELECTED FOR THE REDUCTION IN FORCE AND ELIGIBLE FOR THE SEVERANCE**<br> **PROGRAM** |
| &nbsp;&nbsp;&nbsp;JOB TITLE | AGE |
| &nbsp;&nbsp; Director, Contract Operations | 55 |
| &nbsp;&nbsp; Senior Research Associate, Process Development | 24 |
| &nbsp;&nbsp; Senior Scientist, Translational Medicine | 47 |
| &nbsp;&nbsp; Senior Director, IT Applications | 35 |
| &nbsp;&nbsp; Senior Director, Clinical Scientist | 51 |
| &nbsp;&nbsp; Associate Director, Discovery Research | 35 |
| &nbsp;&nbsp; Director, CMC Regulatory | 40 |
| &nbsp;&nbsp; Accounts Payable Manager | 51 |
| &nbsp;&nbsp; President and Chief Executive Officer | 58 |
| &nbsp;&nbsp; Vice President, Process Sciences | 45 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp; People Operations Manager | 32 |
| &nbsp;&nbsp; Senior Director, Clinical Quality & Risk Management | 54 |
| &nbsp;&nbsp; Associate Director, CMC Technical | 32 |
| &nbsp;&nbsp; Director, Gene Delivery Technical Development | 61 |
| &nbsp;&nbsp; Manager, Payroll and Equity | 38 |
| &nbsp;&nbsp; Associate Scientist, Process Development | 28 |
| &nbsp;&nbsp; Director, External Manufacturing | 36 |
| &nbsp;&nbsp; Director of Safety Operations | 37 |
| &nbsp;&nbsp; Senior Manager, Accounting | 35 |
| &nbsp;&nbsp; Clinical Trial Associate | 25 |
| &nbsp;&nbsp; Principal Scientist, Analytical Development | 40 |
| &nbsp;&nbsp; Associate Director, External Manufacturing | 28 |
| &nbsp;&nbsp; Chief Technical Officer | 57 |
| &nbsp;&nbsp; Supervisor, Lab Operations | 29 |
| &nbsp;&nbsp; Chief Legal Officer | 55 |
| &nbsp;&nbsp; Senior Director, Corporate Counsel | 38 |
| &nbsp;&nbsp; Vice President, Clinical Operations | 53 |
| &nbsp;&nbsp; Principal Engineer, Process Development | 38 |
| &nbsp;&nbsp; Administrative Project Manager | 55 |
| &nbsp;&nbsp; Senior Director, External Manufacturing | 36 |
| &nbsp;&nbsp; Vice President, Intellectual Property & Transactions | 56 |
| &nbsp;&nbsp; Associate Director, Biomarker Operations | 49 |
| &nbsp;&nbsp; Scientist I | 62 |
| &nbsp;&nbsp; Senior Scientist, Process Development | 38 |
| &nbsp;&nbsp; Senior Director, Quality Assurance and Systems | 55 |
| &nbsp;&nbsp; Senior Engineer II | 35 |
| &nbsp;&nbsp; Director, Quality Operations | 43 |
| &nbsp;&nbsp; Associate Director, Lab Operations | 34 |
| &nbsp;&nbsp; Director, Corporate Business Operations | 36 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp; Senior Scientist | 34 |
| &nbsp;&nbsp; Scientist, Discovery | 29 |
| &nbsp;&nbsp; Vice President, Regulatory Affairs | 48 |
| &nbsp;&nbsp; Chief Medical Officer | 60 |
| &nbsp;&nbsp; Chief People Officer | 54 |
| &nbsp;&nbsp; Director, MSAT | 35 |
| &nbsp;&nbsp; Scientist I | 30 |
| &nbsp;&nbsp; Research Associate | 29 |
| &nbsp;&nbsp; Vice President, CMC Regulatory | 46 |
| &nbsp;&nbsp; Senior Scientist | 39 |
| &nbsp;&nbsp; Assistant Controller | 51 |
| &nbsp;&nbsp; Corporate Controller | 41 |
| &nbsp;&nbsp; Vice President, Corporate Strategy & Business Operations | 47 |
| &nbsp;&nbsp; Head MSAT | 36 |
| &nbsp;&nbsp; Senior Director, HRBP & People Operations | 36 |
| &nbsp;&nbsp; Chief Scientific Officer | 44 |
| &nbsp;&nbsp; Senior Director, Process Sciences Late Stage Development | 40 |
| &nbsp;&nbsp; Chief Operating Officer and Chief Financial Officer | 45 |
| &nbsp;&nbsp; Scientist, Discovery Research | 29 |
| &nbsp;&nbsp; Senior Research Associate, Process Development | 24 |
| &nbsp;&nbsp; Vice President, CMC Strategy & Operations | 38 |
| &nbsp;&nbsp; Senior Director, R&D FP&A | 35 |
| &nbsp;&nbsp; Director, Vector MSAT | 37 |
| &nbsp;&nbsp; Senior Manager, Supply Chain Network Planner | 38 |
| &nbsp;&nbsp; Associate Director, Pre-Clinical Research | 47 |
| &nbsp;&nbsp; Senior Director, Statistical Programming | 50 |
| &nbsp;&nbsp; Senior Director, FP&A | 39 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp; Sr. Director, Head of Investor Relations, Public Relations & ESG | 41 |
| &nbsp;&nbsp; Senior Medical Director | 41 |
| &nbsp;&nbsp; Senior Vice President, Finance | 48 |
| &nbsp;&nbsp; Director, Head of Clinical Pharmacology Translational Medicine | 42 |
| &nbsp;&nbsp; Director, Clinical Operations | 51 |
| &nbsp;&nbsp; Director of Facilities | 42 |
| &nbsp;&nbsp; Vice President, Head of IT | 55 |
| &nbsp;&nbsp; Associate Director, Analytical Development | 38 |
| &nbsp;&nbsp; Administrative Business Partner | 35 |
| &nbsp;&nbsp; Senior Director, Procurement | 44 |
| &nbsp;&nbsp; Principal Scientist | 43 |
| &nbsp;&nbsp; Scientist, Discovery Research | 30 |
| &nbsp;&nbsp; Senior Scientist, Analytical Development | 34 |
| &nbsp;&nbsp; Senior Director, Business Development | 36 |
| &nbsp;&nbsp; IT Infrastructure, Operations & Security Senior Manager | 48 |
| &nbsp;&nbsp; Vice President, Data Sciences | 48 |
| &nbsp;&nbsp; Associate Director, Discovery Research | 34 |
| &nbsp;&nbsp; Senior Director, Head of Preclinical Research | 51 |

---

------

**Exhibit B** 

**Separation Date Release** 

**(To be signed and returned on or no later than 45 days after the Separation Date)** 

In consideration for the benefits provided to me by CARGO Therapeutics, Inc. (the "Company") pursuant to the terms of the transition period and separation agreement offer to which this Separation Date Release exhibit is attached (the "Agreement"), including without limitation the Severance Payment (as defined in the Agreement), I agree to the terms below.

I hereby generally and completely release the Company, and its affiliated, related, parent and subsidiary entities, and its and their current and former directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates, and assigns, both individually and in their business capacities, from any and all claims, liabilities, demands, causes of action, and obligations, both known and unknown, asserted or unasserted, arising from or in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date I sign this Release.

This general release includes, but is not limited to: (i) all claims arising from or in any way related to my employment with the Company or the termination of that employment; (ii) all claims related to my compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership, equity, or profits interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys' fees, or other claims arising under the federal Civil Rights Act of 1964, the federal Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act ("**ADEA**"), the California Labor Code, the California Family Rights Act, the California Fair Employment and Housing Act, the Massachusetts Fair Employment Practices Act (M.G.L. c. 151B), the Massachusetts Equal Rights Act, the Massachusetts Equal Pay Act, the Massachusetts Privacy Statute, the Massachusetts Sick Leave Law, the Massachusetts Civil Rights Act, the Massachusetts overtime regulations (M.G.L. c. 151 sections 1A and 1b), and the Massachusetts Meal Break regulations (M.G.L. c. 149 sections 100 and 101.), all as amended and as applicable. **I acknowledge that I have been advised, consistent with California Government Code Section 12964.5(b)(4), that I have the right to consult an attorney regarding this Release and that I was given a reasonable time period of at least five (5) business days in which to do so.** I further acknowledge and agree that, in the event I sign this Release prior to the end of the reasonable time period provided by the Company, my decision to accept such shortening of time is knowing and voluntary and is not induced by the Company through fraud, misrepresentation, or a threat to withdraw or alter the offer prior to the expiration of the reasonable time period, or by providing different terms to employees who sign such an agreement prior to the expiration of the time period.

I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I have under the ADEA, and that the consideration given for the waiver and releases I have given in this Release is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised, as required by the ADEA, that: (i) my waiver and release does not apply to any rights or claims arising after the date I sign this Release; (ii) I should consult with an attorney prior to signing this Release (although I may choose voluntarily not to do so); (iii) I have had at

------

least forty-five (45) days to consider this Release (although I may choose voluntarily to sign it sooner); (iv) I have seven (7) days following the date I sign this Release to revoke this Release (in a written revocation sent to the Company); and (v) this Release will not be effective until the date upon which the revocation period has expired, which will be the eighth day after I sign this Release provided that I do not revoke it (the "**Effective Date**"). **I also hereby further acknowledge that the Company has me you with the ADEA disclosure information (under 29 U.S.C. § 626(f)(1)(H)), attached as <u>E</u><u>xhibit</u><u> </u><u>A</u>** to the Agreement**.**

In giving the release herein, which includes claims which may be unknown to me at present, I acknowledge that I have read and understand Section 1542 of the California Civil Code, which reads as follows: **"A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party."** I hereby expressly waive and relinquish all rights and benefits under that section and any law of any other jurisdiction of similar effect with respect to my release of claims herein, including but not limited to my release of unknown claims.

Notwithstanding the foregoing, I am not releasing the Company hereby from: (i) any obligation to indemnify me pursuant to the Articles and Bylaws of the Company, any valid fully executed indemnification agreement with the Company, applicable law, or applicable directors and officers liability insurance; (ii) any claims that cannot be waived by law; or (iii) any claims for breach of this Release or the Agreement.

I understand that nothing in this Release or the Agreement limits my ability to file a charge or complaint with the Government Agencies. I further understand this Release and the Agreement do not limit my ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. While this Release and the Agreement do not limit my right to receive a government-issued award for information provided to any Government Agency in connection with a government whistleblower program or protected whistleblower activity, I understand and agree that, to maximum extent permitted by law, I am otherwise waiving any and all rights I may have to individual relief based on any claims that I have released and any rights I have waived by signing this Release or the Agreement. Nothing in this Release or the Agreement prevents me from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that I have reason to believe is unlawful. Furthermore, nothing in this Release or the Agreement waives any rights I may have under Section 7 of the National Labor Relations Act (subject to the release of claims set forth herein).

---

| |
|:---|
| <br> **Anup Radhakrishnan** |
| Date |

---